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 Group 2 allergens from dust mites cause allergies in >60% of dust mite 
sensitized individuals. Der p 2 was the most allergenic of the eight group 2 allergens 
tested in individuals from two populations (Singaporean and Italian). Following this 
observation, the IgE epitopes of Der p 2 were characterized in the same populations 
using single alanine site directed mutants of Der p 2. Three mutants (E25A, E102A 
and K96A) showing consistent reduced IgE reactions compared to wild type Der p 2 
were then evaluated for their efficacy as hypoallergen vaccine candidates. Mutants 
E102A and K96A (which resulted in an unfolded protein) were potential hypoallergen 
vaccine candidates as they demonstrated reduced IgE reaction, no skin prick reactivity, 
the ability to elicit blocking IgG antibodies and stimulation of T cell proliferation. 
 The biochemical function(s) of group 2 allergens are unknown to date. To aid 
the elucidation of their function, the ligand of Der p 2 was characterized. Structural 
analysis of Der p 2 and close homologues indicate a hydrophobic cavity with potential 
for lipid binding. Using biochemical assays, cholesterol is the preffered ligand of Der 
p 2 among 11 structurally similar sterols and other lipids, including glycerolipids, 
glycerophospholipids and sphingiolipids. Cholesterol was also found in the lipid 
extract of native and recombinant Der p 2 using tandem mass spectrometry. Site 
directed mutagenesis of selected amino acid residues lining the cavity of Der p 2 was 
used to investigate their role in cholesterol binding. Alanine mutation of eleven amino 
acid residues lining the cavity of Der p 2 did not show a significant change in 
cholesterol binding when compared to wild type Der p 2. In silico docking studies 
showed multiple binding orientations of cholesterol within the cavity of Der p 2, 
suggesting promiscuity in lipid recognition.  
 xx
In addition, a new allergen, Der f 22 was isolated and characterized. This 
allergen showed 32% amino acid sequence identity to the group 2 allergen from D. 
farinae, Der f 2. The full length sequence of Der f 22 coded for 155 amino acids, with 
a 20 amino acid signal peptide, and 6 cystein residues. Both Der f 2 and Der f 22 
belong to the MD-2 related lipid recognition domain family, and was shown to bind to 
cholesterol at equal intensities. Der f 22 and Der f 2 have similar gene organization 
(one intron and two exons). Both Der f 22 and Der f 2 genes are present as single 
copy genes as shown by Southern Blot analysis. Fifty percent of the dust mite allergic 
individuals showed IgE reactivity to Der f 22, and these reactions were not cross 
reactive with that of Der f 2. The low sequence identity, but functional similarities 
(staining at gut region of D. farinae and cholesterol binding) between Der f 22 and 




Chapter 1: Introduction 
 




Allergy affects more than 25% of the world population and the prevalence of 
this disease increases annually (Casolaro et al., 1996; Walker and Zuany-Amorim, 
2001). Allergic rhinitis, asthma, conjunctivitis, dermatitis and anaphylactic shock are 
examples of immediate symptoms resulting from allergic reactions (Beaven and 
Metzger, 1993; Turner and Kinet, 1999). An estimated 100 – 150 million people 
suffer from allergic asthma, and 180 000 die from this disease annually (Sly, 1999). In 
terms of economics, approximately US$12.7 billion is spent on medical expenditure 
for treatment of asthma annually (Weiss and Sullivan, 2001).  
Patients having allergies are characterized by increased IgE production upon 
exposure to normally non-harmful antigens from dust mites, food, fungi, pollen grains 
and animal dander (Kay, 1997). Although the causes of allergies are not known, 
atopic individuals (persons with allergic heredity) are at a higher risk of sensitization 
and allergic diseases (Casolaro et al., 1996). According to the classification by 
Coombs and Gell  allergy isa type I hypersensitivity reaction. Most allergens are 
proteins (or glycoproteins), usually 5-80 kDa in size, and are highly immunogeic 
(Valenta and Kraft, 2001). The immediate symptoms of allergies are caused by the 
cross-linking of the IgE antibodies which are bound to mast cells upon allergen 
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exposure, resulting in the release of inflammatory mediators, such as histamine and 
leukotriene (Beaven and Metzger, 1993; Turner and Kinet, 1999). 
In atopic individuals, the first step in IgE mediated allergic disease is 
sensitization (Figure 1.1). After initial allergen exposure, the antigen presenting cells 
(APC)  process and present the fragmented allergen peptides on their MHC (major 
histocompatibility complex) II molecules. The allergen fragments are then recognized 
by the T- cell receptor (TCR), in the context of MHC II. T-helper cells (Th) can be 
classified into two populations, based on the cytokines that they produce (Romagnani, 
1991). Th1 cells produce interleukin 2 (IL-2), tumor necrosis factor-β (TNF-β) and 
interferon-γ (IFN-γ), while Th2 cells produce IL-4, IL-5 and IL-13 cytokines. IL-4 
and IL-13 promote Ig isotype switching from IgG to IgE in B-cells (Pene et al., 1988; 
Punnonen et al., 1993) and IL-5 plays an important role in the growth, differentiation 
and recruitment of eosinophils to the site of allergic reaction (Romagnani, 1991). B 
cells secrete IgE which then binds to the high affinity FсεRI receptor on mast cells. 
Re-exposure to the allergen leads to binding to and cross-linking of allergen specific 
IgE on the surface of the mast cell. This results in the degranulation of mast cells, 
releasing pre-formed inflammatory mediators such as histamine, leukotrine and 
cytokines (IL-4, IL-5 and IL-13) (Kinet, 1999) which initiates the early phase allergic 
reaction that appears within minutes of allergen exposure. Examples of the resulting 
symptoms of allergies are asthma, rhinitis and conjunctivitis (Valenta, 2002). The late 
phase reaction occurs 2-24 hours after allergen exposure, and is caused by the 
proliferation of allergen-activated Th2 cells, releasing pro-inflammatory cytokines 
that enhance eosinophil recruitment. Mediators produced by eosinophils such as 
major basic protein, eosinophil cationic protein and leukotrienes promote tissue 




Figure 1.1 A simplified overview of the allergic reaction. Antigen presenting cell 
(APC) recognizes processes and presents the allergen as on its MHC class II receptor. 
The allergen fragment is then recognized by the T cell receptor (TCR) in the context 
of MHC II. This drives the T cell to mature to Th2 cells, producing cytokines that 
stimulate IgE production, or eosinophil recruitment. Cross linking of IgE on mast 
cells causes degranulation leading to immediate hypersensitivity. 
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In a non-allergic individual, allergens are recognized and taken up by the 
APCs. The processed allergen fragment is then presented to the Th cells, stimulating 
the proliferation of mainly Th1 subtype of cells. The production of IFN-γ by the Th1 
cells (Ebner et al., 1995; Till et al., 1997), elicits the production of allergen specific 
IgG (subtypes IgG1 and IgG4) (Kemeny et al., 1989). The production of IFN-γ also 
inhibits the action of IL-4 (Pene et al., 1988), which in turn inhibits IgE production.  
 
1.1.2 Dust mites  
 
Dust mites are the most important source of allergens in the indoor 
environment (Thomas and Smith, 1999). Dust mites are small organisms, measuring 
about 0.3 mm in length, with 8 legs and are normally white to light tan in colour, 
making them almost invisible to the unaided eye. Taxonomically, they belong to the 
subclass Acari of the phylum Arthropoda. There are 5 stages in the life cycle of a dust 
mite:egg, larva, protonymph, tritonymph and adult. Female adults can lay 1-2 eggs 
per day which take a month to develop into adults, and can live for up to 3 months 
depending on the availability of food and environmental conditions such as 
temperature (23-30°C) and relative humidity (80-90%) (Colloff, 1998a).  
There are about 40, 000 mites species identified (Nathanson, 1969), but only 
about 13 species of mites have been found in house dust (Arlian et al., 2001). The 
taxonomic relationships of some of the important mites that cause allergies are shown 
in Figure 1.2. Dust mites can be broadly classified as pyroglyphid mites (mites from 
the family Pyroglyphidae) and non-pyroglyphid mites (mites from all other families, 




































PHYLUM CLASS SUBCLASS ORDER GENUSFAMILY
Suidasiidae Suidasia
 
Figure 1.2 Taxonomic classifications of common dust mites (Colloff, 1998b). 
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Non-pyroglyphid mites were formerly called storage mites because they were 
commonly found in farming environments and stored agricultural products such as 
grains. Since these mites are now found in the home indoor environment, and 
sensitization to ‘storage mites’ is not restricted to individuals with occupational 
exposure (Iversen et al., 1990), the term non-pyroglyphid is more appropriate when 
referring to this group of mites. Pyroglyphid mites feed on human skin scales while 
non-pyroglyphid mites feed mainly on plants, grains and microorganisms (Arlian et 
al., 2001). 
Nearly 40 years ago, it was observed that mites from the genus 
Dermatophagoides caused allergic reactions (Voorhorst et al., 1964). Othersuch as 
Euroglyphus maynei and Blomia tropicalis have also been identified as important 
allergy causing mites in homes world wide (Arlian et al., 2002). Mite counts of more 
than 100 mites per gram of dust could be considered as risk factors for sensitization 
and asthma (Platts-Mills, 1989). Mite distribution is dependant on the climate, as 
Dermatophagoides pteronyssinus, D. farinae and E. maynei are commonly found in 
temperate climates (Arlian et al., 1992), while B. tropicalis is found in higher 
numbers in areas with tropical climates (Chew et al., 1999a; Smith et al., 1999a)The 
other common non-pyroglyphid mites within a home environment are from the genus 
Lepidoglyphus, Acarus, Glycyphagus and Tyrophagus (van Hage-Hamsten and 
Johansson, 1992). 
(Lind et al., 1988; Tovey et al., 1989; Dilworth et al., 1991; Lake et al., 1991; Kent et al., 1992; Shen et al., 1993; Yasueda et al., 
1993; Aki et al., 1994; O'Neill et al., 1994; Smith et al., 1994; Aki et al., 1995; Arruda et al., 1995; Shen et al., 1995; Fujikawa 
et al., 1996; King et al., 1996; Puerta et al., 1996; Caraballo et al., 1997; Asturias et al., 1998; Tsai et al., 1998; Epton et al., 
1999; Eriksson et al., 1999; Kawamoto et al., 1999; Mills et al., 1999; Smith et al., 1999b; Tategaki et al., 2000; Epton et al., 
2001; Eriksson et al., 2001; McCall et al., 2001; Ramos et al., 2001; Yi et al., 2002; Cheong et al., 2003; Mora et al., 2003; 
Saarne et al., 2003; Weber et al., 2003) 
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1.1.3 Dust mite allergens 
 
Dust mite allergens are grouped based on similarities in biochemical 
properties and sequence homology (WHO/IUIS, 1994). Currently, 21 groups of 
allergens have been described (Table 1.1). The allergen groups comprise of proteins 
with varied molecular weights (7.2 kDa to 177 kDa) and having diverse biological 
functions enzymes, ligand binding proteins and structural proteins (Table 1.1). 
As observed from Table 1.1, dust mite allergens vary in allergenicity (amount 
of IgE binding), with groups 1 and 2 allergens being the most potent. Most of the 
allergen groups have been identified in Dermatophagoides spp. followed by B. 
tropicalis and L. destructor. As several allergens (groups 1, 2, 7 and 10) have been 
identified in multiple mite species, it is possible that an allergen homologue can be 
found for every allergen group in all pathogenic mite species.  
The name of an allergen is made up of three parts, the first 3 letters of the 
genus, the first letter of the species, and an Arabic numeral which indicates the 
chronological order of identification (e.g. Der p 1 is the first allergen identified in D. 
pteronyssinus) (WHO/IUIS, 1994). A protein showing IgE reactivity in a minimum of 
5 patients, or >5% of the individuals tested may be regarded as an allergen 
(WHO/IUIS, 1994).  
Allergens originating from the same organism, with similar characteristics 
such as molecular weight, biological function, ≥67% amino acid sequence identity are 
regarded as isoallergens(WHO/IUIS, 1994). Polymorphisms observed in isoallergens 
are caused by nucleotide mutations which could be silent (resulting in no change in 
amino acid), or cause changes in the amino acid sequence (named variants) 
(WHO/IUIS, 1994). 
 7
Table 1.1 House dust mite allergens 
Allergen Biological function Molecular IgE binding References
groupsa weight (kDa) (%)
1 Cystein protease 25 70-90 Der f 1 (Dilworth et al., 1991),
Der p 1 (Chua et al., 1988),
Der m 1 (Lind et al., 1988),
Eur m 1 (Kent et al., 1992),
Blo t 1 (Mora et al., 2003).
2 Unknown 14 60-90 Der f 2 (Trudinger et al., 1991),
Der p 2 (Chua et al., 1990),
Tyr p 2 (Eriksson et al., 1998),
Eur m 2 (Smith et al., 1999),
Gly d 2 (Gafvelin et al., 2001),
Lep d 2 (Varela et al., 1994).
3 Trypsin 28, 30 51-90 Der f 3 (Nishiyama et al., 1995),
Der p 3 (Smith et al., 1994),
Eur m 3 (Smith et al., 1999b)b,
Blo t 3 (Cheong et al., 2003).
4 α-Amylase 57, 60 25-46 Der p 4 (Lake et al., 1991),
Der p 4 & Eur m 4 (Mills et al., 1999)
5 Unknown 15 9-70 Der p 5 (Tovey et al., 1989),
Blo t 5 (Arruda et al., 1995),
Lep d 5 (Eriksson et al., 2001).
6 Chymotrypsin 25 30-40 Der f 6 (Kawamoto et al.,1999),
Der p 6 (Yasueda et al., 1993).
7 Unknown 22-31 50-60 Der p 7 (Shen et al., 1993),
Der f 7 (Shen et al., 1995),
Lep d 7 (Eriksson et al., 2001).
8 Glutathione-S-transferase 26 40 Der p 8 (O'Neill et al., 1994).
9 Collagenolytic serine protease 30 >90 Der p 9 (King et al.,1996).
10 Tropomyosin 33-37 5-80 Der p 10 (Asturias et al., 1998),
Der f 10 (Aki et al., 1995),
Blo t 10 (Yi et al., 2002),
Lep d 10 (Saarne et al., 2003).
11 Paramyosin 92, 98, 110 80 Der f 11 (Tsai et al., 1998),
Der p11 (Tategaki et al., 2000),
Blo t 11 (Ramos et al., 2001).
12 Unknown 14 50 Blo t 12 (Puerta et al., 1996).
13 Fatty acid binding protein 14,15 10-23 Blo t 13 (Caraballo et al., 1997),
Lep d 13 (Eriksson et al., 2001),
Aca s 13 (Eriksson et al., 1999).
14 Apolipophorin 177 30c, 39d, 70e Der f 14 (Fujikawa et al., 1996),
Eur m 14 (Epton et al., 1999),
Der p 14 (Epton et al., 2001).
15 98kDa chitinase 98 70 Der f 15 (McCall et al., 2001).
16 Gelsolin-like protein/villin 53 35 Der f 16 (Tategaki et al., 2000).
17 Ca binding EF-hand 53 35 Der f 17 (Tategaki et al., 2000)
18 60kDa chitinase 60 54 Der f 18 (Weber et al., 2003)
19 Anti-microbial peptide homologue 7.2 - Blo t 19b
20 Arginine kinase 40 - Der p 20b
21 Unknown 14 - Der p 21b
Mag 29f Heat shock protein 70kDa 70 10 Der f (Aki et al., 1994)  
 
Species name of dust mites: Der f (D. farinae), Der p (D. pteronyssinus), Der m (D. 
microceras), Eur m (Euroglyphus maynei), Tyr p (Tyrophagus putrescentiae),  
Lep d (Lepidoglyphus destructor), Gly d (Glycyphagus domesticus),  
Blo t (Blomia tropicalis), and Aca s (Acarus siro). 
aListed in the WHO/IUIS list of allergens as of June 2006 (http://www.allergen.org 
/List.htm) 
b Unpublished but sequence data available in WHO/IUIS list of allergens or GenBank. 
c Data for Mag allergen 
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d Data for recombinant Mag 3 allergen 
e Data for natural Mag 3 allergen 
f Not listed in WHO/IUIS list of allergens but published and sequence data is 
available in GenBank. 
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Nomenclature of isoforms is designated by 4 Arabic numerals, following the 
allergen name. The first 2 numerals (01-99) refer to a particular isoallergen and the 2 
subsequent numerals (01-99) refer to a particular variant of the isoallergen. Allergen 
isoforms have been identified in group 1 (Der p 1) (Chua et al., 1988), group 2 
(Schmidt et al., 1995; Chua et al., 1996; Yuuki et al., 1997), group 3 (Smith and 
Thomas, 1996b; Smith and Thomas, 1996a) and group 5 allergens (Der p 5) (Lin et al., 
1994). The effects of polymorphism on the allergenicity (IgE reactivity) and 
antigenicity (T-cell response) of dust mite allergens have not been widely studied. 
Among the group 2 allergen isoforms, polymorphic forms of Lep d 2 show 
comparable in vitro IgE reactivity (Olsson et al., 1998), while isoforms of Der p 2 
display differences in T cell proliferation and cytokine production (Hales et al., 2002).  
Dust mite allergens are found mainly in the fecal material of dust mites 
(Tovey et al., 1981), and have been detected in almost all areas within a home 
environment. Early studies on dust mite allergy have focused on finding a link 
between the amounts of allergen present in the indoor environment, and the risk of 
sensitization. A threshold exposure 2 μg allergen per gram dust for Der p 1 and/or Der 
f 1 can be considered as a risk factor for sensitization to mites and bronchial hyper-
reactivity (Lau et al., 1989; Arruda et al., 1991). In atopic individuals, exposure to 
≥10 µg/g dust of group 1 allergens was found to be a risk factor for both sensitization 
and asthma development (Sporik et al., 1990). 
Allergens belonging to the same group are often found to be cross reactive, 
especially when they come from taxonomically related mites (Ferrandiz and Dreborg, 
1997; Smith et al., 2001b). Two allergens are cross reactive if a single antibody (or T 
cell receptor) reacts to both (Aalberse et al., 2001). Most studies on cross-reactivity 
have been done on group 2 allergens, as it is the most widely represented allergen. 
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Group 2 allergens from pyroglyphid mites have shown low degree of cross reactivity 
to allergens of non-pyroglyphid mites (Gafvelin et al., 2001; Smith et al., 2001b).  
Cross reactivity in unrelated allergens from diverse animal and plant species 
have also been observed, and such allergens are termed pan-allergens. Examples of 
pan allergens are tropomyosins, profilins and arginine kinase (Aalberse et al., 2001; 
Binder et al., 2001). Tropomyosins are highly conserved proteins demonstrating 
cross-reactivity across organisms that are phylogenetically diverse, such as dust mites 
(Reese et al., 1999), cockroaches (Arruda, 2005), and marine crustaceans such as 
lobsters, shrimp and crab (Reese et al., 1999). Understanding the molecular basis of 
cross reactivity is of clinical relevance because sensitization to a single cross-reacting 
allergen can cause an individual to react to other homologous allergens, even without 
prior sensitization, intensifying their allergies.  
 The biochemical functions of many of the dust mite allergens are known, but 
the functions of certain allergen groups, such as group 2, 5, 7 and 13 are unknown. 
Der p 1 (a cystein protease) has been shown to cause disruption of intercellular tight 
junctions (Wan et al., 1999) and apoptosis of epithelial cells (Baker et al., 2003) 
which facilitates Der p 1 to cross the epithelial barrier, explaining why it is such a 
potent allergen. Group 2 allergens have been widely characterized in terms of 
allergenicity, but information on their biochemical function is still lacking. The 
structures of Der p 2 and Der f 2 (Ichikawa et al., 1998; Derewenda et al., 2002; 
Ichikawa et al., 2005) have provide several clues to aid the elucidation of their 
possible functions. Group 2 allergens belong to the ML (MD-2 related lipid 
recognition domain) family (Inohara and Nunez, 2002; Johannessen et al., 2005). 
Members of this family are involved in diverse biological pathways through 
interaction with lipids. In this study, the identification of the lipid ligand of Der p 2, a 
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group 2 dust mite allergen is described. Currently, there is no strong link between the 
biochemical function and allergenicity. 
 
1.1.4 Immunotherapy as a treatment for allergic diseases 
 
Pharmacological agents such as corticosteroids and cyclosporin act as anti-
inflammatory agents and are normally used to treat type 1 allergy (Valenta, 2002). 
Specific immunotherapy (SIT) currently represents a curative form of treatment for 
allergies that is able to prevent the progression of the disease (Bousquet et al., 1998; 
Durham et al., 1999). SIT induces a state of immune unresponsiveness which is 
achieved by the administration of increasing doses of allergens to the allergic patient 
(Durham and Till, 1998; Valenta, 2002). Allergen SIT was first introduced in 1911, 
by Noon (Noon, 1911). He immunized patients having pollen-induced hayfever with 
subcutaneous injections of pollen extracts, and the protection from this therapy lasted 
for up to one year after the discontinuation of treatment. Although clinical studies on 
SIT have shown it to be effective in treating and reducing the symptoms of allergies, 
the underlying immunological mechanisms involved are poorly understood (Bousquet 
et al., 1998; Durham and Till, 1998).  
Currently, allergen extracts which are used for immunotherapy are prepared 
from natural allergen sources. These extracts are made up of allergenic and non- 
allergenic proteins. The composition of these extracts is not well defined in terms of 
types of proteins and their corresponding concentrations in the extracts (Bousquet et 
al., 1998). This is due to the variations in the content of crude allergen extracts from 
differing extraction methods andthe choice of allergen source (Esch, 1997). Based on 
allergen immunoassays using recombinant allergens, it is shown that each allergic 
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patient has a unique reaction profile to allergens originating from the same source 
(Valenta et al., 1999). By using allergen extracts, there is a risk of creating new 
sensitizations against allergens which the patient was not previously sensitized to 
(Ball et al., 1999; Moverare et al., 2002). Another problem could be that the allergen 
extract lacks the specific allergen that the patient is sensitized to (due to degradation, 
or extraction method) and thus immunotherapy with that extract would not be 
successful (van Hage-Hamsten and Valenta, 2002) 
The use of purified recombinant allergens would be able to overcome the 
mentioned limitations of heterogeneous natural allergen extracts. Nevertheless, since 
recombinant allergens are normally comparable to their native counterparts in terms 
of immunogenicity and biological activity (Valenta and Kraft, 1995; Valenta et al., 
1998), there is still a risk of adverse reactions, for instance asthmatic attacks or 
systemic anaphylactic shock post treatment, that can potentially be fatal. These 
problems stem from the recognition of the allergen by IgE. Several strategies to create 
allergen derivatives that do not elicit an allergenic response (or hypoallergens) for 
immunotherapy have been reported. These include recombinant allergens with 
reduced allergenic activity (IgE reaction), and preserved T cell epitopes (Linhart and 
Valenta, 2005). Structurally modified allergens can be prepared using a variety of 
methods: allergen fragments (Vrtala et al., 1997; Zeiler et al., 1997), disrupting 
allergen structure by breaking disulfide bridges via cystein mutation (Smith and 
Chapman, 1996; Takai et al., 1997), peptides containing T-cell (Muller et al., 1998) 
or B-cell epitopes (Focke et al., 2001) or chemical modification of allergens (Sehon, 
1991). Successful SIT is associated with decreased ex vivo T cell allergen specific 
proliferation, reduced ratio of Th2 cytokine (IL-4, IL-5, IL-13) production compared 
to Th1 (IFN-γ), increased production of IL-10, and increased ratio of allergen specific 
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IgG4 to IgE in serum (Akdis and Blaser, 2001; Gabrielsson et al., 2001; Eusebius et 




This thesis focuses on group 2 dust mite allergens- from the isolation of new 
allergens, characterization of their IgE reactivity and cross reactivity, epitope mapping 
of Der p 2 and finally evaluation of hypoallergen vaccine candidates. Using 
biochemistry based assays the ligand of group 2 allergens was identified in aid of 
future studies to elucidate its biochemical function(s). A new allergen, Der f 22 which 
is similar to Der f 2 in terms of allergenicity and ligand binding, but having low 
sequence homology, was identified and characterized. 
 
The specific aims of this study are: 
1. To characterize the IgE reactivity, and cross reactivity of group 2 dust mite 
allergens. 
2. To clone, express and characterize Der f 22, a putative paralogue of Der f 2 in 
terms of IgE reactivity and cross reactivity, characterization of their genes, 
immuno-localization on sections of D. farinae, and ligand binding 
experiments. 
3. To identify the ligand of Der p 2 using liposome sedimentation assays and 
specific lipid-ELISA, and mass spectrometry of the lipid fraction of native Der 
p 2. The possible binding site of the ligand was then evaluated using site 
directed mutagenesis, and validated with in silico docking studies. 
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4. To map the conformational IgE epitopes of Der p 2, using site directed 
mutagenesis. IgE epitope mapping was performed using direct human IgE 
binding, with serum from two populations, representing exposure to different 
mite fauna. 
5. To characterize hypoallergen vaccine candidates using sera from dust mite 
allergic individuals. Hypoallergen candidates are tested for reduced IgE 
reactivity, reduced in vivo histamine release, ability to induce ‘blocking’ IgG, 
retained T cell proliferation ability, and cytokine release profile. 
 15
Chapter 2: Materials and methods 
 
2.1 Cloning, mutagenesis, DNA sequencing and gene characterization 
 
2.1.1 Sub-cloning and site-directed mutagenesis 
 
DNA encoding for allergens were amplified from cDNA of the respective dust mites 
using primers with BamH I and Eco R I restriction sites. Both amplified DNA and 
modified pET-32a plasmid (Novagen) were digested with the restriction enzymes, 
ligated and transformed into DH5-α competent cells. Colonies were randomly 
selected and the sequence of the insert was verified by DNA sequencing (Big Dye 
v3.1, Applied Biosystem). Mutant constructs were generated using the Quikchange® 
kit (Statagene) with primers containing mismatches to code for alanine. Correct 
substitutions were verified by DNA sequence analysis. Mutated DNA insert was sub-
cloned in the same manner as wild type allergens. Sequences of primers used are 
listed in Appendix I. 
 
2.1.2 RT-PCR of putative Blo t 2 using degenerate primers 
 
First strand cDNA was synthesized using SMARTTM RACE cDNA amplification kit 
(CLONTECH Laboratories, USA) with 1 µg B. tropicalis RNA as template. 
Degenerate primers designed based on the conserved regions of group 2 allergens 
(Blo t 2F, 5’-GMTGCCAACCARRACWC-3’ and Blo t 2R, 5’-
CGCADGCBAANACACCRTKVTC-3’) were used to amplify a fragment of Blo t 2. 
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Based on the sequence of the amplification product, specific primers were designed 
and used for 5’ and 3’ random amplification of cDNA ends (RACE). The sequences 
of the RACE products were used to design primers to amplify the full length cDNA of 
Blo t 2. This product was then ligated to a modified pET-32a containing N-terminal 
hexa-histadine tag (Novagen) with T4 DNA ligase (Invitrogen). The plasmids were 
then transformed into the expression host, E. coli BL21.  
 
2.1.3 DNA sequencing 
 
DNA sequencing reactions were performed as suggested in the PrismTM cycle 
sequencing kits (Perkin Elmer, USA) in a 20 μL reaction mixture containing 4 µL 
terminator ready reaction mix, 500 ng DNA template and 10 picomol primer. 
Thermo-cycling profile was set for denaturation at 96°C for 30 sec, annealing at 50°C 
for 15 sec, extension at 60°C for 4 mins and repeated for 25 cycles. Cycle sequencing 
was carried out in PTC-100TM Programmable Thermal Controller (MJ Research, Inc., 
USA). Following cycle sequencing, 2 µL of 3 M sodium acetate (pH 4.6), 50 µL of 
absolute ethanol and 10 µL of sterile distilled H2O were added to the reaction mixture 
and incubated at -20°C for 15 min, followed by centrifugation for 20 mins at 13,000 x 
g. The pellet was then washed with 70% ethanol and dried before DNA sequence 
analysis. The purified extension was sequenced using Applied Biosystems 3100 
fluorescent sequencer using BigDye ver 3.1 using default parameters. 
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 2.1.4 Isolation of Blo t 2 isoforms 
 
Full length Blo t 2 was amplified from B. tropicalis cDNA using primers Blo t 2 LIC 
F: 5'- GACGACGACAAGATCATGTTCAAGTTTATCTGTCTC-3’ and Blot 2 LIC 
R: 5'-GAGGAGAAGCCCGGTTTAATCGACAACCTCGG-3' with highly 
thermostable pfu polymerase. The PCR product was purified from a 1% agarose gel, 
and annealed to pET-32(a) Ek/LIC Vector (Novagen) according to the manufacturer’s 
instructions. The recombinant pET-32(a) vectors were transformed into competent 
XL1-Blue cells (Stratagene). One hundred and forty colonies were picked, inoculated 
overnight and plasmid extracted using the QIAprep® Spin Miniprep Kit (Qiagen). 
The plasmid DNA was then submitted to double pass sequencing, and all sequences 
were analyzed using DNAMAN® (Lynnon Corporation). 
 
2.1.5 Isolation of the genomic DNA encoding for Der f 2 and Der f 22 
 
Genomic clones of Der f 2 and Der f 22 were isolated by PCR with 1 μg of genomic 
D. farinae DNA using primers Df2F_3 (5’-ATGATTTCCAAAATCTTGTGC-3’) and 
Df2R_3 (5’-TTAATCACGCATTTTAGCGTG-3’) for Der f 2 and DF975_MET (5’-
ATGAACCGATTCCTCATTGTT-3’) and EcoR1Df975R (5’-CCGGAATTCCGG 
TTAGTTTTGAAGACT-3’) for Der f 22. The amplified products were separated on a 
1% agarose gel, purified, and ligated into pGEM-T Easy vector (Promega) according 
to the manufacturer’s protocol. The plasmids were then transformed into E. coli DH5-
α competent cells, purified using QIAprep® Spin Miniprep Kit (Qiagen), and 
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sequenced with T3 (5'-GCGCGAAATTAACCCTCACTAAAG-3') and T7 (5'-
TAATACGACTCACTATAGGG-3') primers.  
 
2.1.6 Genomic DNA extraction, Southern Blot analysis and hybridization  
 
Cultured D. farinae mites were purchased from Central Science Laboratories, United 
Kingdom. Fifty milligrams of mites were homogenized using pestle and mortar with 
liquid nitrogen, until a fine powder was obtained. Genomic DNA was then extracted 
using DNeasy® kit (Qiagen), according to manufacturer’s instructions. A segment of 
DNA encoding Der f 2 and Der f 22 (217 bp and 204 bp respectively) was amplified 
by polymerase chain reaction (PCR) to be used as the hybridization probe for 
Southern blot. The amplified product was labeled with digoxigenin (DIG) using PCR 
DIG Probe Synthesis Kit (Roche Diagnostics). The labeled probes were separated on 
a 1% agarose gel and purified using QIAquick® Gel Extraction Kit (Qiagen). Six 
micrograms of D. farinae genomic DNA was digested separately to completion using 
four restriction enzymes, EcoR I, Hind III and BamH I and Msc I. The digested DNA 
was then separated by electrophoresis using 1% agarose gel. The DNA was denatured, 
and transferred to a nylon membrane (Hybond-N+, Amersham International), and 
hybridized with specific DIG labeled probes. DIG luminescent detection kit (Roche 





2.2 Protein expression, purification, CD analysis and antibody generation 
 
2.2.1 Expression and purification of wild type and mutant allergens 
 
Plasmid containing DNA insert of wild type allergens or its mutants was transformed 
into E. coli strain BL21 (DE3) for protein expression. Cultures were induced with 1.0 
mM IPTG at 20˚C for 16 hours. The bacterial cells were then collected by 
centrifugation (6000 rpm, 20 minutes), resuspended in binding buffer (5 mM 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9) with 6 M guanidine hydrochloride 
and sonicated to lyse the cells. The lysate was pelleted and the supernatant containing 
the recombinant protein was purified using Ni-NTA resin (Novagen) under denaturing 
conditions and eluted from the Ni-NTA resin using elution buffer (1 M imidazole, 
0.5M NaCl, 20 mM Tris HCl, pH 7.9) with 6 M guanidine hydrochloride. The protein 
was then refolded by rapid dilution into 50 mM sodium acetate, pH 4.6 at 4ºC. The 
refolded protein was concentrated using Amicon® Stir Cell (Millipore) using a 
molecular weight cut off membrane of 3000 Da (YM3, Millipore). Purified 
recombinant proteins were stored at 4ºC. Protein concentration was measured using 
Bradford assay, with bovine serum albumin (BSA) as the standard. 
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2.2.2 Isolation of native Blo t 2 
 
Native Blo t 2 was isolated using the SeizeTM Primary Immunoprecipitation Kit 
(Pierce) according to the manufacturer’s instructions. Briefly, rabbit polyclonal 
antibody-containing sera was coupled to the gel and incubated with 400 µL B. 
tropicalis crude protein extract. The native protein was subsequently eluted 8 times 
with 400 µL elution buffer, and all the fractions were pooled and concentrated by 
lyophilization.  
 
2.2.3 Circular dichroism (CD) spectropolarimetry 
 
Circular dichroism (CD) spectra was acquired using a J-810 Spectropolarimeter 
(Jasco) using a quartz cuvette with the path length of 1 mm. All experiments were 
conducted at room temperature, using 20 μM of protein in 50 mM sodium acetate pH 
4.6. The spectra was recorded at the resolution of 0.1 nm with a scan speed of 50 
nm/min and averaged for 10 scans from 190 to 260 nm.  
 
2.2.4 Gel Filtration 
 
Hexahistadine tag purified wild type and E102A mutant proteins of Der p 2 were 
subjected to gel filtration chromatography. Proteins (200 μL, approximately 0.5 
mg/mL) were subjected to gel filtration chromatography using a Superdex-75 column 
(Pharmacia) using a flow rate of 1 mL/min, and absorbance at 280 nm was recorded. 
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2.2.5 Generation of rabbit polyclonal antibodies 
 
Polyclonal antibodies against specific allergens were raised in New Zealand White 
Rabbits (2.5 to 3 kg). The rabbits were immunized subcutaneously with 300 μg of 
recombinant protein diluted in 500 μL of PBS mixed well with equal volume of 
Freund’s complete adjuvant (Sigma). Booster shots were given every 3 weeks with 
the same amount of recombinant protein, but mixed with incomplete Freund’s 
adjuvant (Sigma) instead. The sera collected was kept at 4oC overnight to ensure 
complete clotting, centrifuged at 3000x g for 20 mins, and stored at -20oC until use. 
 
2.3 Serum samples 
 
Consecutive serum samples from patients with clinical symptoms of allergies were 
tested. Sera from two populations, Singaporean and Italian were used in this study.  
 
2.4 Immunological assays 
 
2.4.1 Immuno dot blot  
 
For immuno dot blots, 1 μg of each recombinant protein was dotted on a 
nitrocellulose membrane (BIO-RAD Laboratories, USA) and allowed to dry at room 
temperature. The membrane was then blocked with phosphate buffered saline (PBS) 
with 0.1% Tween-20 for 1 hr. The membranes were then washed three times with 
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wash buffer (PBS-0.05% Tween-20) between each step of this assay. Membranes 
were incubated in dust mite allergic individuals’ sera overnight at 4ºC, followed by 
goat anti-human IgE conjugated with alkaline phosphatase (Sigma) diluted 1:1000 for 
2 hrs. Subsequently, membranes were incubated with NBT/BCIP (nitroblue 
tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate) (Promega). Intensities of each dot 
were measured using the Olympus MicromageTM for Windows version 3.01 
(Olympus Optical) image analysis software. IgE binding was classified based on 
optical density (OD) readings of the immuno dot blot. A reaction was classified as 
high (>100), medium (50-99), low (20-49) or negative (<20) from the maximum score 
of 255. All reactions with OD>20 (equivalent to 2 standard deviation above the mean 
of negative responses) were considered positive. For cross comparison, a standard 
curve using the human serum IgE standard (75/502), purchased from the National 
Institute for Biological Standards and Control (NIBSC), United Kingdom, was used. 
Selected positive sera identified from the immuno-dot blot screens were further 
verified using an IgE ELISA. 
 
2.4.2 Specific IgE binding ELISA  
 
Allergens were coated overnight at 4˚C onto Maxisorp microtiter plate (Nunc) at 250 
ng of protein per well. Plates were washed with PBS-T (PBS, 0.05% Tween-20) and 
blocked with PBS-0.1% Tween-20 for 1 hr at room temperature. Patients’ sera diluted 
1:10 or 1:5 in PBS was then added, and incubated at room temperature for 2.5 hrs. 
Wells were then incubated with 100 μL of biotin conjugated anti-human IgE 
monoclonal antibody (BD-Pharmingen, USA) diluted 1:250 in PBS for 2 hours. This 
was followed by a 30 min incubation with avidin conjugated HRP (BD-Pharmingen, 
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USA) diluted 1:1000 in PBS. Microtitre plates were thoroughly washed with PBS-T 
between each step. Finally, 100 μL of TMB substrate (Sigma Aldrich, USA) was 
added, and colour reaction was developed for approximately 30 mins. The reaction 
was stopped by addition of 20 μL of 1 M HCl per well, and absorbance was measured 
at 450 nm with an ELISA plate reader. All experiments were done in duplicates.  
 
2.4.3 Inhibition ELISA 
 
Maxisorp microtiter plates (Nunc) were coated overnight with 250 ng protein per well 
at 4ºC. Sera used were pre-absorbed with varied amounts of recombinant allergen. 
The plates were then washed three times with wash buffer (PBS-0.05% Tween-20) 
between each step of this assay. The plates were blocked for 1 hr with PBS-0.1% 
Tween 20, and incubated with pre-absorbed sera overnight at 4ºC. Biotin conjugated 
anti-human IgE monoclonal antibody (BD-Pharmingen, USA) was diluted 1:4000 in 
PBS and added to the wells for 2 hrs, followed by the addition of avidin conjugated 
HRP (BD-Pharmingen) diluted 1:3000 in PBS for 30 mins. The plates were washed 
six times, and 100 μL of 3,3’,5,5’-Tetramethylbenzidine (TMB) substrate was added 
to each well. The colorimetric reaction was stopped with 20 μL of 1 M HCl, and 
absorbance measured at 450 nm using an ELISA plate reader. The degree of cross 
reactivity was calculated by the percentage of inhibition based on the following 
formula: [(Iu-Ii)/(Iu-B)]x100%, where Iu represents the reaction in the absence of 
inhibitor protein, Ii the reaction at a particular inhibitor concentration, and B 
represents background intensity when the allergen was incubated with blocking 
solution instead of sera. 
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2.4.4 Histamine release assay 
 
Histamine release in heparinized whole blood and histamine ELISA was performed 
using kits from IBL-Hamburg (Germany) according to the manufacturer’s protocol. 
Whole blood was collected from two dust mite sensitized volunteers in heparinized 
tubes. Two hundred microliters of blood was then added to serial dilutions of Blo t 2 
or controls, and incubated for 1 hr at 37ºC in a water bath. Histamine release was 
halted by incubating the samples for 10 mins in an ice bath. The samples were 
centrifuged for 10 mins at 700g. 100 µL of supernatant was then used for Histamine-
ELISA. 
 
2.4.5 Dust sample collection, processing and quantification. 
 
Dust samples were collected from mattresses, kitchens, sofas, carpets and bedroom 
floors from homes in Singapore. Samplings were performed by vacuuming an area of 
1 m2 for 2 mins using a modified Kirby Classic III vacuum cleaner (Kirby Co.). Dust 
samples were sieved using a 500 μm pore size sieve. One milliliter of PBS was added 
for every 50 mg of dust sample, and incubated with shaking overnight at 4ºC. The 
samples were then centrifuged at 2500 rpm for 20 mins at 4ºC, and the supernatant 
was stored at -20ºC. One hundred microliters of individual dust sample were 
incubated overnight onto each well at 4°C on monoclonal antibody coated microtitre 
plates (Maxisorp, Nunc) after the plates were blocked with 1% bovine serum albumin 
(BSA) in PBS for 30 mins at room temperature.  The wells were then washed three 
times with PBS-0.05% Tween-20. The same washing method was used through out 
the assay. The wells were incubated overnight with 100 μl of anti-Bl t 2, anti-Der f 2 
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or anti-Der f 22 IgG at 1:5000 dilutions in PBS at 4°C. Wells were then washed and 
incubated with 1:1000 dilution of anti-rabbit IgG-conjugated horseradish peroxidase 
(BD-Pharmingen) in PBS for 3 hrs at room temperature. Wells were thoroughly 
washed before TMB (Sigma) was added. The reaction was stopped using 20 μL of 1 
M HCl and plates were read at 450 nm. Allergen levels were quantified and denoted 
as microgram of allergen per gram of fine dust (µg/g). 
 
2.4.6 Staining and immunoprobing 
 
Live D. farinae mites were embedded in paraffin and serial microtome sections (~10 
μm) were prepared. For immunoprobing, mite sections were incubated with 
polyclonal antibody raised against Der f 2 and Der f 22 allergen for 1 hr. After 
washing, alkaline phosphatase conjugated anti-rabbit IgG containing 1% BSA was 
reacted for 1 hr at room temperature. The slides were next washed with PBS and 
incubated with NBT/BCIP (Promega) for 30 mins. Blue-purple stain indicated 
positive staining. The identification of organs and the terminologies used are in line 
with the description of D. farinae reported previously (Brody et al., 1972). 
  
2.4.7 Skin prick test 
 
Skin prick test was performed using filter sterilized 0.02 mg/mL of allergen in buffer 
containing 50% glycerol. A 25 gauge sterile lancet was used to introduce the allergen 
into the dermal layer. Resulting wheal and erythema was measured after 20 mins. 
Histamine (10 mg/mL) and PBS were included as positive and negative controls 
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respectively. Skin prick results with wheal diameter of 3 mm or more were considered 
as positive results.  
2.4.8 Isolation of PBMC and measurement of proliferation upon stimulation with 
wild type or mutant allergen 
 
For peripheral blood mononuclear cell (PBMC) extraction, 3 mL of fresh blood from 
dust mite sensitized volunteers was diluted with 3 mL of PBS. The diluted blood was 
then layered gently on 3 mL of Ficoll-Hypaque solution, and centrifuged for 15 mins 
at 2000 rpm. The buffy coat was transferred to a fresh tube, and washed by adding 10 
mL of RPMI media, and centrifuged for 10 mins at 2000 rpm. The pelleted PMBCs 
are then resuspended in RPMI with 10% FBS, 50 units/mL penicillin, 50 μg/mL 
streptomycin and 2 mM L-glutamine and plated at 1 X 105 cells per well. Wild type 
Der p 2 or E102A mutant were added to the cell suspension at a final concentration of 
10 μg/mL. The positive and negative controls used were Phorbol Myristate Acetate 
(PMA) and 50 mM sodium acetate pH 4.6 respectively. The PBMCs were incubated 
for 6 days at 37˚C under 5% CO2, and cell proliferation was measured using the 
Bromodeoxyuridine (BrdU) colorimetric method according to standard manufacturer's 
protocol (Roche Applied Sciences). Absorbance was measured at 450 nm, with a 
reference wavelength of 690 nm using an ELISA plate reader. Proliferation is 
reported as stimulation index, calculated by the formula (S-C)/C*100 with S as 




2.4.9 Measurement of excreted cytokines 
 
PBMCs were cultured as detailed in section 2.4.8. At day 6, supernatants of the cell 
culture were harvested, and cytokine concentrations were measured by using human 
Th1/ Th2 Bioplex Cytokine Assay (Biorad) according to standard manufacturer's 
protocol. 
2.4.10 Mouse immunization  
 
Groups of 4 mice were each injected intraperitoneally with 10 μg of purified Der p 2, 
mutant K96A, mutant E102A or human NPC2 (hNPC2) with 1.25 mg/mL aluminium 
hydroxide gel (Sigma) every 14 days. PBS buffer containing adjuvant aluminium 
hydroxide was similarly injected into another group of 2 mice as controls. Pre-
immune and post-immune blood samples after the 6th injection was drawn by orbital 
bleeding and stored at -20˚C until use. 
 
2.4.11 Inhibition of human IgE binding to Der p 2 by specific mouse IgG 
antibodies 
 
Der p 2 was coated overnight at 4˚C onto Maxisorp ELISA plate (Nunc) at 250 ng of 
protein per well. Plates were washed with PBS-T (PBS, 0.05% Tween-20) and 
blocked with PBS-0.1% Tween-20 for 1 hr at room temperature. Mouse sera diluted 
1:10 in PBS-1% BSA was then incubated in the wells for 2 hrs. This was followed by 
incubation with patients sera diluted 1:10 or 1:5 in PBS-1% BSA for another 2 hrs. 
Next, wells were incubated with 100 μL of biotin conjugated anti-human IgE 
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monoclonal antibody (BD-Pharmingen) diluted 1:250 in PBS for 2 hrs. This was 
followed by a 30 min incubation with avidin conjugated HRP (BD-Pharmingen) 
diluted 1:1000 in PBS. Microtitre plates were washed three times with PBS-T 
between each step. Finally, 100 μL of TMB substrate (Sigma) was added, and colour 
reaction was developed for approximately 30 mins. The reaction was stopped by 
addition of 20 μL of 1 M HCl per well, and absorbance was measured at 450 nm with 
an ELISA plate reader. Percent of inhibition of human IgE binding to Der p 2 was 
calculated using the following formula: % inhibition of IgE binding = 100–(A-B) x 
100%. A and B represent the absorbance values after preincubation with serum from 
immunized mouse and control mouse respectively.  
 
2.5 Computer based characterization and analysis 
 
2.5.1 Analysis of DNA and protein sequences 
 
All nucleotide and amino acid sequences were analyzed and aligned using 
DNAMAN® version 4.15 (Lynnon Corporation). Prediction of the signal peptide 
cleavage site was done with the software SignalP v1.1(Nielsen et al., 1997). N-
glycosylation site prediction was performed online using NetNGlyc 1.0 Prediction 
Server at http://www.cbs.dtu.dk/services/NetNGlyc/21.  
 
2.5.2 Three dimensional protein structure predictions 
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The structures of group 2 allergens were modeled using the automated comparative 
protein modeling server SWISS_MODEL (Peitsch et al., 1995; Peitsch, 1996; Guex 
and Peitsch, 1997). The models are based upon the coordinates of the corresponding 
solved crystal structures deposited in the Protein Data Bank (PDB) (www.pdb.org). 
All 3D structure predictions were done using the solved crystal structure of Der p 2 
(1KTJ.pdb) as the template, except for the structure prediction of Der f 22, which was 
generated using the solved crystal structure of Der f 2 (1XWV.pdb). All figures were 
generated using PyMOL (DeLano, 2002). 
 
2.5.3 Phylogenetic sequence analysis 
 
Group 2 allergen sequences were obtained from NCBI (http://www.ncbi.nlm.nih.gov) 
or the laboratory’s EST sequence database. All EST sequences used showed 
homology to known group 2 allergens on the non-redundant database in GenBank 
using the BLAST-X algorithm (E-value < 0.001). Due to differences in sequence 
lengths between clones, the sequences were trimmed at the 5’ and 3’ end to be of the 
same length. The nucleotide sequences were then aligned using SequenceHelper, and 
manually edited to maximize the alignment. An evolutionary tree was drawn based on 
the multiple alignment using PHYML (Guindon and Gascuel, 2003; Guindon et al., 
2005) using the maximum-likelihood method. The reliability of internal branches was 
examined using 100 bootstrap simulations. 
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 2.5.4 Docking of cholesterol to Der p 2 
 
The binding site of cholesterol on Der p 2 was predicted using the Autodock (Morris, 
1998) based blind docking (BD) (Hetenyi, 2002) approach. The grid box (126 x 126 x 
126) was centered on Der p 2 and the lattice point distance was set to 0.375Å. The 
Lamarckian Generic Algorithm (LGA) with pseudo-Solis and Wets method was used 
with 150 individuals in the population. The grid parameter and docking parameter 
files were generated using AutoDock Tools (Sanner, 1999). The parameters used are 
shown in Table 2.1. 
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Table 2.1 Parameters used for Autodock 
Parameters 
No. of GA runs 200 
Population size 150 
Max no. of energy evaluations 250000 
Max no. of generations 27000 
Max no. of top individual that automatically survives 1 
Rate of gene mutation 0.02 
Rate of crossover 0.8 
Step size for translation (Armstrong/step) 2 
Step size for quaternion (degree/step) 50 
Step size for torsion (degree/step) 50 
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2.6 Lipid assays 
 
2.6.1 Liposome preparation 
 
Ten milligrams of bovine brain extract (Folch fraction 1, Sigma) was dissolved in 5 
mL of chloroform: methanol (1:1). This solution was dried to completion under a 
stream of nitrogen. The dried lipid film was then hydrated in 1mL rehydration buffer 
(30 mM Hepes, 100 mM KCl, 0.3M sucrose), and passed (10 times) through an 
extruder (Avanti Polar Lipids), with 0.2 µm polycarbonate membranes. For 
preparation of liposomes with exogeneous cholesterol, 2 mg of cholesterol was added 
to the bovine lipid extract in the first step. 
 
2.6.2 Detection of liposome binding to Der p 2 by liposome sedimentation and 
SDS-PAGE 
 
Fifty micrograms of Der p 2 or glutathione-S-transferase (GST) of equal volume was 
added to increasing amounts of liposomes (5-40 μL) and incubated for 30 mins at 
37°C. The incubation mixture was then centrifuged at 30,000 rpm for 30 mins at 
37°C. The resulting supernatant and pellet were mixed with equal volume of 2x SDS 
sample buffer (200 mM TrisCl (pH 6.8), 400 mM DTT, 8% SDS, 0.4% Bromophenol 
blue, 50% glycerol) and boiled for 10 mins. The samples were then separated on a 
12% SDS-PAGE gel. The gel was stained with Coomasie Blue. GST was used as a 
negative control in this experiment. 
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2.6.3 Lipid ELISA 
 
The cholesterol binding assay was modified from Kobayashi et al (2001). A 
microtiter plate (Maxisorp, Nunc) was coated with lipids (0.01-2.5 μg/well) by 
ethanol evaporation. The wells were blocked with PBS containing 1% BSA for 1 hr 
prior to incubation with 0.5 µg/mL of protein for 1 hr. Binding of protein was then 
detected using specific anti-rabbit IgG-antibodies. Alkaline phosphatase labeled anti-
IgG antibodies were then added, the color was developed using PnPP (p-Nitrophenyl 
Phosphate) substrate (Sigma), and absorbance was measured at 405 nm. The 
microtitre plate was washed three times between each step using PBS. Native Der p 2 
used was obtained from Indoor Biotechnologies (USA). 
 
2.6.4 Extraction of lipid fraction from Der p 2 
 
Three hundred microliters of chloroform: methanol (1:2) was added to 100 μL of Der 
p 2 (1.5 mg/mL), followed by the addition of 400 μL of chloroform and 300 μL of 1 
M KCl. The mixture was vortexed hard for 1-2 min, and centrifuged for 30 s at 
13,200 rpm. The chloroform layer (bottom) was recovered and transferred to a fresh 
tube. The organic solvent was dried. Samples were next resuspened in chloroform: 
methanol (1:1) for mass spectrometry (section 2.6.5). 
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2.6.5 HPLC/APCI/MS/MS analysis of cholesterol 
 
Analysis of cholesterol was carried out using atmosphere pressure chemical ionization 
(APCI) with an Applied Biosystems 4000 Q-Trap mass spectrometer operated in the 
positive mode (Applied Biosystems). The APCI conditions were set at 500°C 
(vaporizer temperature) and 3 μA (corona discharge current). Samples were 
introduced into mass spectrometer after separation on an Agilent Zorbax Eclipse 
XDB-C18 column (i.d. 4.6x150 mm) using an Agilent 1100 liquid chromatography 
(LC) system (Agilent Technologies). The chromatographic conditions are (1) 
chloroform/methanol (1:1) as a mobile phase at a flow rate of 500 μL. min-1; (2) 
column temperature: 25°C; (3) injection volume: 20 μL. Tandem mass spectra of ions 
at m/z 369.3 for both cholesterol standards and samples, and ions at m/z 375.1 for d6-
cholesterol standard were acquired with a collision energy of 40 ev. Multiple reaction 
monitoring, MRM, of parent/fragment ions were used for quantification of cholesterol 
(369/161) and deuterated cholesterol standard (375/161), respectively. Analysis of 
polar lipids was carried out using electrospray ionization (ESI) instead of APCI. 
Samples were directly introduced into the mass spectrometer using 
chloroform/methanol (1:1) as a mobile phase at a flow rate of 200 μL/min. Twenty 
microlitres of sample or standard mixture was injected to obtain lipid profiles and to 




2.7 Statistical analyses 
 
Statistical analysis was carried using the SPSS statistical package. Correlation of IgE 
binding between allergens was calculated with Spearman’s correlation test at 95% 
confidence interval. Comparisons between allergen levels in the dust samples were 




Written consents were obtained from all allergic patients who participated in the skin 
prick tests. The human and animal studies involved in this report have been reviewed 
and approved by the Institutional Review Board of the National University Hospital, 
the Animal Research Ethics Committee of the National University of Singapore and 
the Hospital Ethics Committee of the KK Women's and Children's Hospital and 
Singapore General Hospital. 
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Among the dust mite allergens, group 2 allergens are the most widely studied. 
Six group 2 allergens have been identified to date (Chua et al., 1990; Trudinger et al., 
1991; Varela et al., 1994; Eriksson et al., 1998; Smith et al., 1999a; Gafvelin et al., 
2001) of which Der p 2 and Der f 2 exhibit the highest degree of IgE binding, 
followed by Eur m 2, Lep d 2, Tyr p 2 and Gly d 2. 
To date, group 2 allergens from B. tropicalis, S. medanensis or A. ovatus have 
not been reported, although these mites are known to cause allergies. B. tropicalis is a 
predominant mite species which is found mainly in tropical countries (Chew et al., 
1999a) and shows positive skin prick reactivity in >90% of dust mite allergic patients 
in Singapore (Chew et al., 1999a; Kuo et al., 1999), while somewhat lower reactivity 
among patients from Taiwan (73%) (Kuo et al., 1999) and Florida (38%) (Stanaland 
et al., 1994). Based on the radioallergosorbent test (RAST), 71 of the 97 allergic 
asthmatic patients tested exhibited IgE reactivity to crude extracts of S. medanensis 
(Puerta et al., 2005). Additionally, allergen extracts of B. tropicalis showed moderate 
cross reactivity to extracts of S. medanensis (Puerta et al., 2005). Suidasia spp. has 
been identified in dust samples collected from homes, albeit at lower levels compared 
to Dermatophagoides spp. and B. tropicalis (Fernandez-Caldas et al., 1993b; 
Montealegre et al., 1997; Chew et al., 1999b). In addition, there have been several 
reports identifying S. medanensis as a contaminating source in foods, such as flour 
and bread, being a possible cause of IgE-mediated reactions in persons who consume 
mite-contaminated foods (Sanchez-Borges et al., 1997; Olsen, 1998).  
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In a study of 77 patients from Colombia with allergic asthma and/or chronic 
rhinitis, 68.8% of the patients showed IgE-binding to extracts of A. ovatus (79.3% of 
the D. pteronyssinus positive patients) as measured by RAST (Puerta et al., 1993a; 
Puerta et al., 1993b). There was a large variation in the number of asthmatic patients 
(adults and children) from 5 Latin American countries showing skin prick reactivity to 
A. ovatus extracts, ranging from 26.6% in Bogota to 71.2% in Sao Paulo (Fernandez-
Caldas et al., 1993a). This discrepancy could be caused by higher prevalence of 
cuteneous sensitivities to mite allergens in children compared to adults (Fernandez-
Caldas et al., 1993a), as patients from Sao Paulo were confined to children. Similarly, 
in another study of 80 Brazilian children, 71% of them displayed positive skin prick 
reactivity to A. ovatus (Rizzo et al., 1997), however this number dropped to 59% 
when a group of 56 adult asthmatics were tested for skin prick reactivity. In 
comparison, only about 40% of the children tested from Florida, USA were RAST 
positive to A. ovatus extracts (Nelson et al., 1996), which was lower compared to their 
cohort in Latin America. This variation may be due to the differences in local mite 
distribution, affecting the sensitization profiles of the allergic individuals (Marks, 
1998; Munir, 1998). 
Although B. tropicalis, S. medanensis, and A. ovatus clearly play a role in 
allergic sensitization, the specific allergens which are important in each species have 
not been determined, except in the case of B. tropicalis, where Blo t 5 has been 
identified as a major allergen (Caraballo et al., 1996). For more precise diagnosis of 
allergies, it is necessary to identify and characterize the group 2 allergens from these 3 
mite species.  
In combination with three newly identified allergens Ale o 2, Sui m 2 and Blo 
t 2, the specific IgE binding to a total of eight group 2 allergens were evaluated, in 
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patients from two populations of varied mite distribution. This allows for a clearer 
understanding of the relative allergenicities of each allergen, and evaluation of its 
cross reactivity using sera from the same population.  
 
3.2 Cloning and sequence analysis of Ale o 2, Sui m 2 and Blo t 2 
 
From the expressed sequence tag (EST) libraries of A. ovatus and S. 
medanensis prepared in the laboratory (Angus et al., 2004), EST clones showing 
homology to group 2 dust mite allergens were identified. These clones were 
subsequently named Ale o 2 (accession number AAS75832) and Sui m 2 (accession 
number AAS75831) respectively, in accordance to the allergen nomenclature 
guidelines (WHO/IUS Allergen Nomenclature Subcommittee World Health 
Organization, 1994). The full length sequence of Ale o 2 has 435 nucleotides, which 
codes for 145 amino acid residues (Figure 3.1), while Sui m 2 has 142 amino acids in 
its full length protein sequence, coded by 426 base pairs (Figure 3.2).  
Blo t 2 was amplified using a combination of two techniques, reverse-
transcription polymerase chain reaction (RT-PCR) and RACE (Random 
Amplification of cDNA Ends). First, RT-PCR amplification of total RNA of B. 
tropicalis was performed using degenerate primers designed based on the conserved 
sequences of known group 2 allergens. A single band of 250 base pairs was observed 
in the agarose gel electrophoresis. Subsequently, specific primers based on the 
sequence of this fragment were designed, and used for 5’ and 3’ RACE. The full 
length clone obtained was sequenced to confirm its identity. 
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1         ATGAAGTTCGTCTTTTTTGCTTTGTTGATCAGCTTTGCTTCGGCAGGTCAAGTTCGGTTC 
1          M  K  F  V  F  F  A  L  L  I  S  F  A  S  A  G  Q  V  R  F   
 
61        GAGGATTGTGGCCATCATGAAGTGACCAAATTGGACATTTCCCAATGTGCCGATGGTGCA 
21         E  D  C  G  H  H  E  V  T  K  L  D  I  S  Q  C  A  D  G  A   
 
121       TCAACCTGTGTTATTCACAAAGGAAAGGAGCTCAAACTGGATGCTGAGATACTTGCAAAT 
41         S  T  C  V  I  H  K  G  K  E  L  K  L  D  A  E  I  L  A  N   
 
181       CAAGATTCGGCAAAAATTGAGGTCCATTTGACCGCCAACATCGATGGTTTGAGCATTCCC 
61         Q  D  S  A  K  I  E  V  H  L  T  A  N  I  D  G  L  S  I  P   
 
241       ATTCCTGGAGTTGACAAGGATGGTTGCAAGTACGTCACGTGCCCCATAAAGAAGGGCGAG 
81         I  P  G  V  D  K  D  G  C  K  Y  V  T  C  P  I  K  K  G  E   
 
301       AAGGTCCATTTCAACTATTCTTTGGTTGTCCCAAAATTGATTCCAAACCTTCACAACGTT 
101        K  V  H  F  N  Y  S  L  V  V  P  K  L  I  P  N  L  H  N  V   
 
361       GAGGTCGGCGCTAAAATCACTGGTGACCACGGTTTGCTGGCTTGCTTGCGGCTGAAGGGC 
121        E  V  G  A  K  I  T  G  D  H  G  L  L  A  C  L  R  L  K  G   
 
421       GACATTGCCAACTAA 
141        D  I  A  N  -   
 
 
Figure 3.1 Nucleotide and translated amino acid sequence of Ale o 2. The predicted 
initiation Met start codon is in bold faced and underlined. The signal peptide of Ale o 
2 is underlined. The predicted N-glycosylated site (N-Y-S, aa 105-107) is italicized 
and underlined. Cystein residues along the predicted mature protein sequence are 
italicized bold faced. The stop codon (TAA) is represented by a dash. The ML domain 




1         ATGAAGTTCATCATCTTGGCTATGTTTGTGGCAGTGGCTGCCGCTGGTGAGATGAAGTTC 
1          M  K  F  I  I  L  A  M  F  V  A  V  A  A  A  G  E  M  K  F   
 
61        CAGGACTGTGGACACGGAGAGGTGAAGAAGCTCTTGGTTTCCGACTGCTCTGGCGACTAC 
21         Q  D  C  G  H  G  E  V  K  K  L  L  V  S  D  C  S  G  D  Y   
 
121       TGCATCATCCACAAGGGCAAGAAGCTGAGCATGGAGGCTGACTTTGTTGCCAACCAGGAC 
41         C  I  I  H  K  G  K  K  L  S  M  E  A  D  F  V  A  N  Q  D   
 
181       TCGCCAACTGCCGTGATCAAGATCTCCGCCAAGGTGAACGGTGTCGAGTTGCAAGTGCCA 
61         S  P  T  A  V  I  K  I  S  A  K  V  N  G  V  E  L  Q  V  P   
 
241       GGCATTGAGACCAACGGATGCCACCACATGAAGTGCCCCCTGGTCAAGGGACAGTCCTAC 
81         G  I  E  T  N  G  C  H  H  M  K  C  P  L  V  K  G  Q  S  Y   
 
301       CAGTTCAAGTATGACATGGTCATCCCTCAGATCCTCCCCAACGTGAAGGCTGACGTCACC 
101        Q  F  K  Y  D  M  V  I  P  Q  I  L  P  N  V  K  A  D  V  T   
 
361       GCCTCGTTGACTGGCGCTCACGGTCTCCTTGCCTGCGGTACCGTCCACGGTGAGGTCCAG 
121        A  S  L  T  G  A  H  G  L  L  A  C  G  T  V  H  G  E  V  Q   
 
421       AACTAA 
141        N  -   
 
 
Figure 3.2 Nucleotide and translated amino acid sequence of Sui m 2. The predicted 
initiation Met start codon is in bold faced and underlined. The signal peptide of Sui m 
2 is underlined. Cystein residues along the predicted mature protein sequence are 
italicized bold faced. The stop codon (TAA) is represented by a dash. The ML domain 




Homology search using the sequence obtained against the non-redundant database in 
NCBI using BLAST-X (Altschul et al., 1990) matched group 2 dust mite allergens, 
with closest homology to Lep d 2 at 52% amino acid sequence identity. This clone 
was subsequently named Blo t 2 (GenBank accession number DQ677253), in 
accordance to the nomenclature guidelines of the WHO/IUIS Allergens Nomenclature 
Subcommittee, Switzerland (WHO/IUS Allergen Nomenclature Subcommittee World 
Health Organization, 1994). The complete clone of Blo t 2 has an open reading frame 
of 426 nucleotides, coding for 142 amino acid residues (Figure 3.3).  
Using the SignalP program (Nielsen et al., 1997), Ale o 2, Sui m 2 and Blo t 2 
were predicted to have a signal peptide (15 amino acids for Sui m 2 and Ale o 2, 16 
amino acids for Blo t 2). Only Ale o 2 had a potential N-glycosylation site at amino 
acid residues 105-107 (N-Y-S) as predicted by the NetNGlyc algorithm (Gupta, 2004). 
Using Pfam domain search (Bateman et al., 2004), all three allergens belong to the 
ML domain family, which is associated with lipid recognition (Inohara and Nunez, 
2002). 
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1         ggggatcattcacttctctcgaattgaaagaaaaccccaaacaaaaaatctaaacaaaaA 
 
61        TGTTCAAGTTTATCTGTCTCGCCCTTTTGGTCTCGTACGCCGCCGCCGGTGATGTCAAAT 
20        M  F  K  F  I  C  L  A  L  L  V  S  Y  A  A  A  G  D  V  K    
      
 
121       TTACCGATTGTGCACATGGTGAGGTTACCTCATTGGACTTGTCTGGATGCTCTGGCGACC 
40        F  T  D  C  A  H  G  E  V  T  S  L  D  L  S  G  C  S  G  D    
 
181       ATTGCACAATCCACAAGGGAAAGAGCTTTACCTTGAAGACCTTTTTCATTGCTAACCAAG 
60        H  C  T  I  H  K  G  K  S  F  T  L  K  T  F  F  I  A  N  Q    
 
241       ACTCTGAAAAGTTGGAGATCAAGATCAGCGCCACCATGAACGGTATTGAGGTTCCAGTTC 
80        D  S  E  K  L  E  I  K  I  S  A  T  M  N  G  I  E  V  P  V    
 
301       CAGGTGTCGACAAGGACGGTTGCAAGCACACCACCTGCCCATTGAAGAAGGGACAAAAGT 
100       P  G  V  D  K  D  G  C  K  H  T  T  C  P  L  K  K  G  Q  K    
 
361       ACGAACTCGACTACAGTTTGATCATCCCAACCATCTTGCCAAACTTGAAGACCGTCACCA 
120       Y  E  L  D  Y  S  L  I  I  P  T  I  L  P  N  L  K  T  V  T    
 
421       CCGCATCGTTGGTTGGCGATCACGGTGTCGTTGCTTGCGGAAAGGTCAACACCGAGGTTG 
140       T  A  S  L  V  G  D  H  G  V  V  A  C  G  K  V  N  T  E  V    
        
481       TCGATTAAactctttagtcattctaatttttataattatcaaacttgatcttatgtcaag 
160       V  D  -   
 
541       ttttgattattattactaataaatcttcta 
 
 
Figure 3.3 Nucleotide and translated amino acid sequence of Blo t 2. The sequences 
in uppercase represent the open reading frame, while the sequences in lowercase are 
the untranslated sequences. The predicted initiation Met start codon is in bold faced 
and underlined and the polyadenylation signal is double underlined. The signal 
peptide of Blo t 2 is underlined. Cystein residues along the predicted mature protein 
sequence are italicized bold faced. The stop codon (TAA) is represented by a dash. 
The ML domain spans from Y21 to V140 of the full length sequence.  
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The 3 newly characterized allergens have 6 cystein residues in the mature 
protein sequence (Figure 3.1, 3.2 and 3.3). Based on the solved three dimensional (3D) 
structures of two group 2 allergens, Der p 2 and Der f 2 (Ichikawa et al., 1998; 
Derewenda et al., 2002), the 6 cystein residues are involved in the formation of 3 
disulfide bonds in the 1-6, 2-3, 4-5 arrangement. The 3D structures of Ale o 2, Sui m 
2 and Blo t 2 were predicted based on the crystal structure of Der p 2 (Figure 3.4).  
In all the predicted structures, the formation of a β sandwich with a 
hydrophobic cavity in the centre is seen, similar to the solved structures of Der p 2 
and Der f 2. Based on the predicted structures, all three disulfide bonds are thought to 
be formed. Circular dichrosim (CD) spectra of Ale o 2 and Sui m 2 showed that both 
proteins have a typical β-sheeted structure, with minima and maxima wavelengths at 
~218 and 195 nm respectively (Figure 3.5). CD spectra of both proteins were 








Figure 3.4 Predicted 3D structures of recombinant allergens. (A) Ale o 2, (B) Sui m 2 
and (C) Blo t 2. The model was predicted based on the solved Der p 2 structure 
(1KTJ.pdb). Cystein residues forming the 3 disulfide bridges are shown in yellow 
sticks. The image is displayed using PyMOL (DeLano, 2002). 
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Figure 3.5 Far UV circular dichroism spectra of recombinant Ale o 2, Sui m 2, Blo t 2 
and Der p 2. Twenty micromolar of each protein, in 50 mM sodium acetate pH 4.6 
was used to obtain the circular dichroism spectra. Ale o 2, Sui m 2 and Blo t 2 showed 
typical β-sheeted protein spectra, similar to Der p 2. Average spectra from 10 scans 
are shown.  
 46
Multiple alignment of mature protein sequences of nine group 2 allergens 
(from 9 mite species, belonging to 5 separate families) are shown in Figure 3.6. Of 
these allergens, Blo t 2, Ale o 2 and Sui m 2 are newly identified allergens, and 
sequences of the remaining 6 allergens have been previously published. From the 
multiple alignments, the six cystein residues are shown to be conserved across all the 
group 2 allergens. A phylogenetic tree was drawn based on the multiple alignments of 
group 2 protein sequences (Figures 3.6 and 3.7) and shows that allergens from mites 
belonging to the same family cluster in the same clade. For instance, Gly d 2 and Lep 
d 2 from dust mites G. domesticus and L. destructor belonging to the family 
Glycyphagidae are seen to form one clade, while D. pteronyssinus, D. farinae and E. 
maynei from the Pyroglyphidae family cluster form a separate clade. The 
phylogenetic tree drawn based on multiple alignments of group 2 allergen protein 
sequences (Figure 3.7) was similar to that based on morphological classifications 
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Figure 3.6 Multiple alignments of the mature protein sequence of group 2 allergens. 
Dots are introduced to optimize the alignments. Residues coloured black show 100% 














































Figure 3.7 Phylogenetic tree of group 2 allergens from nine mite species. Mature 
protein sequences were used for the alignments. Tree was drawn using a bootstrap 








3.3 IgE reactivity to group 2 allergens  
 
3.3.1 IgE reactivity to group 2 allergens in the Singaporean population 
 
Using immuno dot blot assays, the amount of specific IgE reactivity to each of 
the group 2 allergen was measured. Sera from a total of 202 individuals from 
Singapore were assayed for IgE reactivity to eight recombinant group 2 allergens. 
From the 202 individuals tested, 116 showed IgE reaction to dust mite crude proteins 
(assayed using crude proteins extracts of D. pteronyssinus, D. farinae and B. 
tropicalis) (Table 3.1). The majority of the dust mite positive individuals (91 of 116, 
78%) had specific IgE binding to Der p 2, followed by Der f 2 (56 of 116, 48%) 
(Table 3.1). The proportion of the dust mite positive individuals having IgE reaction 
to the 6 other group 2 allergens from the non-pyroglyphid mites ranged between 22% 
(Gly d 2) to 34% (Blo t 2) in the Singaporean population. Overall, the majority of the 
dust mite allergic individuals from Singapore showed IgE reaction to Der p 2 and Der 
f 2. 
The amount of IgE binding to each allergen was next quantified based on the 
optical density (OD) of the IgE reaction. Among the Singaporean individuals with IgE 
reactivity to Der p 2, 16 showed high reaction, 18 moderate while the remaining had 
low reaction (Figure 3.8). For Der f 2, 11 of the 56 Der f 2 positive patients showed 
high reaction, while 9 showed moderate reaction. For all other allergens tested, 
between 2 (Tyr p 2) to 6 (Sui m 2 and Ale o 2) individuals showed high reactions, 
while the number of moderate reactors ranged between 7 (Tyr p 2, Sui m 2 and Ale o 
2) to 9 individuals (Blo t 2 and Lep d 2) (Figure 3.8).  
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Table 3.1 The number of patients showing IgE reaction to each recombinant group 2 
allergen from the Singaporean and Italian dust mite positive patients. The percentage 
of patients reacting to each allergen is calculated based on the number of dust mite 




Dust mite positive 116 85
Der p 2 91 (78%) 59 (69%)
Der f 2 56 (48%) 47 (55%)
Blo t 2 40 (34%) 29 (34%)
Tyr p 2 30 (26%) 22 (26%)
Sui m 2 42 (36%) 34 (40%)
Lep d 2 27 (23%) 24 (28%)
Gly d 2 25 (22%) 15 (18%)


























Figure 3.8 IgE binding of Singaporean dust mite positive individuals’ sera to eight 
group 2 allergens. Specific IgE binding is measured as optical density (OD). 
Reactions were grouped by levels of binding, low (20-49 OD), moderate (50-100 OD) 
and high (>100 OD). IgE reactions with OD<20 were considered negative. 
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  The concordance of IgE reaction between group 2 allergens was assessed 
based on the Spearman’s rank correlation values. IgE reactivity between Der p 2 and 
Der f 2 (allergens from pyroglyphid mites) were highly concordant (r2=0.82, 
p<0.0001) (Table 3.2, Figure 3.9A). Similarly, strong concordance between the IgE 
reactivity of Blo t 2 and Tyr p 2 (both from to non-pyroglyphid mites) was observed 
(Table 3.2, Figure 3.9B). Moderate to high concordance was observed between group 
2 allergens from the non-pyroglyphid mites (Table 3.2, Figure 3.9C). These 
observations were reflective of the phylogenetic relationship between the mite species 
(Figure 3.7). For example the IgE reactivity to Der p 2 and Der f 2 were highly 
concordant as D. pteronyssinus and D. farinae shared high amino acid sequence 
identity (88%). In comparison, D. pteronyssinus and B. tropicalis belong to different 
families, and this phylogenetic distance is reflected in the moderate concordance of 
IgE reactions observed between Der p 2 and Blo t 2 (r2=0.47, p<0.0001).  
Concordance of IgE reactions between 2 allergens could be due to cross-
reactivity or co-sensitization (dual sensitization). An inhibition ELISA assay was used 
to evaluate the presence of cross-reactivity between the allergens tested. Sera from 
three individuals (MSG, AS419 and AS223) with high IgE reaction (OD>100) to Der 
p 2, Der f 2, Blo t 2 and Tyr p 2 were used for the inhibition assay. Serial dilutions of 
allergens (5x10-5 – 5x102 μg/mL) were incubated with individual sera before it was 
reacted with either Der p 2 or Blo t 2 bound to the solid surface.  
Complete homologous inhibition of Blo t 2 in all three patients tested was 
achieved at different inhibitor concentrations (Figure 3.10). Der p 2 and Der f 2 was 
able to fully inhibit IgE binding to Blo t 2 in individuals MSG and AS223, but not in 
AS419, even at high inhibitor concentrations (50 μg/mL). Tyr p 2 showed high cross 
reactivity (>80% inhibition) to Blo t 2 in all three individuals tested. 
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Table 3.2 Correlation of amount of IgE binding to group 2 allergens in the 116 dust 
mite allergic patients from Singapore. Correlation coefficient was calculated using the 
Spearman’s correlation, using 95% confidence interval. Coefficient values >0.5 were 
bold faced. The calculated p-value for all coefficients of correlations were <0.0001. 
 
Der f 2 Blo t 2 Tyr p 2 Sui m 2 Lep d 2 Gly d 2 Ale o 2
Der p 2 0.8261 0.4679 0.4891 0.5419 0.4998 0.6212 0.4167
Der f 2 0.4969 0.4599 0.4232 0.5057 0.6077 0.3780
Blo t 2 0.8444 0.7027 0.7732 0.6118 0.6651
Tyr p 2 0.8219 0.7913 0.6662 0.7069
Sui m 2 0.7431 0.5497 0.7751
Lep d 2 0.8046 0.8497
Gly d 2 0.7102
Ale o 2  
 


















































Figure 3.9 Correlation between IgE binding of dust mite allergic individuals from 
Singapore. Correlation between (A) Der p 2 and Der f 2, (B) Der p 2 and Blo t 2 and 
(C) Blo t 2 and Tyr p 2 is shown. The correlation coefficients for each bi-plot are 
indicated (p<0.0001). 
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Der f 2 was able to completely inhibit IgE binding to immobilized Der p 2 
(>80% inhibition) in all three individuals (Figure 3.10). Both Blo t 2 and Tyr p 2 were 
only able to partially inhibit IgE binding to Der p 2 (52%-88% for Blo t 2; 70%-75% 
for Tyr p 2), indicating moderate to high cross reactivity between the allergens, in 
individuals with high IgE reactions to Der p 2, Blo t 2 and Tyr p 2. It is noteworthy 
that the majority of individuals show higher IgE reaction to Der p 2 compared to Blo t 
2 (Figure 3.8B), suggesting that individuals in this group would show low or no cross-
reactivity with Blo t 2.  
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Figure 3.10 IgE inhibitions of selected group 2 allergens using ELISA in three 
allergic individuals from the Singaporean population. Inhibition of IgE binding from 
individual sera of three individuals (MSG, AS419 and AS223) to immobilized Blo t 2 
and Der p 2 was evaluated. Each serum was preincubated separately with 4 allergens, 
Blo t 2, Der f 2, Der p 2 or Tyr p 2, as indicated in the graph legends. The amount of 
inhibition was calculated in relation to the uninhibited control. 
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3.3.2 IgE reactivity to group 2 allergens in the Italian population 
 
Fifty nine percent (85 of 145) of the Italian individuals tested showed IgE 
binding to dust mite crude extracts (Table 3.1), and were further evaluated for specific 
IgE reactivity to group 2 allergens. Most individuals showed specific IgE binding to 
Der p 2 (59 of 85, 69%), followed by Der f 2 (47 of 85, 55%). The percentage of 
allergic individuals with IgE binding to the other 6 allergens ranged between 44% for 
Ale o 2 to 18% for Gly d 2. This trend was similar to the IgE reaction profile of the 
Singaporean dust mite allergic individuals (Table 3.1).  
In comparison to the Singaporean population, fewer individuals in the Italian 
population demonstrated high IgE reaction to all allergens tested (Figure 3.11). 
Among the individuals who showed IgE binding to Der p 2, 8 of them had high 
reaction, 18 moderate and the remaining had low reaction. For Der f 2, five of the 47 
Der p 2 positive individuals had high reaction and 12 showed moderate reactions. 
There were no high reactors for Lep d 2 and Gly d 2, and for these two allergens, even 
the number of moderate reactors was low, 7 patients for Lep d 2 and 2 for Gly d 2. 
Among the non-pyroglyphid mites, there were 2 patients who showed high IgE 
reaction to Blo t 2 and Ale o 2, while there was 1 high reactor each for Tyr p 2 and 
Sui m 2.  
IgE binding to Der p 2 and Der f 2 in the Italian population was highly 
concordant (r2=0.75, p<0.0001), and but showed moderate to low IgE reactivity 
concordance to the allergens from non-pyroglyphid mites (r2 values ranging from 
0.25-0.45, p<0.01) (Table 3.3 and Figure 3.12).  
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Figure 3.11 IgE binding of Italian dust mite positive individuals’ sera to eight group 2 
allergens. Specific IgE binding is measured as optical density (OD). Reactions were 
grouped by levels of binding, low (20-49 OD), moderate (50-100 OD) and high (>100 




Table 3.3 Correlation of amount of IgE binding to group 2 allergens in the 85 dust 
mite positive allergic individuals from Italy. Correlation coefficient was calculated 
using the Spearman’s correlation, using 95% confidence interval. Coefficient values 
>0.5 were boldfaced. The number of asterisks indicates the p-values; (***) represents 
p<0.0001, (**) represents p<0.001, (*) represents p<0.01. Values which did not have 
significant correlation were denoted as ns. 
 
Der f 2 Blo t 2 Tyr p 2 Sui m 2 Lep d 2 Gly d 2 Ale o 2
Der p 2 0.7469*** 0.4473*** 0.2508* 0.2656* 0.2575* 0.3725*** 0.2534*
Der f 2 0.4501*** 0.2737* 0.2946** ns 0.4230*** ns
Blo t 2 0.862*** 0.8225*** 0.7272*** 0.4802*** 0.7655***
Tyr p 2 0.829*** 0.7389*** 0.4442*** 0.7559***
Sui m 2 0.7431*** 0.5497*** 0.7751***
Lep d 2 0.6883*** 0.8090***
Gly d 2 0.4648***  
 


















































Figure 3.12 Correlation between IgE binding of dust mite positive allergic patients 
from Italy to (A) Der p 2 and Der f 2, (B) Der p 2 and Blo t 2 and (C) Blo t 2 and Tyr 
p 2. The correlation coefficients for each bi-plot are indicated (p<0.0001).  
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The amount of IgE binding between group 2 allergens from the non-pyroglyphid 
mites showed moderate to high concordance (r2 values ranging from 0.44-0.86, 
p<0.001). In order to identify the basis of the concordance of IgE reactions observed 
(cross reactivity or co-sensitization), inhibition studies were next performed.  
For inhibitions studies, three representative sera (645, I3454 and I3480) from 
the Italian population with high IgE reactivity (OD>100) to Der p 2, Der f 2, Blo t 2 
and Tyr p 2 were used. In all 3 individuals evaluated, Der p 2 and Der f 2 were able to 
fully inhibit IgE binding to Blo t 2 (>80% inhibition), although the amount of 
inhibitor required was variable (5μg/mL of Der p 2 or Der f 2 for individual 645, 50 
μg/mL of Der p 2 or Der f 2 for individuals I3454 or I3480) (Figure 3.13). In all 3 
individuals, Tyr p 2 was able to almost completely inhibit IgE reaction to Blo t 2 
(>80% inhibition). 
Der f 2 demonstrated almost complete cross reaction (>90%) to Der p 2 in all 
the individuals tested. Both Tyr p 2 and Blo t 2 showed high degree of cross reactivity, 
~85% to Der p 2 in all three patients, which was higher compared to the Singaporean 
patients (52%-88% inhibition). 
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Figure 3.13 IgE inhibitions of selected group 2 allergens using ELISA in three 
allergic individuals from the Italian population. Inhibition of IgE binding from 
individual sera of three individuals (645, I3454 and I3480) to immobilized Blo t 2 and 
Der p 2 was evaluated. Each serum was preincubated separately with 4 allergens, Blo 
t 2, Der f 2, Der p 2 or Tyr p 2, as indicated in the graph legends. The amount of 
inhibition was calculated in relation to the uninhibited control. 
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3.4 Further characterization of Blo t 2 
 
3.4.1 Isolation of native Blo t 2 
 
Native Blo t 2 (nBlo t 2) was isolated from the total protein extract of B. 
tropicalis by antibody pull down, using rabbit polyclonal antibodies raised against 
recombinant Blo t 2 (rBlo t 2). Both nBlo t 2 and rBlo t 2 were then tested for IgE 
binding in 20 dust mite allergic individuals using immuno dot blot assay. The IgE 
binding response to rBlo t 2 was highly concordant to its native counterpart (nBlo t 2) 
(r2=0.77, p<0.05) (Figure 3.14), suggesting that both proteins have comparable 
allergenicity. Hence, rBlo t 2 could be used in place of nBlo t 2 in allergen 
characterization experiments. 
 
3.4.2 Histamine release of Blo t 2 
 
Whole blood of two dust mite allergic individuals, P16 and P17 were collected, 
and incubated with serial dilutions of recombinant Blo t 2 (0.1, 1.0, 10 and 100 ng/µL) 
to stimulate in vitro histamine release. The amount of histamine released was 
measured by ELISA. Both individuals (P16 and P17) displayed dose dependant 
histamine release capacity upon stimulation with rBlo t 2 (Figure 3.15). The ability of 
rBlo t 2 to elicit histamine release suggests that it is able to cross-link specific IgE 
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Figure 3.14 Correlation between the amount of IgE binding of 20 dust mite allergic 
individuals sera to native Blo t 2 (nBlo t 2) and recombinant Blo t 2 (rBlo t 2). The 
amount of IgE binding is represented by optical density (OD) of the immuno-dot blot 
colourimetric reaction. Linear regression analysis shows that the IgE binding to the 
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Figure 3.15 In vitro histamine release from whole blood of two dust mite allergic 
individuals. Two hundred microliters of blood from indivduals P16 and P17 were 
challenged with varied concentration of Blo t 2 (0.1, 1, 10 and 100 ng/μL) for 1 hr to 
stimulate histamine release. Amount of histamine was then measured by an ELISA 
assay. 
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3.4.3 Blo t 2 is present in the environmental dust samples 
 
Next, the concentration of Blo t 2 in the dust samples from 101 homes was 
measured (Figure 3.16). Dust samples were collected by vacuuming 4 areas within a 
home: bed, carpet, kitchen and sofa, and the amount of allergen present were assayed 
by ELISA. The levels of Blo t 2 were compared with that of a major dust mite 
allergen, Der f 2, to investigate the presence of a link between the levels of allergen in 
the environment and its allergenicity. The concentration of Blo t 2 measured was the 
highest in beds (12.2 μg/g dust) and lowest in carpets (2.3 μg/g dust), whereas for Der 
f 2, the highest concentration as detected in the kitchens (2.0 μg/g dust) and the lowest 
in carpets (0.64 μg/g dust). Of the four niches studied, the levels of Blo t 2 was only 
significantly higher than Der f 2 in beds and sofas (p<0.05). On the average, the 
























Figure 3.16 Concentration of Blo t 2 and Der f 2 in dust samples from 101 homes. 
Dust samples were collected by vacuuming four areas within a home, and assayed for 
the amounts of Blo t 2 (●) and Der f 2 (○) in beds (n=101; 31), carpets (n=19; 10), 
kitchens (n=63; 22) and sofas (n=65; 56). Horizontal bars on the scatter plot show the 
geometric mean concentration for each allergen. 
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3.4.4 Isoforms of Blo t 2 
 
Isoforms are a common feature of group 2 allergens (Smith et al., 2001a; Park 
et al., 2002). In order to identify polymorphic forms of Blo t 2, seventy four E. coli 
colonies containing the Blo t 2 insert were randomly selected, and sequenced. Nine 
isoforms of Blo t 2 were identified based on the mature protein sequence of Blo t 2, 
and were named according to the allergen nomenclature guidelines (WHO/IUS 
Allergen Nomenclature Subcommittee World Health Organization, 1994) (Table 3.4). 
Two nucleotide changes, C15T and G43A, were observed at the signal peptide region 
of Blo t 2, whereas the DNA sequence coding for the mature protein contained 9 
nucleotide changes. All isoforms had at least one amino acid change, with a 
maximum of 3 amino acid substitutions for Blo t 2.0108. Blo t 2.0101 was the isoform 
with the highest frequency of 82.4%, followed by Blo t 2.0102 with 8.1% frequency. 
In 3 of the 9 isoforms identified, changes in the property of the amino acid residues 
were observed. In Blo t 2.0104, D126A caused a switch from charged polar to a non-
polar residue, whereas for Blo t 2.0107 and Blo t 2.0108, polymorphisms in G23D 
and G20R respectively caused a change from non-polar to charged polar residues. All 
polymorphic residues of Blo t 2 were solvent exposed and clustered in the same 
region of which 7 of the 8 residues were situated at the loop region, and one residue 
was situated on the β-strand (Figure 3.17). 
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Table 3.4 Nucleotide and amino acid changes in isoforms of Blo t 2. (A) Codon and 
amino acid replacements (in parentheses) for each polymorphic form are shown. The 
nucleotide changes are underlined. (B) Amino acid polymorphism in the isoforms of  
Blo t 2 is shown using Blo t 2.0101 as the reference clone. The number of clones 
corresponding to each isoform is reported. 
  
A 
Amino acid residue no. 
(mature protein) 
Blo t 2.0101 Polymorphic form 
-12 ATC (I) ATT (I) 
-2 GCC (A) ACC (T) 
20 GGA (G) AGA (R) 
23 GGC (G) GAC (D) 
29 CAC (H) CGC (R) 
32 AAG (K) AAA (K) 
96 ATC (I) GTC (V) 
100 TTG (L) GTG (V) 
103 GTC (V) ATC (I) 
125 GTC (V) ATC (I); TTC (F) 





Isoforms Reference clone Polymorphism Number of 
clones 
Blo t 2.0101 Blo t 2 - 61 
Blo t 2.0102 Blotn11 I96V, L100V 6 
Blo t 2.0103 Blotn38 H29R 1 
Blo t 2.0104 Blotn52 D126A 1 
Blo t 2.0105 Blotn56 V125F 1 
Blo t 2.0106 Blotn71 V103I 1 
Blo t 2.0107 Blotn75 G23D 1 
Blo t 2.0108 Blotn88 G20R, I96V, L100V 1 































Figure 3.17 Location of the 8 polymorphic residues on the predicted 3D structure of 
Blo t 2. The model was predicted based on the solved Der p 2 structure (1KTJ.pdb). 















 Three new group 2 allergens, Ale o 2, Sui m 2 and Blo t 2 are described in this 
study. All three allergens share many similar characteristics to previously identified 
group 2 allergens, such as the presence of a signal peptide, 6 cystein residues in the 
mature protein sequence, β-sheeted secondary structures and presence of the ML 
domain. Members of the ML domain family mediate various biological functions, but 
are similar because of their association with lipid ligands. Although the ligands of Ale 
o 2, Sui m 2 and Blo t 2 have not been identified, it is possible to postulate that it is 
most likely a sterol, as this study shows that Der p 2 binds to cholesterol3.1 in the 
hydrophobic cavity, which is also present in the predicted structures of the newly 
characterized allergens.  
The IgE binding profile of eight group 2 allergens was evaluated using sera 
from a total of 347 individuals from two geographical locations, Singapore and Italy, 
selected based on their differing predominant mite fauna. The predominant mites in 
Singapore are B. tropicalis and Dermatophagoides spp., while in Italy; 
Dermatophagoides spp. is the predominant mite, with no reports on the identification 
of B. tropicalis. In both populations, approximately 60% of the individuals tested 
reacted to crude dust mite extracts. The highest proportion of dust mite positive 
individuals had specific IgE binding to Der p 2, 78% and 69% respectively in the 
Singaporean and Italian populations, which was in agreement with previous studies 
(Platts-Mills et al., 1997; Thomas and Smith, 1998). However, IgE reactivity to Der f 
2 observed in this study (48% in the Singaporean population; 55% in the Italian 
population) was lower than previously reported (80-90%) (Platts-Mills et al., 1997). 
                                                 
3.1 Details on the identification of the ligand of Der p 2 is discussed in chapter 5. 
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Nevertheless, the IgE responses between Der f 2 and Der p 2 displayed a high degree 
of concordance. Using inhibition assays, Der f 2 was found to have high levels of 
cross reactivity to Der p 2 in individuals from both populations.  
 The percentage of individuals with IgE reactivity to Tyr p 2, Lep d 2 and Gly 
d 2 as much lower in this study than those in previous reports. In this study, 26% of 
the dust mite positive individuals from both populations showed IgE reaction to Tyr p 
2, whereas previously 45% (Kronqvist et al., 2000) to 60% (Johansson et al., 1999) of 
the T. putrescentiae positive individuals were shown to have specific IgE to Tyr p 2. 
For Lep d 2, 52.2% (Kronqvist et al., 2000) to 73% (Johansson et al., 1999) had been 
shown to have IgE binding in the L. domesticus positive sera, which was at least 2 
fold higher compared to the results from this study (23% - 28%). Sixteen of the 17 
(94%) RAST-positive G. domesticus individuals tested positive to Gly d 2 (Gafvelin 
et al., 2001), but in this study, only about 20% of the dust mite positive individuals 
showed reactivity to Gly d 2. The discrepancies in the proportion of patients reacting 
to Der f 2, Tyr p 2, Lep d 2 and Gly d 2 may be attributed to the differences in the 
origins of sera tested.  
 In previous reports, IgE cross reactivity between D. pteronyssinus, T. 
putrescentiae, L. destructor and G. domesticus have shown conflicting results. 
Gafvelin et. al. demonstrated extensive cross reactivity between recombinant Gly d 2, 
Lep d 2 and Tyr p 2, but there was almost no cross-reactivity between these allergens 
and Der p 2 (Gafvelin et al., 2001). Similar observations were described in other 
studies using crude extracts from D. pteronyssinus, T. putrescentiae, L. destructor and 
G. domesticus (Johansson et al., 1991; Ebner et al., 1994; Johansson et al., 1994). In 
other studies, extensive cross-reactivity has been observed among the crude extracts 
of D. pteronyssinus, L. destructor, and T. putrescentiae (Park, 1999).  
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In this study, the cross-reactivity between Der p 2, Der f 2, Blo t 2 and Tyr p 2 
in 6 individuals from both populations (3 from each population) were evaluated. All 6 
individuals were chosen as they demonstrated high IgE binding (OD>100) to the 4 
allergens tested. In all 6 individuals, a high degree of cross reactivity between Der p 2 
and Der f 2 was observed, which is likely due to the high sequence identity (88%) 
between these two allergens leading to structural similarities. Similar observations of 
high cross reactivity between Der p 2 and Der f 2 have been reported previously 
(Smith et al., 2001b). All 6 individuals also demonstrated high cross reactivity to Tyr 
p 2 and Blo t 2, as shown in previous studies (Ferrandiz and Dreborg, 1997) possibly 
also owing to the high sequence identity (51%) between the two allergens. 
The influence of B. tropicalis as the predominant mite in Singapore was 
observed as more individuals from Singapore had high and moderate IgE reactions to 
Blo t 2 (and other group 2 allergens from non-pyroglyphid mites) compared to 
individuals from Italy. The majority of individuals that showed IgE reactivity to both 
Blo t 2 and Der p 2 had higher IgE reactions to Der p 2. This suggests that in the 
majority of individuals, there was no or low IgE cross reactivity between Blo t 2 and 
Der p 2. In individuals with high IgE reactions to Blo t 2 and Der p 2 (OD>100), 
moderate to high cross reactivity (52%-88%) was observed among 3 individuals from 
Singapore, whereas high cross reactivity (>80%) was observed among 3 individuals 
from Italy. The high levels of B. tropicalis in Singapore could have elicited the 
production of Blo t 2 specific IgE antibodies, which cross react with Tyr p 2 but not 
with Der p 2 or Der f 2, therefore resulting in moderate cross reactivity in some 
individuals. As Dermatophagoides spp. is the predominant mite species in Italy (with 
almost no reports on the presence of Blomia spp., and low numbers of non-
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pyroglyphid mites), it was not surprising that Blo t 2 and Der p 2 were highly cross 
reactive in individuals with IgE reactions to both allergens.  
IgE reactivity to native Blo t 2 isolated from the crude protein extract of B. 
tropicalis was highly concordant to recombinant Blo t 2, suggesting that the 
recombinant allergen was immunologically similar to its native counterpart, and may 
be used in place of native Blo t 2 for characterization experiments. For an allergen to 
cause an allergic reaction, it must be able to bind to IgE and cross-link IgE antibodies 
bound to mast or basophil cells, causing the cells to degranulate and release 
inflammatory mediators. Recombinant Blo t 2 was able to elicit dose dependant 
histamine release from whole blood of 2 dust mite allergic individuals, suggesting that 
it is capable of in vivo IgE cross-linking.  
Exposure to ≥2 µg of Der p 1 and/or Der f 1 per gram of dust has been shown 
to be a risk factor for sensitization to mites and bronchial hyper-reactivity (Lau et al., 
1989; Arruda et al., 1991). In the indoor environment, the average concentration of 
Blo t 2 was found to be 6 times higher than that of Der f 2 in Singaporean homes, and 
was well over the minimum threshold value of 2 µg/g dust to cause sensitization. 
Although the allergenicities of group 1 allergens of Dermatophagoides spp. (Der p 1 
and Der f 1) were higher than Blo t 2 (Platts-Mills and Chapman, 1987; Thomas et al., 
2002), it was 10 times lower in concentration (Zhang et al., 1997), in comparison to 
the levels of Blo t 2 detected in this study. Similarly, it was observed that the average 
concentration of Der f 2 was lower in the dust samples but demonstrated higher 
allergenicity (14%-21%) compared to Blo t 2. Hence, there is no clear relationship 
between the level of allergen present in the environment and its allergenicity. 
  There have been several reports on the identification of group 2 allergen 
isoforms. In Der p 2, 13 isoforms have been identified with frequent polymorphisms 
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at positions 40, 47, 111 and 117 (Smith et al., 2001b). The isoforms of Der p 2 do not 
vary greatly in IgE binding capacity or T cell response (Hales et al., 2002; Park et al., 
2002). Other group 2 allergens, such as Der f 2, Lep d 2 and Gly d 2 have also been 
reported to have isoallergenic variants. Similarly, in this study, 9 isoforms of Blo t 2 
have been identified. Polymorphic changes in Blo t 2 occur in 8 positions, with 
changes in positions 96, 100 and 125 being the most frequent (each occurring twice). 
There seem to be no preference in the positions at which polymorphisms in group 2 
allergens occur, although it appears like there is some selectivity of polymorphic 
forms based on geographical regions or between cultured and wild mites (Kaiser et al., 
2003; Piboonpocanun et al., 2006). In Blo t 2, all the amino acid residues with 
polymorphic changes were situated on the surface of the molecule, thus are likely to 
cause variations in the allergenic capacities (IgE binding and T-cell reactivity) of 
these isoforms.  
 The evaluation of group 2 allergens from 8 dust mite species using the same 
population of patients enabled a clearer understanding of the allergenic relationship 
between these proteins. The results of this study indicate that Der p 2 is the most 
important group 2 allergen, followed by Der f 2. The six group 2 allergens from the 
non-pyroglyphid mites demonstrated IgE reactivity in a lower percentage of 
individuals (18-40%), with most reactions classified as moderate or low, based on the 
amount of IgE binding. The correlation of IgE reactivity was strong between Der p 2 
and Der f 2, and among the non-pyroglyphid mites. Moderate correlation was 
observed between the IgE reactivity to the pyroglyphid and non-pyroglyphid mites. 
Based on the inhibition experiments, Der p 2, Der f 2, Blo t 2 and Tyr p 2 demonstrate 
moderate to high degree of cross-reactivity in patients with moderate to high 
reactivity to pyroglyphid and non-pyroglyphid mite allergens. Taken collectively, the 
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data generated from this study points to the importance of identifying the cross-
reactive epitopes across group 2 allergens. This would be particularly useful to 
generate molecules lacking the cross-reactive IgE epitopes, for immunotherapy 
treatment of individuals who are polysensitized to multiple group 2 allergens. Similar 
approaches have been taken to generate hypoallergens candidates against other cross-
reactive allergens with encouraging results (Swoboda et al., 2002; Neudecker et al., 
2003). 
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Chapter 4: Identification and characterization of Der f 22, a novel allergen from 




Dermatophagoides farinae and D. pteronyssinus mites belonging to the 
Pyroglyphidae family, are the most important allergy-causing mites (Thomas et al., 
2004). To date, twenty one groups of dust mite allergens have been identified, of 
which the group 1 and 2 are major allergens, causing IgE reactions in about 80% of 
dust mite sensitized patients (Platts-Mills et al., 1997; Thomas and Smith, 1998). 
Thomas et al (2004) however noted that the remaining 20% still constitute a large 
number of allergic individuals worldwide (Thomas et al., 2004). Hence, the 
identification of new allergens, especially those that show limited cross-reactivity to 
group 1 and 2 allergens will be useful in the diagnosis of allergy in this group of 
patients. 
A new putative allergen was first identified in the laboratory from an 
expressed sequence tag (EST) catalogue of D. farinae. This antigen was not 
significantly homologous (i.e., shared >67% amino acid sequence identity) to any 
other allergens identified thus far but was found to bind IgE, and was subsequently 
named Der f 22. This name was accepted by the World Health Organization (WHO) / 
International Union of Immunological Societies (IUIS) Sub-committee of Allergen 
Nomenclature. Der f 22 showed 32% amino acid sequence identity to the published 
Der f 2 sequences (GenBank accession BAA01241). Domain analysis using Pfam 
indicated that both proteins had the ML domain. Homology modeling, performed 
using Swiss-Model accessible via the ExPASy web proteomics server of the Swiss 
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Institute of Bioinformatics, revealed that Der f 22 showed high structural homology to 
Der f 2. Due to the low primary sequence identity, but high 3D structure similarity, it 
was hypothesized that Der f 22 could be a paralogue of Der f 2. 
This study aims to characterize Der f 22 in terms of its gene organization, its 
ability to bind human IgE and its potential biochemical function, in comparison to Der 
f 2, which is a major allergen in D. farinae, and one that share the same functional 
domain (the ML domain). 
 
4.2 Identification, isolation and characterization of Der f 22 
 
An EST clone from the D. farinae library, which did not show significant homology 
(i.e., shared >67% amino acid sequence identity) to any other allergen presently 
characterized was identified. Preliminary IgE binding screens showed that this antigen 
bound to IgE and is thus an allergen. Hence, this clone was named Der f 22, in 
accordance to the allergen nomenclature guidelines (WHO/IUIS, 1994). The complete 
clone of Der f 22 has 468 nucleotides, encoding for 155 amino acid residues (Figure 
4.1). Der f 22 has a predicted signal peptide with a cleavage site between amino acid 
residues 20 and 21, VQA-DE, resulting in a mature protein of 135 amino acid 
residues. The presence of a signal peptide suggests that Der f 22 is a secreted protein. 
The mature protein of Der f 22 has 6 amino acid residues more than Der f 2. 
Additionally, the pro-peptide sequence of Der f 22 (20 amino acid residues) was 
slightly longer than that of Der f 2 by 3 amino acids. There was one predicted N-
glycosylation site for Der f 22 at amino acid residues 129-131 (N-V-T), as predicted 
by the NetNGlyc algorithm (Gupta, 2004).  
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 1         ATGAACCGATTCCTCATTGTTTGCATGGCATTGTTCTGCTTGGCGGCGGCAGTGCAGGCC 
1          M  N  R  F  L  I  V  C  M  A  L  F  C  L  A  A  A  V  Q  A  
 
61        GACGAAACCAACGTCCAGTACAAAGACTGTGGTCATAATGAAATCAAATCCTTCTTTGTG 
21         D  E  T  N  V  Q  Y  K  D  C  G  H  N  E  I  K  S  F  F  V   
         
121       ACCGGCGGCAACCCGAACCAGAAATCGTGTGTTATCCACAAACATAGCAAAAACCAACTG 
41         T  G  G  N  P  N  Q  K  S  C  V  I  H  K  H  S  K  N  Q  L   
              
181       CGAATCAGCTTTGTGGCCAACGAAAACACCGGCAACAAGATCAACACCCGGTTCATCTGC 
61         R  I  S  F  V  A  N  E  N  T  G  N  K  I  N  T  R  F  I  C   
              
241       AACCTGGGCGGCATTGAACTTGGTTGGCCAGGCATCGACGGAACCGACGCTTGCCAAGGC 
81         N  L  G  G  I  E  L  G  W  P  G  I  D  G  T  D  A  C  Q  G   
             
301       CACGGTCTTTCCTGTCCACTGACCAAAGGCCAGACCTACAATTACCACCTTGACTTTAAT 
101        H  G  L  S  C  P  L  T  K  G  Q  T  Y  N  Y  H  L  D  F  N   
                        
361       CTCGGCGACGATGTACCAACAGCTAACGTAACGGCCACAGTGCGATTGGAAAACGGACAT 
121        L  G  D  D  V  P  T  A  N  V  T  A  T  V  R  L  E  N  G  H   
 
421       GGTGGCGACTTGCTTTGCGGCAGAATGCACATTAGTCTTCAAAACTAA 
141        G  G  D  L  L  C  G  R  M  H  I  S  L  Q  N  -   
                           
 
Figure 4.1 Nucleotide and translated amino acid sequence of Der f 22. The predicted 
initiation Met start codon is in bold face and underlined. The signal peptide of Der f 
22 is underlined. The predicted N-glycosylated site (N-V-T, aa 129-131) is italicized 
and underlined. Cystein residues along the predicted mature protein sequence are 
italicized bold faced. The stop codon (TAA) is represented by a dash. The ML domain 
spans from Y21 to R148 of the full length sequence.  
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  Analysis of the amino acid sequence of Der f 22 using the Pfam software 
(Bateman et al., 2004) revealed the presence of the Der-p2_like domain, which is also 
found in other group 2 allergens. This domain is a member of the ML (MD-2-related 
lipid-recognition) domain family. The structure of this domain is characterized by two 
anti-parallel β-pleated sheets, and the presence of an accessible central hydrophobic 
cavity. This domain is predicted to be involved in lipid binding. The ML domain has 
also been identified in MD-1, MD-2, GM2 activator protein, Niemann-Pick type C2 
(NPC2) protein, phosphatidylinositol/ phosphatidylglycerol transfer protein (PG/PI-
TP) and several proteins of unknown function from plants, animals and fungi. 
Although Der f 22 and Der f 2 shared the same functional domain, they only shared 
32% identity at the amino acid level (Figure 4.2). Forty five amino acid residues of 
Der f 22 were identical to Der f 2, and of those, 39 were situated on the surface of the 
protein, while the remaining 6 were placed in the hydrophobic core. 
The solved protein structures of Der p 2 and Der f 2 shows the presence of 3 
disulfide bonds formed by 6 cystein residues in the mature protein, in a 1-6, 2-3, 4-5 
arrangement (Derewenda et al., 2002; Suzuki et al., 2006). A detailed analysis of the 
amino acid sequence of Der f 22 revealed that the second disulfide bond (between 
cysteine residues 30 and 60) may not form due to its distance (Figures 4.3 and 4.4). 
The distance between the Cα atoms of these two residues was calculated to be 13.81Å, 
from the predicted structure of Der f 22, modeled using the solved x-ray crystal 
structure of Der f 2 (1XWV.pdb) as the template. Distances between the Cα atoms of 
all other cysteine residue pairs involved in the disulfide bridge formation ranged 
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Figure 4.2 Alignment between the mature protein sequences of Der f 2 and Der f 22. 
Gaps (represented by dots) were included for optimal alignment. Identical amino 
acids in both sequences are shaded grey and boxed. Asterisks indicate the residues 





Figure 4.3 Cystein pairing in Der f 22 and Der f 2. The distance between the two 
cystein residues which form a disulfide bond is shown in Angstroms (Å). The number 
below each cystein residue refers to its position on the mature protein sequence.The 































Figure 4.4 Ribbon structures of Der f 22 and Der f 2. Predicted 3D structure of Der f 
22 (A) and solved structure of Der f 2 (B). The six cystein residues (shown as sticks) 
forming disulfide bridges are shown. The dotted white line in (A) shows the distance 
between Cys30 and Cys 60. 
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In general, a disulfide bond could potentially formed between two cysteine resides 
when the distance between the Cα atoms is within 8Å, when mapped onto its 
homologous structure (O'Connor and Yeates, 2004).  
The far UV spectra of Der f 2 showed a typical β-sheet structure with a 
minima peak at ~218 nm, and maxima peak at ~195 nm (Figure 4.5). The spectra of 
Der f 22 is shifted from the typical β-sheeted structure, showing a minima peak at 
~207 nm. The shift could be caused by the possible non-formation of the disulfide 
bond between cysteine 30 and cysteine 60, causing 3D structural changes in Der f 22. 
This suggests that Der f 22 and Der f 2 are structurally distinct. 
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Figure 4.5 CD spectra of Der f 22 (solid line) and Der f 2 (dashed line). Twenty 
micromolar of each protein, in 50 mM sodium acetate pH 4.6 was used to obtain the 
circular dichroism spectra. Spectra shown were recorded at room temperature, and are 
averages of 10 scans. Der f 2 shows a spectrum of a typical β-sheeted protein with 
minima at 218 nm, whereas Der f 22 does not. 
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4.3 Genomic organization of Der f 22 and Der f 2 
  
 The genomic organization of Der f 22 and Der f 2 was further characterized. 
The genomic clone of Der f 22 consists of a type 0 intron of 78 base pairs, located 
between codons 127 and 128 of the mature protein sequence (Figure 4.6). Der f 2 had 
a 90 base pair type 1 intron interrupting the codon at amino acid residue 9 of the 
mature protein sequence. This finding was similar to the results published previously 
by Yuuki et. al. (1997) with the exception that the intron identified in this study was 3 
bases longer, owing to a longer poly-T sequence found within the intron. The 
presence of these additional bases was confirmed by re-sequencing the amplified 
products, and by further re-evaluation of the raw electropherogram files (data not 
shown). Twelve nucleotide substitutions were observed when the cDNA and gDNA 
sequences of Der f 2 were compared. These variations are likely to be polymorphisms, 
which is a common phenomenon observed in group 2 allergens (Trudinger et al., 
1991; Yuuki et al., 1991; Smith et al., 2001b).  
Der f 22 and Der f 2 showed similar gene structures with one intron and 2 
exons. However, the position of the introns varied. The intron of Der f 2 was 
positioned at the 5’ end of the gene, similar to the genomic organization of other 
group 2 allergens, namely Der p 2, Lep d 2.01 and Lep d 2.02. In contrast, the intron 
of Der f 22 was positioned at the 3’ end of the clone. For both Der f 22 and Der f 2, 
the sequence of the intron-exon splice junction was in agreement with the GT-AG 
rule (Mount, 1982).  
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A 
Der f 22 cDNA   ATGAACCGATTCCTCATTGTTTGCATGGCATTGTTCTGCTTGGCGGCGGCAGTGCAGGCC 
Der f 22 gDNA   ATGAACCGATTCCTCATTGTTTGCATGGCATTGTTCTGCTTGGCGGCGGCAGTGCAGGCC 
                ************************************************************ 
 
Der f 22 cDNA   GACGAAACCAACGTCCAGTACAAAGACTGTGGTCATAATGAAATCAAATCCTTCTTTGTG 
Der f 22 gDNA   GACGAAACCAACGTCCAGTACAAAGACTGTGGTCATAATGAAATCAAATCCTTCTTTGTG 
                ************************************************************ 
 
Der f 22 cDNA   ACCGGCGGCAACCCGAACCAGAAATCGTGTGTTATCCACAAACATAGCAAAAACCAACTG 
Der f 22 gDNA   ACCGGCGGCAACCCGAACCAGAAATCGTGTGTTATCCACAAACATAGCAAAAACCAACTG 
                ************************************************************ 
 
Der f 22 cDNA   CGAATCAGCTTTGTGGCCAACGAAAACACCGGCAACAAGATCAACACCCGGTTCATCTGC 
Der f 22 gDNA   CGAATCAGCTTTGTGGCCAACGAAAACACCGGCAACAAGATCAACACCCGGTTCATCTGC 
                ************************************************************ 
 
Der f 22 cDNA   AACCTGGGCGGCATTGAACTTGGTTGGCCAGGCATCGACGGAACCGACGCTTGCCAAGGC 
Der f 22 gDNA   AACCTGGGCGGCATTGAACTTGGTTGGCCAGGCATCGACGGAACCGACGCTTGCCAAGGC 
                ************************************************************ 
 
Der f 22 cDNA   CACGGTCTTTCCTGTCCACTGACCAAAGGCCAGACCTACAATTACCACCTTGACTTTAAT 
Der f 22 gDNA   CACGGTCTTTCCTGTCCACTGACCAAAGGCCAGACCTACAATTACCACCTTGACTTTAAT 
                ************************************************************ 
 
Der f 22 cDNA   CTCGGCGACGATGTACCAACA--------------------------------------- 
Der f 22 gDNA   CTCGGCGACGATGTACCAACAGTGAGTTTATCCAGACAGTCAATTATGGCGATAAATAAA 
                *********************                                        
 
Der f 22 cDNA   ---------------------------------------GCTAACGTAACGGCCACAGTG 
Der f 22 gDNA   TGATTTATTCATTATTTTTTATTATTACACTTCACACAGGCTAACGTAACGGCCACAGTG 
                                                       ********************* 
 
Der f 22 cDNA   CGATTGGAAAACGGACATGGTGGCGACTTGCTTTGCGGCAGAATGCACATTAGTCTTCAA 
Der f 22 gDNA   CGATTGGAAAACGGACATGGTGGCGACTTGCTTTGCGGCAGAATGCACATTAGTCTTCAA 
                ************************************************************ 
 
Der f 22 cDNA   AACTAA 
Der f 22 gDNA   AACTAA 















Der f 2 cDNA    ATGATTTCCAAAATCTTGTGCCTTTCATTGTTGGTAGCAGCCGTTGTTGCCGATCAAGTC 
Der f 2 gDNA    ATGATTTCCAAAATCTTGTGCCTTTCATTGTTGGTAGCAGCCGTTGTTGCCGATCAAGTC 
                ************************************************************ 
 
Der f 2 cDNA    GATGTTAAAGATTGTG-------------------------------------------- 
Der f 2 gDNA    GATGTTAAAGATTGTGGTAAGTTTGTTTGTGTGATACATTTTTTTTTTCTTTTCATTTAT 
                ****************                                             
 
Der f 2 cDNA    ----------------------------------------------CCAACAATGAAATC 
Der f 2 gDNA    TCAACACTAAACACAATTTTCTTTTTTATTGTTTATATTCTTATAGCCAACAATGAAATC 
                                                              ************** 
 
Der f 2 cDNA    AAAAAAGTAATGGTCGATGGTTGCCATGGTTCTGATCCATGCATCATCCATCGTGGTAAA 
Der f 2 gDNA    AAAAAAGTAATGGTCGATGGTTGCCATGGTTCTGATCCATGCATCATCCATCGTGGTAAA 
                ************************************************************ 
 
Der f 2 cDNA    CCATTCACTTTGGAAGCCTTATTCGATGCCAACCAAAACACTAAAACCGCTAAAATTGAA 
Der f 2 gDNA    CCATTCACTTTGGAAGCCTTATTCGATGCCAATCAAAACACTAAAACCGCTAAAATTGAA 
                ******************************** *************************** 
 
Der f 2 cDNA    ATCAAAGCCAGCCTCGATGGTCTTGAAATTGATGTTCCCGGTATCGATACCAATGCTTGC 
Der f 2 gDNA    ATCAAAGCTAACATCAATGGTCTTGAAGTTGATGTTCCCGGTATCGATACCAATGCTTGC 
                ******** * * ** *********** ******************************** 
 
Der f 2 cDNA    CATTTTATGAAATGTCCATTGGTTAAAGGTCAACAATATGATATCAAATATACATGGAAT 
Der f 2 gDNA    CATTATATCAAATGTCCATTGGTTAAAGGTCAACAATATGATGCCAAATATACATGGAAT 
                **** *** *********************************  **************** 
 
Der f 2 cDNA    GTGCCGAAAATTGCACCAAAATCTGAAAACGTTGTCGTTACAGTCAAACTTATCGGTGAT 
Der f 2 gDNA    GTACCGAAAATTGCACCAAAATCTGAAAACGTTGTCGTTACAGTCAAACTTATCGGTGAT 
                ** ********************************************************* 
 
Der f 2 cDNA    AATGGTGTTTTGGCTTGCGCTATTGCTACCCATGGTAAAATCCGTGATTAA 
Der f 2 gDNA    AATGGTGTTTTGGCTTGCGCTATTGCTACCCACGCTAAAATCCGTGATTAA 
                ******************************** * **************** 
 
 
Figure 4.6 Location of intron sequences of Der f 22 and Der f 2. Alignments of 
cDNA and gDNA sequences of Der f 22 (A) and Der f 2 (B) are shown. Identical 
nucleotides at the same position are indicated by asterisks, and deletions of 
corresponding nucleotides are indicated by dashes. GT and AG boundaries of the 




4.4 Southern blot analysis 
 
Southern blot was performed using genomic DNA of D. farinae digested with 
four restriction enzymes, EcoR I, Msc I, Hind III and BamH I. None of the restriction 
enzyme sites were present in the complete sequence of Der f 2, whereas for Der f 22, 
Msc 1 restriction site was present 116 bp upstream of the hybridization probe. A 
single labeled band was observed in each restriction enzyme reaction for both Der f 
22 and Der f 2 (Figure 4.7), showing that the genes encoding for each allergen was 
present as a single gene copy. However, each of these genes was located at different 
loci on the mite genome, as seen by the different banding pattern obtained when the 
genomic DNA was digested with the same restriction enzymes. Hence, it is clear that 
Der f 22 and Der f 2 were encoded by two different genes, each belonging to a single 
































Figure 4.7 Genomic Southern blot analysis of Der f 2 and Der f 22. Genomic DNA of 
Der f 2 (A) or Der f 22 (B) were digested completely with four restriction enzymes, 
EcoR I (1), Msc I (2), Hind III (3) and BamH I (4) and separated by electrophoresis on 
a 1.0% agorose gel. The separated fragments were transferred to a Hybond-N 




4.5 IgE binding capacities of Der f 22 and Der f 2  
 
Sera specific IgE responses of 253 dust mite sensitized individuals to Der f 22 
and Der f 2 was measured using immuno-dot blot assay (Figure 4.8). Sera of 121 out 
of the 253 dust mite sensitized individuals showed IgE binding to Der f 2, in contrast 
to 126 to Der f 22. 
For Der f 2, sixteen of the 121 positive responders showed strong IgE binding 
reactions on immuno-dot blots (OD of above 100 units), while 23 had moderate 
reactions (OD 50-100 units). In contrast, 12 of 126 sera of individuals who responded 
positively to Der f 22 had strong IgE binding reaction, and 27 patients showed 
moderate reactions. A total of 70 sera showed IgE binding to both allergens, of which 
10 showed strong IgE binding responses. There was no correlation between the IgE 
binding responses between the two allergens (Pearson’s coefficient = 0.132, p<0.05) 
as seen in Figure 4.9. Next, the extent of cross-reactivity between Der f 2 and Der f 22 
by inhibition ELISA was investigated, using sera of 3 atopic individuals who showed 
high IgE binding to both allergens. Various concentrations of Der f 2 or Der f 22 were 
incubated with sera, before adding to wells coated with either allergen. When Der f 2 
was used to inhibit the IgE binding to Der f 2 immobilized on the solid surface, the 
amount of IgE inhibition increased with the inhibitor concentration, up to a maximum 
of 100%. In contrast, Der f 22 was not able to inhibit the IgE binding to Der f 2 
(Figure 4.10). Similar results were observed when Der f 2 was used as the inhibitor.  
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Figure 4.8 IgE binding capacities of Der f 22 and Der f 2. Scatter plot of IgE binding 
of 253 dust mite allergic individuals. The amount of IgE binding was measured as 
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Figure 4.9 Correlation between IgE binding of dust mite allergic individuals’ sera to 
Der f 22 and Der f 2. Linear regression analysis showed that there was no correlation 
between the IgE binding to the two proteins (r2 =0.132, p<0.05).  
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Figure 4.10 Competitive IgE ELISA assay between Der f 22 and Der f 2. Two 
individual sera (S1 and S2) who had high reactions to both Der f 2 and Der f 22 (OD 
of above 100 units) were pre-absorbed with various concentrations of inhibitors 




4.6 Localization of Der f 22 and Der f 2 on sectioned D. farinae  
 
Microtome sections of D. farinae were probed with anti-Der f 22 and anti-Der 
f 2 IgG antibodies (Figure 4.11C, D). Der f 2 was observed to be localized strongly at 
the hindgut and anterior mid gut region (Figure 4.11C). Faint staining was also 
observed in the area surrounding the anterior mid gut. In contrast, localization of Der f 
22 showed strong staining at the anterior mid gut region (Figure 4.11D). No staining 
was observed when pre-immune sera were used to stain the mite sections (Appendix 
II). The anti-Der f 22 and anti-Der f 2 polyclonal antibodies used for localization were 
not cross-reactive (Figures 4.11A, B), ensuring that the reaction to each antibody was 
specific. The control experiment conducted using bovine serum albumin (BSA) as a 
non-specific inhibitor with the same concentrations showed no inhibitory effect 
(Figure 4.11A, B). 
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Figure 4.11 Cross reactivity of polyclonal IgG antibodies raised against Der f 22 and 
Der f 2, and immunolocalization on D. farinae sections. (A, B) Competitive IgG 
ELISA assay with polyclonal antibodies generated from rabbits. Various 
concentrations of anti -Der f 2 IgG, anti-Der f 22 IgG or BSA were inhibited with (A) 
Der f 2 or (B) Der f 22 in coated plates. Microtome-cut D. farinae sections probed 
with rabbit polyclonal against Der f 2 (C) and Der f 22 (D). Sections were viewed 
using light microscope with 200X magnification. Blue-purple color indicates positive 
staining (arrows) of anterior midgut (Amg) and hindgut (Hg). Negative control using 
pre-immune sera in place of the polyclonal antibody did not show any staining 
(Appendix II).  
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4.7 Concentration of Der f 22 and Der f 2 in the indoor environment  
 
Dust samples from four niches of 56 homes of atopic patients, namely carpets, 
bedrooms, sofas and kitchens were assayed for the levels of Der f 22. In all 4 
locations, the concentration of Der f 22 present was significantly higher than Der f 2 
(p<0.05) (Figure 4.12). The concentration of Der f 22 was highest in the kitchen with 
an average allergen concentration of 12.19 μg/g. Similarly, the highest level of Der f 2 
were detected in the kitchen, with an average allergen concentration of 2.04 μg/g. The 























Figure 4.12 Concentration of Der f 22 and Der f 2 in dust samples. The levels of Der 
f 22 (filled circles) and Der f 2 (open circles) were assayed using ELISA. Dust 
samples were collected by vacuuming four areas within a home, carpet (n=10), 
bedroom (n=31), sofa (n=56) and kitchen (n=22). Horizontal bars indicate the 
geometric mean concentration of allergen in each environmental niche. 
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4.8 Der f 2 and Der f 22 binds to cholesterol  
 
Both Der f 22 and Der f 2 contain the ML domain, suggesting that they may 
share similar functions. Proteins with the ML domain are putative lipid binding 
proteins. In a previous study of a structural homologue of Der p 2, NPC2 was shown 
to bind to cholesterol. The cholesterol binding capacity of Der f 22 and Der f 2 was 
assayed using an ELISA based assay. Both allergens bound to cholesterol at the 
similar intensity, in a dose dependant manner (Figure 4.13). There was no binding 
observed for palmitoyloleoylphosphatidylglycerol (POPG), a phospholipid which was 
used as a negative control in this experiment.  
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Figure 4.13 Binding of Der f 22 and Der f 2 to cholesterol and POPG. Cholesterol or 
POPG was coated on microtiter plates in serial dilutions, and incubated with 0.5 
μg/mL of Der f 22 or Der f 2. The bound protein was then probed with anti-Der f 22 
and anti-Der f 2 IgG antibodies, followed by anti-IgG linked to alkaline phosphatase. 
Intensity of the colorimetric reaction was measured at 405 nm, after the addition of 
the PnPP substrate. Mean and standard deviations of duplicate experiments are shown.  
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4.9 Presence of paralogues of group 2 allergens  
 
A phylogenetic tree drawn from the multiple alignment of published group 2 
allergens and EST sequences that show homology to group 2 allergens (E-value 
<0.001 using BLAST-X algorithm). In total, sequences from 9 dust mite species, 
belonging to 5 families were studied. Since some of the EST sequences were not full 
length, truncated nucleotide sequences were used to prepare the multiple alignments, 
to ensure that the differences observed between sequences reflected the changes in 
amino acid residues, rather than variations in sequence lengths. The phylogenetic tree 
was then drawn using PhyML, using human NPC2 (hNPC2) was used as the outgroup. 
The tree obtained suggests that the event of paralogy is common for this group of 
proteins (Figure 4.14). This tree is a representation of the sequences currently at hand, 
and lacks information on paralogous sequences from Dermatophagoides 
pteronyssinus, Euroglyphus maynei and Blomia tropicalis.  
 Der f 22 falls in the same clade as Der f 2, and the other allergens from the 
family Pyroglyphidae (Der p 2 and Eur m 2). The long branch length of Der f 22 
shows that it has more substitutions than other members of that clade. Also, the event 
of paralogy most likely took place after speciation, as paralogues, Der f 22 and Der f 2 
are clustered in the same clade.  
 Group 2 allergen homologues from Tyrophagus putrescentiae, Acarus siro and 
Aleuroglyphus ovatus (belonging to the family Acaridae) clustered in 3 separate 
clades, suggesting that there were 2 events of gene duplication that occurred before 
speciation. Sequences from A. siro and T. putrescentiae showed additional events of 






Figure 4.14 Phylogenetic relationships of known and putative group 2 allergens. All 
sequences showed homology to group 2 allergens (E-value <0.001) when searched 
using BLAST-X algorithm. Nucleotide sequences were first aligned using 
SequenceHelper, followed by manual editing to obtain an optimal alignment. The 
phylogenetic tree was generated with PHYML using the maximum-likelihood method. 
Numbers on branches indicate bootstrap values (100 simulations). Tree was rooted 
with hNPC2 sequence, which was used as the outgroup. The expected number of 
substitutions per site is 0.1. Some sequence names in the tree were shortened: Gly d 
201 (Gly d 2.01), Gly d 202 (Gly d 2.02), Gly d 203 (Gly d 2.03), Lep d 201 (Lep d 
2.01) and Lep d 202 (Lep d 2.02). The GenBank accession numbers for the sequences 
used are: hNPC2 (AAH02532), TP1461 (CN767356), AS0835 (DR075304), TP1023 
(CN767227), Ale o 2 (AAS75832), Blo t 2 (DQ677253), TP0598 (CN766836), 
AO1003 (CN765143), SM0194 (CN737971), Sui m 2 (AAS75831), Der f 22 
(DQ643992), Der f 2 (Q00855), Eur m 2 (Q9TZZ2), Der p 2 (DQ677264), GDBG28 
(CO437347), AS0498 (DR075197), AS0504 (DR075200), Tyr p 2 (CAA73221), 
TP1905 (CN767658), Gly d 2.01(Q9U5P7), Gly d 2.03 (AAQ54603), Gly d 2.02 
(CAB76459), GDAE81 (CO438261), GDAF87 (CO438634), Lep d 2.01 (P80384), 
Lep d 2.02 (S66499). 
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In the first clade of Acaridae family, sequences from A. siro, T. putrescentiae and A. 
ovatus were seen to cluster together. However, in the second and third Acaridae 
clusters, only 2 of the 3 putative allergen sequences were present. It is speculated that 
there should be 2 events of duplication of each member in the Acaridae family 
preceding speciation, and the missing sequences could be due to incomplete data, or 
loss in evolution. 
 The event of gene duplication in group 2 allergen homologues in Suidasia 
medanensis was observed to occur after speciation. This was similar to sequences 
from Glycyphagus domesticus and Lepidoglyphus destructor (belonging to the family 
Glycyphagidae), except the number of gene duplications were more for G. domesticus 
compared to L. destructor. The two putative group 2 allergen paralogues of L. 
destructor, Lep d 2.01 and Lep d 2.02 were previously reported as variants, and these 
2 sequences differed by 13 amino acid residues (Kaiser et al., 2003). The presence of 
two different Lep d 2 genes, one with and one without the intron, and the presence of 
more than one copy of the Lep d 2 gene at different loci of the L. destructor genome 
suggest that the variants are likely to be paralogues (Kaiser et al., 2003) 
 Two sequences, GDBG28 (from G. domestricus) and TP1461 (from T. 
putrescentiae) were very divergent from other sequences originating from the same 






 The full length clone of Der f 22 was identified from the D. farinae EST 
library. The 135 amino acid mature protein had 6 cysteine residues and a signal 
peptide, a feature that is shared by all group 2 mite allergens isolated thus far. The 
genome organization of Der f 22 was similar to that of Der f 2, in terms of the number 
of introns and exons. Although Der f 22 shares many similar characteristics with Der f 
2, there were some differences. The signal peptide in Der f 22 (20 amino acids) is 3 
amino acids longer than in Der f 2. The length of the signal peptide in group 2 
allergens is normally in the range of 15-17 amino acid residues. Curiously, the intron 
size of Der f 22 (78 bp) showed more similarity to that of Lep d 2.01 (76 bp) and Lep 
d 2.02 (75 bp) (Kaiser et al., 2003) as compared to Der f 2 (90 bp) (Yuuki et al., 
1997). However, the position of the intron in the gene encoding for Der f 22 was 
located further downstream compared to Der f 2, Lep d 2.01 and Lep d 2.02. Southern 
blot hybridization showed that both genes encoding for Der f 22 and Der f 2 were 
from a single gene family and located at different loci on the mite genome. The 
concentration of Der f 22 in the indoor environment was at least 6 times higher than 
Der f 2 in all niches assessed in this study. However, there has been no evidence of a 
direct link between amounts of allergen present in the environment with the extent of 
allergenicity. 
 The allergenicity of both allergens was comparable, although Der f 22 
probably lacked the second disulfide bond. Previous studies on the contribution of 
each disulfide bond in the allergenicity of Der f 2 shows that mutations to C73 or C78, 
and C21 or C27 only resulted in moderate reduction in IgE binding, as compared to 
mutation to C8 or C119 which exhibited the lowest amounts of IgE binding among 
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the 3 mutants (Nishiyama et al., 1995; Takai et al., 2000). This was unlike the results 
observed when the cystein residues in Der p 2 were mutated. Mutation to C73 or C78 
in Der p 2 resulted in the greatest reduction in IgE binding, up to 100 fold lesser than 
the wild type Der p 2, but mutations to the other four cystein residues decreased IgE 
binding between 10-40 folds (Smith and Chapman, 1996). Nevertheless, mutations to 
residues C73 or C78 in Der f 2 also resulted in structural changes in the protein, as 
shown by CD spectra (Takai et al., 2000), similar to the observations seen in this 
study. Taken together, it appears that the second disulfide bond, C73-C78 in Der f 2 
and C30-C60 in Der f 22, is crucial in maintaining the β-sandwich structure, but does 
not play a major role in maintaining the allergenicity of the proteins.  
Both Der f 22 and Der f 2 stained the gut region of D. farinae, although anti-
Der f 22 antibodies showed stronger staining which was contained exclusively in the 
anterior midgut area. The staining with anti-Der f 2 antibodies showed faint staining 
in other organs apart from the gut. Additionally, both proteins show similar dose 
response binding curves to cholesterol, but did not bind to POPG. Since both 
allergens show binding to cholesterol, and the binding site of cholesterol is most 
likely in the cavity region (Derewenda et al., 2002; Ichikawa et al., 2005), the 
residues which are involved in the cholesterol binding should be evolutionarily 
conserved. Based on the solved structure of Der f 2, eleven amino acid residues were 
located in the cavity of the protein, and had hydrophobic side chains. Ten of the 11 
corresponding residues in Der f 22 were hydrophobic residues, except for one residue, 
F35 on Der f 2. The corresponding amino acid residue in Der f 22 was an asparagine, 
which is polar and hydrophilic, making this residue the most unlikely cholesterol 
binding site in Der f 22. Although Der f 2 and Der f 22 have low amino acid identity, 
the conservation of hydrophobic residues in the cavity region of the proteins supports 
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the observation of similarities in lipid binding. Although it is not clear why both 
proteins stain the gut region of D. farinae, it is tempting to speculate that this could 
have some relationship with the cholesterol binding property of the protein.  
The conservation of function in evolutionarily distant proteins, originating 
from the same species is most likely due to a prior event in gene duplication, resulting 
in gene products with modified function. In the case of Der f 22 and Der f 2, both 
proteins have similar IgE and cholesterol binding capacity, and stain the same internal 
organs in the mite. However, both had different secondary structures, most likely due 
to the lack of the second disulfide bond.  
Paralogue gene families are results of gene duplication, and are thought to be 
retained in an organism because of selective benefits. These genes may have 
overlapping functions for the initial period after duplication, but this functional 
redundancy could diminish over time, as these genes acquire more refined roles 
(Green, 2004). Based on the preliminary observation on the allergenic and lipid 
binding capacities of Der f 22 in relation to Der f 2, Der f 22 is likely to be a putative 
paralogue of Der f 2 because of several reasons. First, both proteins belong to the 
same ML domain family and show similar dose responsive cholesterol binding curves. 
Second, two of the three cystein pairs corresponding to the first and third disulfide 
bridges are conserved in Der f 22. All members of the ML domain family show a 
minimum of 2 cystein pairs, except in the case of group 2 dust mite allergens where 
there is the presence of an additional disulfide bridge. Third, although Der f 22 and 
Der f 2 have similar IgE binding capacities, both allergens did not show any cross-
reactivity. 
Owing to the vast sequence diversity of these paralogous genes, discovery 
using standard molecular biology can be difficult and time consuming. Using the 
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expressed sequence tag (EST) approach (Angus et al., 2004), putative paralogues in 
other dust mite allergen groups, including groups 5, 7 and 13 allergens (28-31) have 
been previously identified. This indicates that the occurrence of paralogous sequences 
was not limited to one group of allergens, but is wide spread in the dust mite genome. 
 The identification of Der f 22 is not only important in terms of characterizing a 
new allergen, but also in aiding the understanding and discovery of putative 
paralogous gene products that could potentially be allergens. As 50% of the 
individuals tested showed IgE reactivity to Der f 22, it can be classified as a major 
allergen, as indicated by the allergen nomenclature guidelines (WHO/IUIS, 1994). As 
Der f 22 does not cross-react with Der f 2, it should be added to the allergen test panel 
to accurately diagnosis the cause of allergies. Future work includes investigating the 
IgE binding epitopes of Der f 22 to generate hypoallergen vaccine candidates for 
immunotherapy.  
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Der p 2 and Der f 2 are major allergens from the dust mites Dermatophagoides 
pteronyssinus and D. farinae respectively, and cause IgE mediated responses in >80% 
of the dust mite allergic individuals (Platts-Mills et al., 1997; Thomas and Smith, 
1998). Although Der p 2 and Der f 2 have been characterized extensively in terms of 
their allergenicity, little is known about their biological function. 
Group 2 dust mite allergens belong to the ML family of proteins (Inohara and 
Nunez, 2002; Johannessen et al., 2005). The ML domain, also known as the MD-2 
related lipid recognition domain, belongs to the E set domain superfamily, as 
classified by the Orientations of Proteins in Membranes (OPM) database (Lomize et 
al., 2006). Three dimensional structures of the members of this family (group 2 dust 
mite allergens, NPC2 and GM-2 activator protein) have been solved. The structure of 
group 2 allergens (Der p 2 and Der f 2) shows a single domain β-sandwich protein, 
with 6 anti-parallel β-strands stabilized by 3 disulfide bonds. It has an accessible 
central hydrophobic cavity (Derewenda et al., 2002; Ichikawa et al., 2005). The 
structure of NPC2, another member of the ML domain family, closely resembles the 
group 2 allergen structure with some differences in the size of the cavity (Friedland et 
al., 2003). The third protein, GM2-activator protein shows a β-cup fold, formed by 8 
β-strands (Wright et al., 2000), which is structurally different from group 2 allergens 
or NPC2 structures.  
Members of the ML family of proteins are thought to mediate diverse 
biological functions through interactions with specific lipids (Inohara and Nunez, 
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2002). For example, MD-2 plays an important role in innate immune response against 
bacterial lipopolysaccharide (LPS) (Miyake, 2004) and has been demonstrated to bind 
to LPS with high affinity (Keber et al., 2005).  
Here, the aim is to identify putative ligands of Der p 2. The ligand is most 
likely a hydrophobic (lipid) molecule. The crystal structure of Der p 2 (Derewenda et 
al., 2002) showed the presence of two distinct elongated fragments of high electron 
density within the cavity of the protein, which, in their dimensions, could correspond 
to aliphatic chains of 14-16 carbon atoms. In addition, the cavity of the Der p 2 is 
lined with hydrophobic amino acid residues. The closest structural neighbour of Der p 
2, NPC2 has been shown to bind cholesterol with nanomolar affinity (Ko et al., 2003). 
Since both 3D structures of Der p 2 and NPC2 show high similarity, it is hypothesized 
that the ligand of Der p 2 is likely to be a lipid with close molecular similarity to 
sterols. 
In relation to its function as an immunological molecule, possibly involved in 
the mite’s antibacterial defense system, Der p 2 was shown to bind to the surface of E. 
coli (Ichikawa et al., 1998). In another study, DNA of Gram-negative bacteria was 
identified in washed D. pteronyssinus mites (Valerio et al., 2005). Lipopolysaccharide, 
the major component of Gram-negative bacteria’s cell membrane showed weak 
binding to Der p 2, compared to another protein MD-2 which belongs to the same 
domain family (ML) as Der p 2 (Keber et al., 2005). Therefore, it is likely that Der p 
2 may not play a role in response to Gram-negative bacteria. 
Based on information gathered from the structure of Der p 2 and its close 
structural homology with NPC2, the hypothesis that Der p 2 is a lipid/sterol binding 
protein was tested. Using biochemical lipid binding assays and mass spectrometry, 
direct evidence that Der p 2 binds to cholesterol is provided. Furthermore, the 
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cholesterol binding ability of two other allergens belonging to the ML domain family, 
another group 2 allergen, Der f 2 and a newly identified allergen, Der f 22, was 
demonstrated. 
5.2 Der p 2 binding to liposomes  
 
 A biochemical binding experiment was carried out to investigate the binding 
of Der p 2 to unilamellar lipid vesicles. Crude bovine brain lipid extract, which 
contains approximately 10% phosphatidylinositol, 50% phosphatidylserine, and 
several other brain lipids was used as a lipid source. Liposomes with a defined size 
(0.2 μm in diameter) were prepared in HEPES-KCl buffer, and incubated with Der p 2. 
Bound protein was separated from free protein by centrifugation and separated by 
SDS-PAGE. It was observed that Der p 2 weakly bound to liposomes in a dose 
dependant fashion (Figure 5.1). Binding to liposomes was substantially enhanced 
when cholesterol (20% w/w) was included in the liposomal membrane. This indicated 
that cholesterol may be a ligand of Der p 2. Control experiments using glutathione-S-
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Figure 5.1 Liposome pull down assay. Liposomes with a fixed diameter of 0.4 μm 
were prepared using bovine brain lipid extract in HEPES-KCl buffer with 0.3 M 
sucrose, with (+) or without (-) exogenous cholesterol (20% w/w). Increasing amounts 
of liposomes (5, 10, 20 or 40 µL of a 2 mg/mL lipid suspension) were incubated with 
45 μg of Der p 2, or glutathione-S-transferase (GST) for 30 minutes at 37ºC. The 
incubation mixture was then centrifuged at 30 000 rpm, and the resulting supernatant 
(s) and pellet (p) were separated on a 12% SDS-PAGE gel. The gel was then stained 
with Coomasie Blue to visualize the amount of proteins bound to the liposome (p), or 
unbound (s). 
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5.3 Binding of Der p 2 to purified lipids 
  
An ELISA based assay (Kobayashi et al., 2001) was next used to characterize 
the specificity of Der p 2-lipid interactions in more detail. Various different lipids 
were immobilized and assayed with recombinant Der p 2 followed by detection by 
anti-Der p 2 antibodies. The panel of lipids consisted of sterols, phospholipids, 
triacylglycerols and sphingiolipids, thus representing a wide variety of different lipid 
chemistries (Fahy et al., 2005). Der p 2 exhibited binding to cholesterol consistent 
with the results from liposome sedimentation (Figure 5.2). Eleven closely related 
sterols were included in this assay and it was found that only lathosterol and 7-
ketocholesterol showed a moderate degree of binding to Der p 2 (Figures 5.2 and 5.3). 
The other nine sterols used in this assay, ergosterol, cholesterol ester, β-sitosterol, 
stigmasterol, coprastanol, campesterol, 24-hydroxycholesterol, 7α-hydroxycholesterol 
and 5β, 6β-epoxycholestan-3β-ol did not bind to recombinant Der p 2 in this assay 
(Figures 5.2 and 5.3). 
Five non-sterol lipids, ceramide, palmitoyloleoylphosphatidylcholine (POPC), 
palmitoyloleoylphosphatidylethanolamine (POPE), triacylglycerol (TG) and 
palmitoyloleoylphosphatidylglycerol (POPG) were also tested for their ability to bind 
to Der p 2. Of these, only POPC showed binding to Der p 2, albeit to a much lower 
extent when compared to cholesterol (Figure 5.2).  
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Figure 5.2 Binding of recombinant Der p 2 to five sterol as well as non-sterol lipids. 
Lipids were coated (in serial dilutions) onto microtiter plates and incubated with 0.5 
μg/mL of Der p 2. The bound Der p 2 was then probed with anti-Der p 2 IgG 
antibodies, followed by anti-IgG linked to alkaline phosphatase. Absorbance was 
measured at 405 nm after adding the PnPP substrate. Standard deviations of duplicate 










































Figure 5.3 Binding of recombinant Der p 2 to sterols, phospholipids and 
sphingiolipids. Lipids were coated (in serial dilutions) onto microtiter plates and 
incubated with 0.5 μg/mL of Der p 2. The bound Der p 2 was then probed with anti-
Der p 2 IgG antibodies, followed by anti-IgG linked to alkaline phosphatase. 
Absorbance was measured at 405 nm after adding the PnPP substrate. Standard 
deviations of duplicate experiments are shown. POPC, 




5.4 Analysis of lipid extracts from nDer p 2 and rDer p 2  
 
Next, liquid chromatography (LC) and mass spectrometry (MS) were used to 
determine the identity of lipid ligands bound to Der p 2. Recombinant Der p 2 was 
purified using histidine-tag affinity columns and lipids were extracted with 
chloroform:methanol. This organic extract was then analyzed by LC-MS. In positive 
mode APCI, a prominent ion at m/z 369 is observed at 3.5 min when synthetic 
cholesterol standard is introduced into the LC-MS system. Cholesterol ions, [M+H]+, 
m/z at 387, lose one water molecule, thus m/z 369 [M+H-H2O]+ is the predominant 
parent ion for cholesterol under these conditions. Figure 5.4A shows tandem mass 
spectrometry (MSMS) and collision induced dissociation of cholesterol standard. 
Fragmentation of the parent ion at m/z 369 mainly occurred at C-ring, and produced 
two major daughter ions at m/z 161.0 and 147.0, and m/z 175.1, respectively. Ions at 
m/z 215.2 originate from cleavages in the D-ring. In lipid extracts of recombinant Der 
p 2 (rDer p 2), ions at m/z 369 (i) have the same elution time as cholesterol standard, 
and (ii) also show the same fragmentation pattern as cholesterol standard (Figure 
5.4B), indicating the presence of cholesterol in extracts of rDer p 2. Comparable 
results were observed when the lipid extract of native Der p 2 (nDer p 2) were used in 
place of rDer p 2. These results indicate that cholesterol indeed is a natural lipid 



































































Figure 5.4 LC-MSMS analysis of cholesterol. (A) Cholesterol standard was separated 
on a reversed phase column followed by atmospheric pressure chemical ionization 
(APCI) mass spectrometry on a triple quadrupole instrument. Ions at m/z 369 
correspond to dehydrated singly charged cholesterol in positive mode. The parent ion 
was selected in the first quadrupole and fragmentation induced with a collision energy 
of 40ev. This leads to product ions which originate from various parts of the sterol 
molecule, including the C and D ring. (B) Tandem mass spectrum using the same 
experimental conditions and an organic extract derived from recombinant Der p 2 
(rDer p 2). 
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The presence of other potential lipids in the lipid extract was also investigated using 
electrospray ionization which is generally used for polar compounds. Only low 
amounts of common glycerophospholipid were detected among a number of solvent 
peaks. Quantification (using deuterated internal standard) indicated that the 
cholesterol content was > 10 times higher than that of other polar lipids such as 
phosphatidylcholine (POPC) (data not shown).  
 
5.5 Characterization of potential cholesterol binding sites in Der p 2 via site 
directed mutagenesis  
 
 Eleven amino acid residues lining the cavity of Der p 2 were individually 
mutated to alanine in order to assess their contributions to cholesterol binding of Der 
p 2 (Figure 5.5). All amino acids chosen for site directed mutagenesis (SDM) were 
hydrophobic, and comprised of 6 valines, 2 phenylalanines, one leucine, one 
tryptophan, and one tyrosine. The SDM were expressed in E. coli, purified under 
denaturing conditions, and refolded by rapid dilution into 50 mM sodium acetate pH 
4.6. Circular dichroism (CD) spectra of each SDM were then collected to evaluate any 
changes in the secondary structure of the protein caused by the mutation. The CD 
spectra of all mutants showed typical β-sheeted secondary structures, similar to wild 
type (WT) Der p 2, although there were some differences in the intensity of the 
minima and maxima molar ellipticities (Figure 5.6B,C). When these alanine mutants 
were tested for their cholesterol binding ability using the ELISA based assay, there 
was no significant reduction in cholesterol binding observed, when compared to WT 
Der p 2. Mutants V104A and V16A (Figure 5.6A) represent the extreme cases of 






 YTWNVP VKIAPKSENDer p 2         IEIKASIDGLEVDVPGIDPNACHYMKCPLVKGQQYDIK V
Der f 2         IEIKASLDGLEIDVPGIDTNACHFMKCPLVKGQQYDIKYTWNVPKIAPKSENVVVTVKLI
Der f 22        ICNLGGIELGWPGIDGTDACQGHGLSCSLTKGQTYNYHLDFNLGDDVP-TANVTATVRLE
*     ..     . * *    * . * * *** *  .   *.    * . **  **.. 
Der p 2         -RDQVDVKDCANHEIKK CHG---SEPCIIHRGKP V QNT----KTAK
Der f 2         --DQVDVKDCANNEIKKVMVDGCHG---SDPCIIHRGKPFTLEALFDANQNT----KTAK
Der f 22        DETNVQYKDCGHNEIKCFFVTGGNPNQKS--CVIHKHSKNQLRISFVANENTGNKINTRF
.*  *** ..***   * * .    *  *.**.     *   * **.**     *  
Der p 2         GDDGVLACAIATHAKIRD
Der f 2         GDNGVLACAIATHGKIRD
Der f 22        NGHGGDLLCGRMHISLQN













Figure 5.5 Multiple alignments of the amino acid sequences of Der p 2, Der f 2 and 
Der f 22 coded by their mature proteins. Sequences of Der p 2 and Der f 2 show 88% 
and Der f 2 and Der f 22 32% identity, respectively. Residues lining the cavity of Der 
p 2 which were chosen for generation of alanine mutants are coloured in red and bold 
faced. Stars indicate identical residues, while dots indicate residues with similar 


















































































Figure 5.6 Binding of single site directed mutants of Der p 2 to cholesterol. (A) 
Binding of mutants V16A and V104A to cholesterol using a microtiter ELISA based 
assay. These two mutants represent the extreme cases out of 11 single amino acid 
mutants which were generated. (B and C) Circular dichroism spectra of wild type Der 
p 2 and mutant V104A (B) and V16A (C). Spectra were recorded using 20 μM 
solutions of each protein (in 50 mM sodium acetate pH 4.6 at room temperature). 
Average spectra from 10 scans are shown. V104A leads to a loss of secondary beta 
sheet structure while V16A resembles closely the wild type protein. 
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5.6 Native Der p 2 and two other allergens of the ML domain family bind to 
cholesterol  
 
Next, the cholesterol binding of native Der p 2 (nDer p 2), which was purified 
from a crude protein extract of D. pteronyssinus by immuno-isolation with a 
monoclonal antibody was assayed. Binding of nDer p 2 to cholesterol was 
indistinguishable from recombinant Der p 2 (rDer p 2) (Figure 5.7). The binding 
affinities of two allergens from D. farinae, Der f 2 and Der f 22 to cholesterol were 
assayed as well. Der f 2 and Der p 2 share 88% amino acid identity. Der f 22 is a 
newly identified allergen5.1. Both Der f 2 and Der f 22 showed similar dose response 
binding curves to cholesterol but did not bind to POPG (Figure 4.13). 
                                                 
5.1 The characterization of Der f 22 is detailed in Chapter 4. 
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Figure 5.7 Binding of native or recombinant Der p 2 to cholesterol or POPG. 
Cholesterol or POPG was coated on microtiter plates in serial dilutions, and incubated 
with 0.5 μg/ mL of nDer p 2 or rDer p 2. The bound protein was then probed with 
anti-Der p 2 IgG antibodies, followed by anti-IgG linked to alkaline phosphatase. 
Intensity of the colorimetric reaction was measured at 405 nm, after the addition of 
the PnPP substrate. Mean and standard deviations of duplicate experiments are shown.  
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5.7 Docking of cholesterol on Der p 2 
 
A computational approach was used to predict potential binding locations of 
cholesterol in Der p 2. This method is based on ‘blind’ docking approach (Hetenyi, 
2002). Out of 200 docked conformations, 58 (~30%) were found to be located in the 
cavity of Der p 2. Next, the 200 conformations were ranked according to their docked 
energy. Out of the top 20 conformations, 18 of them (90%) lay in the cavity of Der p 
2, suggesting that the hydrophobic pocket is indeed the most likely site for ligand 
binding. Figure 5.8A-C show the Der p 2/cholesterol arrangements with the lowest 
docked energy. The orientation of the cholesterol molecule within Der p 2 appears to 
be fairly variable, consistent with the relatively spacious cavity (Figure 5.8A-C). The 
same experimental parameters were used to predict the binding site of cholesterol in 
NPC2 and the results reproduced a similar docking orientation as previously reported 








































Figure 5.8 Predicted binding site of cholesterol in Der p 2. A space filled model of 
cholesterol has been docked to Der p 2 (green ribbon), using (Autodock based) blind 
docking approach. The arrangements with minimal docking energies were found to be 
those where cholesterol is located in the hydrophobic cavity of Der p 2 and three 
representative conformations are shown (A-C). (D) Docking of cholesterol onto 
NPC2 (blue ribbon) using the same parameters as in A-C. Note the differences in the 





Lipid binding appears to be a common feature among allergens (Thomas et al., 
2005). Apart from group 2 allergens, group 14 allergens of dust mites are homologous 
to apolipophorin or vitellogenin-like proteins, which are proposed to have energy 
storage and transport functions (Thomas et al., 2005). In plants, several lipid transfer 
proteins such as Ole e 7 from olive (Rodriguez et al., 2001) and Art v 3 from 
mugwort weed (Gadermaier et al., 2004) are important allergens. In mammals, 
several major allergens are identified to belong to the lipocalin super family 
(Mantyjarvi et al., 2000). Many of these allergens were comprehensively studied and 
several structures are now available. However, the identity and role of putative lipid 
ligands in allergenic proteins is not well established.  
In this study, direct evidence that both native and recombinant Der p 2 bind to 
cholesterol is provided. This suggests that cholesterol is indeed a natural lipid ligand 
of Der p 2. The cholesterol bound to native Der p 2 (nDer p 2) could originate from 
dietary sources of the dust mite Dermatophagoides pteronyssinus, which feeds on 
debris of human skin. In the case of recombinant Der p 2 (rDer p 2) on the other hand, 
the cholesterol might originate from the growth medium used for bacterial cultures. 
Indeed, a delipidated fraction of Luria Bertani medium (BioBasic Inc.) used here 
contained 82ng/mL of cholesterol, as measured by mass spectrometry (data not 
shown). 
In addition to Der p 2, it is shown that two other dust mite allergens belonging 
to the ML domain family, Der f 2 and Der f 22 also bind to cholesterol. Thus, it is 
postulated that (chole)sterol binding could reflect a general property of group 2 
allergens, owing to the presence of the ML domain in these proteins. The three 
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allergens assayed in this study are produced in dust mites from the genera 
Dermatophagoides spp. Mites from this genera feed primarily on shed human skin, 
while pathogenically important mites from other genera such as Blomia spp., 
Glycyphagus spp. and Tyrophagus spp. feed on plant proteins (Arlian et al., 2001). 
Due to the dietary differences of these mites, it is suspected that the natural ligand of 
their corresponding group 2 allergens could be a sterol molecule from plant origin. 
Der p 2 bound selectively to cholesterol compared to the other lipids tested 
here. These included representatives of glycerolipids (major component of fat), 
glcyerophospholipids (major membrane lipids) as well as sphingolipids (signaling 
molecules). Moderate binding was observed to lathosterol, 7-ketocholesterol and 
palmitoyloleoylphosphatidylcholine (POPC), possibly indicating promiscuity in 
ligand specificity. This in fact is a common feature of many lipid recognizing protein 
modules, such as the pleckstrin homology (PH) (Lemmon, 2004) or the C-like domain 
1 (CD1) domains (Grant et al., 2002). The structurally similar NPC2 however, 
appears relatively specific for cholesterol (Ko et al., 2003). 
The cavity of Der p 2 varies in size between 1000 – 1700 cubic Angstrom (Å3) 
(Ichikawa et al., 2005). This is large in relation to a cholesterol molecule which 
occupies ~ 700 Å3. To further investigate the exact site of cholesterol binding within 
Der p 2, 11 site directed mutants (SDM) were generated. Single alanine mutation to 
11 amino acid residues lining the cavity of Der p 2 did not show a significant 
difference in cholesterol binding compared to WT Der p 2. The secondary structures 
of these mutants were similar to the WT Der p 2 structure as evaluated by the CD 
spectra (data not shown). This finding can be rationalized by the docking studies. 
Based on the docking conformation of cholesterol on Der p 2 in the three lowest 
docking energies, the orientation of cholesterol appears to be quite variable.  
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These results are different from what was observed in the case of NPC2 (Ko et 
al., 2003). Single alanine mutations of F66, Y100 and V96 almost completely 
abolished binding to cholesterol, suggesting that these three side chains were essential. 
The absence of such dramatic reduction in cholesterol binding to Der p 2 would 
suggest that lipid recognition is mediated by a different mechanism. It is conceivable 
that, in the case of Der p 2, multiple cholesterol binding sites exist within the cavity 
region.  
Several suggestions on the possible role of Der p 2 have been proposed. Early 
reports suggested possible avian lysozyme function (Stewart et al., 1992), which now 
remains less likely, particularly in the light of the fact the Der p 2 structure is mainly 
beta sheeted. Later, Der p 2 was proposed to play a role in male mite reproduction, 
based on 35% identity to a human epididymal gene product (HE1) (Thomas and Chua, 
1995). However, localization study of Der p 2 on sections of D. pteronyssinus 
identified the allergen in the gut and fecal pellets of both male and female mites (Park 
et al., 2000). One promising lead to the elucidation of Der p 2 function came from the 
discovery of its ability to bind to bacterial surfaces (Ichikawa et al., 1998), suggesting 
a role in the innate immunity of dust mites. Although it has been previously 
speculated that acyl groups of lipopolysaccharide (LPS) lipid A bind to the cavity of 
Der p 2, in a similar manner as MD-2 (Ichikawa et al., 2005), this remains 
controversial (Keber et al., 2005). 
  Cholesterol has previously been shown to mediate allergic reactions, which 
are characterized by increases in serum IgE levels, elevated Th2 and suppressed Th1 
cytokines, and increased airway inflammation. Exogeneous addition of cholesterol to 
peripheral blood mononuclear cells of latex allergic patients resulted in increased 
latex-specific IgE, reduction in Th1 cytokine and increase in Th2 cytokine production 
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(Kimata, 2005). In a murine model of asthma, intraperitoneal injections of 
cholesterol-lowering agents caused suppression of eosinophilic airway inflammation 
and reduced the Th2 cytokine levels (McKay et al., 2004). These experiments suggest 
that cholesterol enhances the allergic response in sensitized individuals. Thus, it is 
interesting to find that a major allergen, Der p 2, captures cholesterol. It remains to be 
investigated how this property relates to its potency as an allergen.  
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 An allergic response occurs when IgE antibodies bind to an allergen, resulting 
in its cross-linking on the surface of mast cells, causing it to degranulate and release 
inflammatory mediators such as histamine and leukotriene. Specific allergen 
immunotherapy represents a curative form of treatment for allergies (Bousquet et al., 
1998) and has been reported to have lasting effects, up to 3 years after discontinuation 
of treatment (Mosbech and Osterballe, 1988; Hedlin et al., 1995; Jacobsen et al., 1997; 
Durham et al., 1999). Immunotherapy is based on repeated injections of increasing 
doses of allergen extracts. Conventional immunotherapy using crude allergen extracts 
risk allergic side effects, including anaphylaxis which can be fatal. Safer molecules 
that could be used in immunotherapy would be those with lower IgE binding but 
retained T cell proliferation (King and Spangfort, 2000; Vrtala et al., 2000). 
Maintaining T cell proliferation is important as studies on the mechanisms of 
immunotherapy have highlighted the role of allergen-specific CD4+ T cells in 
tolerance mechanisms and control of allergic responses (Akdis and Blaser, 1999).  
 So far, IgE binding epitopes have mostly been studied using short peptide 
fragments spanning the length of the protein, which provides information for linear 
IgE epitopes. However, most IgE epitopes including that of Der p 2 have been 
reported to be conformational (Van Regenmortel, 1996; Aalberse, 2000). Attempts to 
map the IgE epitopes of Der p 2 using short synthetic peptides or large polypeptides 
from cDNA fragments were unsuccessful, as very low frequency of IgE binding was 
observed for fragments spanning the whole molecule (Chua et al., 1991; van 't Hof et 
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al., 1991). Mutation of cystein residues forming the disulfide bonds which are 
important in the structural stability of Der p 2 drastically reduced IgE reactivity 
(Lombardero et al., 1990; Nishiyama et al., 1993; Smith and Chapman, 1996), 
providing further evidence that IgE binding epitopes of Der p 2 are conformational.  
 There are several approaches in identifying conformational epitopes. In nature, 
less allergenic molecules have been identified as isoforms of potent allergens, e.g. in 
the case of Bet v 1 (a major pollen allergen) (Ferreira et al., 1997; Arquint et al., 
1999). However, identification of isoforms is time consuming, and there is no 
certainty that all allergens have less-allergenic isoform counterparts. A more 
systematic approach to generating less allergenic molecules for therapy would to 
genetically engineer natural allergens by modifying their IgE binding epitopes via site 
directed mutagenesis. The residues located within the IgE epitope region can then be 
identified by direct IgE binding or IgE inhibition studies.  
There have been only four studies on conformational IgE epitope mapping of 
Der p 2 (Smith and Chapman, 1997; Hakkaart et al., 1998; Mueller et al., 2001; Ipsen 
et al., 2004). Each study identified different residues to be important in the IgE 
epitope region. This discrepancy could have been due to the method of epitope 
mapping, which was dependant of the ability of murine monoclonal antibodies to bind 
to Der p 2. It is not known if the specificity of murine and human antibodies are 
similar. Another limitation in the previous studies were that the sample size of allergic 
patients studied was small (<10 patients).  
In this study, the conformation IgE epitopes of Der p 2 were mapped using site 
directed mutagenesis of selected surface residues. These mutants were then assayed 
for IgE binding capacity by direct binding to human serum IgE. A large population of 
dust mite allergic individuals, from two geographical regions were screened to 
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account for variations in IgE specificities in these patients (Karisola et al., 2002). 
Screening of large patient populations enables the identification of 
‘immunodominant’ epitope regions. Designing hypoallergenic molecules based on 
these regions would be effective in the treatment of a larger number of allergic 
individuals. 
 
6.2 Design and production of Der p 2 alanine mutants with single amino acid 
substitution. 
 
A three-stage selection process was employed to select amino acid residues on 
Der p 2 for epitope mapping. Firstly, side chain surface accessibility of each residue 
of Der p 2 was calculated using the WHATIF algorithm (Vriend, 1990) to select for 
residues with high side chain accessibilities, as this is indicative of its accessibility to 
protein-protein interactions (Karisola et al., 2004). Second, using the solved 3D 
crystal structure of Der p 2 (Derewenda et al., 2002), residues which were buried in 
the cavity of the protein were eliminated from the selection, as amino acid residues 
involved in the IgE interactions are mainly located on the surface of the protein 
(Spangfort et al., 2003; Holm et al., 2004).  
Based on the pilot study, a structural homologue of Der p 2, human NPC2 
(hNPC2) (Friedland et al., 2003) did not bind to allergic patients’ serum IgE (Figure 
6.1). In addition, there have been no reports on the allergenicity of hNPC2 in 

















Figure 6.1 Amount of IgE binding to Der p 2 and NPC2. An ELISA assay was used 
to measure the amount of IgE binding to Der p 2 (stripped bar) and human NPC2 
(black bars) in 5 dust mite allergic individuals. Experiment was performed in 
duplicates, and mean and standard deviation of results are shown. 
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As hNPC2 and Der p 2 shared similar 3D structures, it was reasoned that the amino 
acid residues in IgE epitope of Der p 2 are most likely residues that differ in both 
sequences. To refine this selection further, residues with similar side chain properties 
(Q-E, D-N, S-T and V-T) were not selected, in order to have a selection of residues of 
Der p 2 which were distinctly different from hNPC2 (Figure 6.2). Glycines and 
alanines were also not included in the selection, because these residues are normally 
not involved in IgE interactions (Karisola et al., 2004).  
 Based on these considerations, the top 10 residues with the highest side chain 
solvent accessibility and with different chemical properties from hNPC2 were 
selected for epitope mapping. In addition, 11 residues which were previously reported 
to be important residues in the epitope of Der p 2 (Smith and Chapman, 1997; 
Hakkaart et al., 1998; Mueller et al., 2001; Ipsen et al., 2004) were included (Table 
6.1). From the total of 21 residues selected, 15 residues were polar and charged 
residues (His, Lys, Glu and Arg), 5 residues were polar and not charged (Gln, Asn 
and Ile), and one residue, Leu61 was non polar. The average side chain accessibility 
of the selected residues was 32.26 Å2 (ranging from 47.98 Å2 to 19.31 Å2) Residue 
W92 was not included in the panel although it had side chain solvent accessibility of 
39.73 Å2, as its side chain located in the cavity of Der p 2. The remaining residues 
which were not selected had an average solvent accessibility of 21.15 Å2 (ranging 
from 11.36 to 39.73 Å2). Each residue was mutated to alanine using the 
QuikChange® Site Directed Mutagenesis kit (Stratagene) by long distance PCR with 
primers containing mismatches.  
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 Figure 6.2 Alignment of the mature protein sequence of Der p 2 and hNPC2. 
Residues selected for mutagenesis in Der p 2 are shaded grey. 
 
Table 6.1 List of amino acid residues selected for epitope mapping of Der p 2. The 
amino acids were sorted in descending order based on their side chain solvent 
accessibility. Values for total accessibility (Tot.Acc.), backbone accessibility (Back.) 
and side chain accessibility (Side) were calculated using WHATIF (Vriend, 1990), 
and is presented in Å2. 
 
No. PDB# Res Tot. Acc. Back. Side
1 128 ARG 55.86 7.88 47.98
2 6a,* LYS 46.79 1.38 45.42
3 11 HIS 46.74 3.01 43.73
4 22 HIS 44.28 4.80 39.48
5 30a,b HIS 44.57 9.51 35.06
6 55 LYS 35.12 0.56 34.56
7 96b LYS 35.93 1.68 34.25
8 89 LYS 38.19 4.40 33.79
9 97b ILE 36.57 3.02 33.55
10 77 LYS 41.93 8.73 33.19
11 100c LYS 33.48 2.45 31.03
12 61 LEU 32.50 1.57 30.93
13 74a HIS 42.83 12.00 30.83
14 15a LYS 31.11 0.87 30.23
15 25 GLU 31.25 1.38 29.87
16 85 GLN 38.06 8.22 29.84
17 10 ASN 30.18 2.14 28.04
18 114d,* ASN 36.59 10.15 26.44
19 93b ASN 25.61 5.49 20.12
20 102b GLU 20.50 0.63 19.87
21 62a GLU 25.27 5.96 19.31  
a Ipsen et al., 2004 
b Mueller et al., 2001 
c Smith and Chapman, 1997 
d Hakkaart et al., 1998 
*Residues which were similar in Der p 2 and hNPC2 were selected because they were 
shown to be important in previous studies. 
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Alanine was chosen as it is a simple amino acid, with almost neutral charge and no 
bulky side chains. Sequences of mutants were confirmed by DNA sequencing, and 
proteins were expressed, purified and refolded in the same way as wild type (WT) Der 
p 2. All mutant recombinant proteins showed similar β-sheeted secondary structure as 
WT Der p 2, with maxima and minima wavelengths at ~195 and 218 nm respectively, 
except for mutation to residue K96. Alanine mutant of residue K96 caused unfolding 
of the resulting recombinant protein, as observed in the CD spectra (Figure 6.3). 
Nevertheless, mutant K96A was retained in the panel, as a means of studying the 
effects of protein unfolding on IgE binding. Mutant K96A will be refered to as 
unfolded Der p 2 in this thesis. 
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Figure 6.3 Far UV circular dichroism spectra of wild type Der p 2, the unfolded 
protein (K96A) and mutants E25A, and E102A. Spectra were recorded using 20μM 
solutions of each protein (in 50 mM sodium acetate pH 4.6 at room temperature). 




6.3 Reaction profile of dust mite allergic patients from Singapore and Italy 
 
Prior to IgE epitope mapping of Der p 2, the IgE reaction of the dust mite 
allergic individuals to WT Der p 2, Blo t 2 and hNPC2 were assayed. Blo t 2 was 
included, as a representative of the non-pyroglyphid mites, as it had been previously 
established that the IgE reactivity of Der p 2 and Blo t 2 were moderately cross-
reactive. hNPC2 was included, as it has not been reported as an allergen to date, and 
from the pilot study carried out, none of the individuals tested had IgE binding to this 
protein. A total of 347 individuals from 2 regions were selected (Singapore and Italy), 
as they represented environments with distinct predominant dust mite species. The 
predominant dust mites in Singapore are B. tropicalis followed by Dermatophagoides 
spp. (Chew et al., 1999a) while Dermatophagoides spp. predominates the mite fauna 
in Italy, where the presence of B. tropicalis has not been reported (Bigliocchi et al., 
1996; Verini et al., 2001). The varied mite distribution in the two geographical areas 
is most likely due to the differences in climate as B. tropicalis favours tropical regions 
with higher relative humidity and temperature (Arlian et al., 1993), whereas D. 
farinae is found mostly in dryer temperate regions (Bigliocchi et al., 1996). Patients 
from different geographical areas may develop IgE antibodies with variable 
specificities, recognizing different epitopes on the same allergen (Karisola et al., 
2002). 
A total of 202 Singaporean and 145 Italian allergic individuals were evaluated 
in this study. Fifty seven percent of the Singaporean and 59% of the Italian allergic 
individuals tested positive to dust mites. Among the dust mite positive individuals, 
most showed IgE reactions to Der p 2; 78% of the Singapore population, and 69% of 
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the Italian population. The proportion of individuals with IgE reaction to Blo t 2 was 
much lower in comparison, at 34% in both populations.  
In the pilot study, none of the 5 allergic individuals showed IgE binding to 
hNPC2, but the screening of a larger population showed that among the dust mite 
positive individuals, 29% in the Singapore population, and 41% in the Italian 
population had IgE reaction to hNPC2. The occurrence of allergic individuals who 
displayed IgE reactions to hNPC2 alone in each population was rare (<0.1% of 
patients). Moderate concordance of IgE response was observed between Der p 2 and 
hNPC2, and between Der p 2 and Blo t 2 in both populations (Figures 6.4A,B and 
6.5A,B). Most of the allergic individuals from both populations showed higher IgE 
reactivity to Der p 2 when compared to hNPC2 or Blo t 2 (Figures 6.4A,B and 
6.5A,B). As described in chapter 3, individuals with high IgE reactivity to Der p 2 and 
Blo t 2 showed moderate to high cross-reactivity between the two allergens. Similarly, 
it is speculated that in individuals with high IgE reactivity to Der p 2 and hNPC2, it is 
likely that the IgE reactions to hNPC2 is cross reactive to that of Der p 2. Inhibition 
assays to validate the cross-reactivity between hNPC2 and Der p 2 were not carried 
out due to the lack of sera. IgE reactions between Blo t 2 and hNPC2 were highly 
concordant in both populations (Figures 6.4C and 6.5C) suggesting that both allergen 
were likely to be cross reactive. 
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Figure 6.4 Biplots of IgE reaction between Der p 2, Blo t 2 and hNPC2 among dust 
mite allergic individuals in the Singaporean population. The amount of IgE binding 
was assayed using immuno dot blots and measured as optical density (OD). The 
coefficients of correlation are presented on each graph (p<0.01). 
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Figure 6.5 Biplots of IgE reaction between Der p 2, Blo t 2 and hNPC2 among dust 
mite allergic individuals in the Italian population. The amount of IgE binding was 
assayed using immuno dot blots and measured as optical density (OD). The 
coefficients of correlation are presented on each graph (p<0.01). 
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Based on the Venn diagram showing the number of patients who had IgE binding to 
each protein tested (Figure 6.6), the allergic individuals of each population were 
further divided into four groups, based on their IgE reactivity profile; (i) Der p 2 
positive (Blo t 2 and hNPC2 negative), (ii) Der p 2 and hNPC2 positive (Blo t 2 
negative), (iii) Der p 2, Blo t 2 and hNPC2 positive, and (iv) Der p 2 and Blo t 2 
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Figure 6.6 Venn diagram of number of allergic individuals with IgE reactivity to Der 
p 2, NPC2 and Blo t 2. The numbers of individuals having IgE reactivity to all three 
allergens in the (A) Singapore and (B) Italian populations are shown. IgE reactivity 
was measured using the immuno dot blot assay. The Venn diagram was not drawn to 
scale. 
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6.4 IgE epitope mapping of Der p 2 in the Singaporean and Italian populations 
based on sensitization profiles. 
 
IgE binding to each mutant protein was assayed using an immuno dot-blot 
assay. One microgram of each recombinant protein was spotted on a nitrocellulose 
membrane and incubated with sera from allergic individuals. The amount of IgE 
binding was then detected using alkaline phosphatase conjugated anti-human IgE. 
Intensity of the colorimetric reaction after the addition of NBT/BCIP substrate was 
measured as optical density (OD), and was proportional to the amount of IgE binding. 
The amount of IgE binding for each mutant was calculated as a percentage based on 
the allergic individuals’ reaction to WT Der p 2. Mutants showing 75% or less IgE 
binding (of WT Der p 2) in at least 40% of the patients were considered as important 
IgE binding residues. Based on this criterion, the critical residues in each sensitization 
group from the Singapore and Italian populations were evaluated.  
In group (i) of individuals who show IgE binding to Der p 2, and not to Blo t 2 
or hNPC2, 17 residues were identified to be important in the Singapore population, 
and 13 in the Italian population (Figure 6.7). All 13 residues identified in the Italian 


























































































































































































































































































Figure 6.7 IgE binding of the 21 single alanine mutants of Der p 2 in individuals of 
group (i) sensitization profile. Individuals in group (i) sensitization profile show IgE 
binding to Der p 2, but not NPC2 or Blo t 2. Bars indicate percentage of individuals 
showing less than 75% IgE binding, compared to WT Der p 2 in the Singaporean (A) 
and Italian (B) populations respectively. The mutants were ordered numerically. A 
mutant was considered to be important in the IgE epitope of Der p 2 (indicated by the 
black bars) when at least 40% of the population (indicated by the horizontal dotted 
line) showed <75% IgE binding. Asterisks at mutant K96A indicate that this mutant is 
unfolded. 
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The positions of these residues were mapped onto the solved crystal structure 
of Der p 2 (Derewenda et al., 2002) (Figure 6.8). As seen from the structure, some 
residues such as H22-E25, L61-E62 and R128-E102-H30 were clustered together, 
forming a larger epitope region. Ten of the 13 residues identified were polar and 
charged residues, while of the remaining 3, N93 and I97 were polar but not charged 
residues, and L61 was non-polar. In addition, most of the residues identified were 
located on one ‘side’ of Der p 2. Residue K96 was not presented on the structure of 
Der p 2 because mutation of this residue to alanine causes unfolding of the protein 
structure, and therefore the effect of this mutation is no longer localized, but rather 
























Figure 6.8 Location of important IgE binding residues which were conserved in the 
Singaporean and Italian populations on Der p 2 in the group of patients from the 
group (i) sensitization profile. Individuals in group (i) sensitization profile show IgE 
reaction to Der p 2, but not to Blo t 2 or hNPC2. Positively charged residues are 
coloured red, negatively charged residues are coloured blue, polar uncharged residues 
are coloured green and non- polar residues are coloured yellow. Residue K96 is not 
shown on the structure of Der p 2 as mutation to this residue resulted in structural 
changes to the mutant protein. 
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In group (ii) which consists of individuals with IgE binding to both Der p 2 
and hNPC2, but not Blo t 2, nine important IgE binding residues were identified in the 
Singaporean population, and 10 residues in the Italian population (Figure 6.9). The 
number of important residues identified in both populations is reduced, compared to 
patients in group (i) sensitization profile. This may be an effect of additional IgE 
reactivity to hNPC2.  
Alanine mutation to five amino acid residues showed reduced IgE binding in 
both populations, N10, E25, K77, K96 and E102. Only residue N10 was polar and 
uncharged, while the other four amino acid residues were polar and charged (Figures 
6.9 and 6.10). 
Six residues were identified as important in the Singapore population, and 7 
residues in the Italian population in group (iii), individuals showing IgE binding to 
Der p 2, Blo t 2 and hNPC2 (Figure 6.11). Five residues (N10, E25, K77, K96 and 
E102) were common across both populations in this group, and these residues were 
similar to the common residues identified in patients from group (ii) sensitization 
































































































































































































































































































Figure 6.9 IgE binding of the 21 single alanine mutants of Der p 2 in individuals of 
group (ii) sensitization profile. Individuals in group (ii) sensitization profile show IgE 
binding to Der p 2 and hNPC2, but not to Blo t 2. Bars indicate percentage of 
individuals showing less than 75% IgE binding, compared to WT Der p 2 in the 
Singaporean (A) and Italian (B) populations respectively. The mutants were ordered 
numerically. A mutant was considered to be important in the IgE epitope of Der p 2 
(indicated by the black bars) when at least 40% of the population (indicated by the 
horizontal dotted line) showed <75% IgE binding. Asterisks at mutant K96A indicate 







Figure 6.10 Location of important IgE binding residues which were conserved in the 
Singaporean and Italian populations on Der p 2 in patients from the groups (ii) and (iii) 
sensitization profiles. Individuals in group (ii) sensitization progile show IgE 
reactions to Der p 2 and hNPC2 but not Blo t 2, whereas individuals in group (iii) 
sensitization profile show IgE reactions to Der p 2, hNPC2 and Blo t 2. Positively 
charged residues are coloured red, negatively charged residues are coloured blue and 
polar uncharged residues are coloured green. Residue K96 is not shown on the 























































































































































































































































































































Figure 6.11 IgE binding of the 21 single alanine mutants of Der p 2 in individuals of 
group (iii) sensitization profile. Individuals in group (iii) sensitization profile show 
IgE binding to Der p 2, hNPC2 and Blo t 2. Bars indicate percentage of individuals 
showing less than 75% IgE binding, compared to WT Der p 2 in the Singaporean (A) 
and Italian (B) populations respectively. The mutants were ordered numerically. A 
mutant was considered to be important in the IgE epitope of Der p 2 (indicated by the 
black bars) when at least 40% of the population (indicated by the horizontal dotted 




The final group of individuals, (group (iv)), were those exhibiting IgE binding 
to both Der p 2 and Blo t 2, but not to hNPC2. From the Singapore population, 14 
individuals were categorized in this group, whereas there was only 1 individual in the 
Italian population. Since the number of individuals in this group from the Italian 
population was small, it was omitted from this study. In the Singaporean population, 
20 of the 21 residues were classified as important, based on the previous selection 
criteria (Figure 6.12). Mutation at residue I97 caused almost no change in IgE binding 






























































































































































































Figure 6.12 IgE binding of the 21 single alanine mutants of Der p 2 in the Singapore 
population in the group (iv) sensitization profile, with individuals who show IgE 
binding to Der p 2 and Blo t 2, but not NPC2. The mutants were ordered numerically. 
Bars indicate percentage of individuals showing less than 75% IgE binding, compared 
to WT Der p 2. The mutants were considered to be significant (indicated by the black 
bars) when at least 40% of the population (indicated by the horizontal dotted line) 
showed this reduction. Asterisks at mutant K96A indicate that this mutant is unfolded. 
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 In summary, three mutants, E25A, E102A and unfolded Der p 2, showed 
consistent reduction in IgE binding in all sensitization groups from the Singapore and 
Italian populations (Table 6.2). N10 and K77 were important IgE binding residues in 
all groups, except in Italian individuals from sensitization group (i). Mutants H11A, 
Q85A, K6A and N114A showed the least reduction in IgE binding, compared to all 
the mutants studied (Table 6.2). 
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Table 6.2 Summary of IgE reactions to dust mite allergic individuals based on 
population and sensitization groups. Group (i) refers to individuals with IgE reaction 
to Der p 2, but not Blo t 2 or hNPC2; group (ii) refers to individuals with IgE reaction 
to Der p 2 and hNPC2 but not to Blo t 2; group (iii) refers to individuals with IgE 
reaction to Der p 2, Blo t 2 and hNPC2; group (iv) refers to individuals with IgE 
reaction to Der p 2 and Blo t 2, but not to hNPC2. The dot (●) indicates that the IgE 
binding to the mutant was <75% in at least 40% of the population. Individuals from 
Singapore are denoted as Sg, and individuals from Italy are denoted as It. Asterisks at 




Sg It Sg It Sg It Sg
K6A ● ●
N10A ● ● ● ● ● ●
H11A ●
K15A ● ● ● ●
H22A ● ● ●
E25A ● ● ● ● ● ● ●
H30A ● ● ● ●
K55A ● ●
L61A ● ● ● ●
E62A ● ● ● ●
H74A ● ●
K77A ● ● ● ● ● ●
Q85A ●
K89A ● ● ● ●
N93A ● ● ● ●
K96A* ● ● ● ● ● ● ●
I97A ● ● ●
K100A ● ● ● ● ●
E102A ● ● ● ● ● ● ●
N114A ● ●
R128A ● ● ● ●





6.5 Evaluation of the changes in secondary structures of mutant E102A and 
unfolded Der p 2 
 
As seen in the previous section, both mutants E25A, E102A and unfolded Der 
p 2 shows reduced IgE binding capacity, although these mutants only differed from 
the WT protein by one amino acid residue. To evaluate if this reduction in IgE 
reactivity was due to a change in local structure, or a more globalized structural 
disruption, the secondary structures of the mutants were evaluated. The CD spectra of 
mutants E25A and E102A was similar to that of WT Der p 2 (Figures 6.3), with both 
mutants showing a typical β-sheeted structure with minima and maxima wavelengths 
at ~195 and 218 nm respectively. Additionally, both wild type and E102A mutant of 
Der p 2 showed similar elution profile when separated using the size exclusion 
column (Figure 6.13A), suggesting that the overall 3D structures of both proteins 
were comparable. The 3D structure of mutant E102A was then predicted by modeling 
against the solved crystal structure of Der p 2. The predicted mutant structure shows 
reduced surface area and change in topography at residue 102 compared to WT Der p 
2, corresponding to the change in the size of the side chain (Figure 6.13B), whereas 









































Figure 6.13 Size exclusion chromatography elution profiles and predicted structures 
of WT Der p 2 and E102A mutant of Der p 2. (A) Size exclusion chromatography 
elution profiles of Der p 2 (solid line) and E102A mutant (dotted line). Both proteins 
eluted at the same time, indicating the similarity in conformation and size of the 
proteins. (B) Location of residue E102 on solved crystal structure of Der p 2 (1KTJ) is 
shown. 
 152
In contrast, mutation to residue K96 to alanine resulted in a drastic change in 
its secondary structure. The unfolded Der p 2 (resulting from mutation of residue K96 
to alanine) showed a typical spectrum of unstructured protein, with a pronounced 
minimum near 200 nm (Figure 6.14A). It is likely that the change in the structure of 
mutant K96A resulted in the dramatic reduction in IgE binding observed. Alanine 
mutation of several residues adjacent to K96 (Y90, W92, N93, I97, K100 and E102) 
did not show significant changes to the secondary structure of the mutant proteins, 
when compared to WT Der p 2 (Figures 6.14B,C).  
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Figure 6.14 Circular dichroism (CD) spectra of WT Der p 2 and alanine mutants of 
Der p 2. (A) Far-UV CD spectra of WT Der p 2 (solid line) and K96A mutant (the 
unfolded Der p 2) (dotted line) were recorded at room temperature, and averages of 
10 scans are presented. WT Der p 2 shows a typical spectrum of a β-sheet protein, 
while unfolded Der p 2 (K96A) shows a typical spectrum of an unstructured protein, 
with a pronounced minimum at 200nm. (B-C) CD spectra of mutants Y90A, W92A, 





 As Der p 2 is a potent allergy elicitor among dust mite sensitized individuals, 
identifying the critical IgE epitopes on this molecule is the first step to generating safe 
hypoallergenic vaccines lacking the IgE-binding residues (Valenta, 2002). To this end, 
the IgE epitopes of Der p 2 were mapped using single alanine mutants in two 
populations coming from regions varied in their predominant mite fauna. The IgE 
epitopes of Der p 2 were mapped in a total of 201 dust mite allergic individuals from 
Singapore and Italy. When sera from these allergic individuals were tested for IgE 
reaction to Der p 2, Blo t 2 and hNPC2, it was observed that 69 individuals (34 
Singaporean and 35 Italian) showed IgE reactivity to hNPC2. This was unexpected as 
similar results were neither observed in the pilot study nor reported previously. The 
moderate to strong correlation of IgE reactivity between hNPC2 and Der p 2 and Blo t 
2 in the majority of the individuals suggests that IgE reaction to hNPC2 is most likely 
due to cross-reactivity between the proteins.  
 Based on the IgE reaction profiles to Der p 2, Blo t 2 and hNPC2, the dust 
mite positive individuals were further divided into four sensitization groups. 
Individuals reacting to more allergens displayed reduced IgE binding to fewer 
mutants, compared to those reacting to only one allergen. For instance, individuals 
reacting to Der p 2 (and not Blo t 2 or hNPC2) showed reduced IgE binding to 13 
mutants, whereas individuals reacting to Der p 2, Blo t 2 and hNPC2 displayed 
reduced IgE binding to only 5 mutants. However, this trend was not observed in the 
Der p 2 and Blo t 2 positive Singaporean individuals. This group of individuals 
showed reduced IgE binding to all mutants, except mutant I97A. The reason for this is 
presently unclear, as there are only results from one population of 14 individuals.  
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There were more similarities within the same sensitization group in terms of 
important residues involved in IgE binding, compared to within a population of 
allergic individuals originating from the same geographical region. This stresses the 
importance of defining the groups based on their sensitization profiles prior to IgE 
epitope mapping. Three mutants, E25A, E102A and unfolded Der p 2 which showed 
consistent reduction in IgE binding for all sensitization groups from both the 
Singaporean and Italian populations, have been identified earlier as IgE epitopes of 
Der p 2 using a different approach (Mueller et al., 2001). However, there were no 
reports on the effect of single alanine mutation to the 3D structure of the protein. 
Based on the CD spectra data, mutation of residue K96 to alanine caused a drastic 
change in the secondary structure of the protein, from a β-sheeted structure to an 
unfolded structure. Residue K96 appears to be crucial in the correct refolding of Der p 
2 as no significant changes in secondary structures were observed when residues 
adjacent to K96 were mutated (3 residues on either side of K96). In another study, 
mutation to a single amino acid in Pru av 1 (a cherry allergen) resulted in a unfolded 
structure, compared to WT allergen, with nearly complete loss of IgE binding 
(Neudecker et al., 2003). On the other hand, alanine mutation to residues E25 and 
E102 showed no obvious changes in the secondary structures of the protein, as their 
CD spectra was superimposable with that of the WT Der p 2. Therefore, the reduction 
in IgE binding could be a result of the local changes in surface accessibility or charge 





E25A, E102A and unfolded Der p 2 could be potential hypoallergen vaccine 
candidates, as they demonstrate reduced IgE binding capacity, compared to the WT 
Der p 2. Further evaluation of their ability to stimulate T-cell proliferation, produce 
blocking IgG antibodies and reduced skin prick reactivity is necessary to assess their 
applicability as hypoallergens.  
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The use of allergen specific immunotherapy has been practiced for over 90 
years, and was first introduced for the treatment of hay fever (Freeman, 1911; Noon, 
1911). Administration of increasing dosages of pollen extracts by subcutaneous 
injections reduced the symptoms associated with grass pollen induced allergic rhinitis 
(Freeman, 1911; Noon, 1911). The use of crude proteins for immunotherapy risks 
allergic side effects in some individuals. Therefore, research is now being done to 
design and evaluate the efficacy of hypoallergenic molecules, with reduced IgE 
reactivity to increase the safety of immunotherapy (Ferreira et al., 2002; Vrtala et al., 
2004).  
The dust mite D. pteronyssinus is widely distributed, from tropical to 
temperate regions (Thomas et al., 2004). More than 80% of dust mite sensitized 
individuals have IgE binding to Der p 2, the group 2 allergen from this dust mite 
(Platts-Mills et al., 1997; Thomas and Smith, 1998), emphasizing the need to generate 
and evaluate hypoallergens of this allergen. Although some research has been done 
previously to identify the IgE epitopes of Der p 2 (Smith and Chapman, 1997; 
Hakkaart et al., 1998; Mueller et al., 2001; Ipsen et al., 2004), the mutants generated 
were not well characterized for their efficacy as a hypoallergen vaccine candidates. 
Alanine mutation to three residues, E25, K96 and E102 showed greater than 
75% reduction in IgE binding (compared to WT Der p 2) in at least 40% of the 
allergic individuals tested, and therefore were considered important in the IgE 
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epitopes of Der p 2 (described in Chapter 6). Alanine mutation to residues E25 and 
E102 did not result in major changes in the secondary structure of Der p 2, suggesting 
that the reduction in IgE binding observed was attributed to differences in the local 
topography or surface charge. Mutation of residue K96 to alanine however resulted in 
an unfolded protein. Nevertheless, this mutant was included in this study, as both 
unfolded and correctly folded proteins have been previously identified as potential 
hypoallergen vaccine candidates for other allergens (Neudecker et al., 2003; Buhot et 
al., 2004). Hypoallergen candidates that are suitable for immunotherapy should 
display reduced IgE reactivity, no skin prick test reactivity, ability to produce 
blocking IgG antibodies and induce T-cell proliferation, and a change in cytokine 
profiles from Th2 to Th1 type (Valenta, 2002). 
 
7.2 Specific IgE binding to site directed mutants of Der p 2 in five allergic 
individuals 
 
 Twenty one site directed alanine mutants of Der p 2 were generated to 
evaluate their contribution to the IgE epitope of Der p 2 (as described in section 6.2 
and Figure 6.2). WT Der p 2 and its mutants were expressed as recombinant proteins 
in E. coli (BL21). The proteins were formed in inclusion bodies and were purified 
under denaturing conditions. The proteins were then refolded using the rapid dilution 
method, to obtain them in their native state. 
The IgE reactivity to WT and mutants of Der p 2 were assessed in five allergic 
individuals selected as representatives from two sensitization profiles. Four 
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individuals, OS, YV, KE and ED showed IgE reactivity to Der p 2, but not to hNPC2 
or Blo t 2 (group (i) sensitization profile as described in chapter 6), while HE showed 
IgE reactivity to Der p 2 and Blo t 2, but not hNPC2 (group (iv) sensitization profile) 
(Figure 7.1). Individuals who reacted to all three proteins (Der p 2, Blo t 2 and hNPC2) 
were not included in this study, so that the effects of Der p 2 mutagenesis could be 
clearly delineated without the influence of hNPC2. 
IgE reactivity of sera from five dust mite allergic individuals were tested to 
each alanine mutant using ELISA. Each individual displayed varying amounts of IgE 
binding to WT Der p 2, and unique IgE binding profiles to the mutants of Der p 2 
(Figure 7.1). All individuals showed almost negligible levels of IgE reactivity to 
hNPC2 (absorbance of 0.1-0.3 at OD 450 nm). Only one of the five individuals (HE) 
showed IgE binding to Blo t 2 (62% of WT Der p 2). 
In the previous chapter, three site directed mutants, E25A, E102A and 
unfolded Der p 2 (due to mutation of residue K96 to alanine) consistently showed 
reduced IgE binding amounts in a screen of 201 dust mite allergic individuals among 
the 21 mutants tested. In the five individuals selected, reduced IgE reaction compared 
to WT Der p 2 was consistently observed for two mutants, E102A and unfolded Der p 
2. Mutant E25A only displayed lower IgE binding in one of the five individuals (KE), 
and was therefore not tested in the following sections. For mutant E102A, the relative 









































































Figure 7.1 Amount of IgE binding of 5 allergic individuals to Der p 2, hNPC2, Blo t 
2 and selected site directed mutants of Der p 2. The amount of IgE binding was 
assayed using ELISA. The mutants were ordered numerically. Mean and standard 
deviations of two independent assays are presented. Results of each individual are 
indicated with abbreviated names at the top of the graph. Asterisks at mutant K96A 
indicate that this mutant is unfolded. 
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In 2 individuals, YV and HE, the reduction in IgE binding to mutant E102A was 38% 
and 30% respectively, which was not as high compared to the other 3 individuals all 
of whom averaged 75% reduction in IgE binding. Nevertheless, this mutant showed 
the biggest drop in IgE binding compared to other mutants evaluated in these two 
individuals (Figure 7.1, Table 7.1). The unfolded Der p 2 showed the lowest amount 
of IgE binding in all individuals (averaging 89% reduction compared to WT Der p 2) 
almost comparable the levels of IgE binding to hNPC2.  
Serum from an allergic individual with high serum IgE, which was not 
specific to Der p 2 was included in this study as a negative control. For this individual, 
the amount of IgE binding to WT Der p 2 was very low (absorbance of 0.20), which 
was comparable to the amount of IgE binding of other dust mite allergic individuals to 
hNPC2. This individual also did not display IgE reactivity to any of the alanine 
mutants of Der p 2 (data not shown). 
Mutants showing 75% IgE binding or lesser compared to WT Der p 2 were 
considered to be important in the IgE epitope. Using this cut-off value, there were 
additional mutants showing reduction in IgE binding in ED and KE (Table 7.1). In ED, 
mutants L61A, K77A and N114A showed 43%, 37% and 52% reduction in IgE 
binding respectively when compared to WT Der p 2. KE displayed reduction in IgE 
binding to an additional 7 mutants, E25A, K55A, H74A, K77A, K100A, N114A and 
R128A ranging from 25% (H74A) to 59% (N114A). 
In combination with results from the large population screen, mutants E102A 
and unfolded Der p 2 consistently displayed reduced IgE binding and were therefore 
selected for further evaluation as hypoallergen vaccine candidates.  
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Table 7.1 Site directed mutants with <75% IgE binding compared to WT Der p 2 in 5 
selected dust mite allergic individuals. Mutants K96A and E102A are in bold, as they 
show reduced IgE binding in all 5 allergic individuals tested. Asterisks at mutant 
K96A indicate that this mutant is unfolded. 
 




ED L61A, K77A, K96A*, E102A, N114A
KE E25A, K55A, H74A, K77A, K96A*, K100A, E102A, N114A, R128A  
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 An inhibition ELISA was next used to investigate the lack of serum IgE 
reactivity to mutants E102A and unfolded Der p 2. Various concentrations of each 
mutant or WT Der p 2 (1x10-4 to 1x10-11 μg/μL) were incubated overnight with sera 
from allergic individuals before incubation with immobilized WT Der p 2. When WT 
Der p 2 was used to inhibit allergic individuals’ IgE binding to WT Der p 2, the 
amount of IgE inhibition observed increased with the concentration of the inhibitor, 
up to a maximum of 100% (Figure 7.2). In contrast, the maximum inhibition for 
mutant E102A was about 80% for HE and 40% for KE at the highest inhibitor 
concentration tested. The calculated IC50 (inhibitor concentration required to achieve 
50% inhibition) of mutant E102A was at least 4 folds higher compared to WT Der p 2 
in all allergic individuals tested (Table 7.2, Figure 7.2). For unfolded Der p 2, the 
amounts of IgE inhibition was very low for the range of inhibitor concentration tested. 
The IC50 values were at least 16 folds higher compared to WT Der p 2 (Table 7.3, 
Figure 7.3).  
 Mutant E102A showed higher IgE inhibition to WT Der p 2 compared to 
unfolded Der p 2. This could be a result of the presence of other IgE epitopes on Der 
p 2, as mutant E102A is only different by one amino acid, compared to WT Der p 2. 
In contrast, unfolded Der p 2 most likely lacks the conformational IgE epitope(s) due 
to the change in structure. 
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Table 7.2 Inhibition of IgE binding to immobilized WT Der p 2, by addition of 
mutant E102A. IC50 native refers to the concentration of Der p 2 that inhibits 50% of 
the IgE from binding to immobilized Der p 2. IC50 mutant refers to the concentration 
of mutant E102A that inhibits 50% of the IgE from binding to immobilized Der p 2. 
The fold difference between the concentrations of mutant and native protein to cause 
50% inhibition is calculated in ‘mutant/native’. 
 
Patient IC50 native IC50 mutant mutant/native
µg/mL µg/mL
OS 1.1E-03 1.1E-02 9.49
YV 3.2E-04 1.5E-03 4.59
ED 7.9E-03 4.6E-01 57.93
KE 4.5E-06 2.2E-01 48145.67

































Figure 7.2 Inhibition of IgE antibody binding from allergic individuals between WT 
Der p 2 and mutant E102A. Binding of human polyclonal IgE to Der p 2 was 
inhibited with Der p 2 (■ solid line) and E102A mutant (▲dashed line). 
Representative results from individuals HE and KE are shown. Mean and standard 
deviations of two experiments are shown. 
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Table 7.3 Inhibition of IgE binding to immobilized WT Der p 2, by addition of 
unfolded Der p 2. IC50 native refers to the concentration of Der p 2 that inhibits 50% 
of the IgE from binding to immobilized Der p 2. IC50 mutant refers to the 
concentration of mutant K96A (unfolded Der p 2) that inhibits 50% of the IgE from 
binding to immobilized Der p 2. The fold difference between the concentrations of 
mutant and native protein to cause 50% inhibition is calculated in ‘mutant/native’. 
 
Patient IC50 native IC50 mutant mutant/native
µg/mL µg/mL
OS 1.1E-03 1.9E-02 16.43
KE 4.5E-06 1.1E-01 23949.96
HE 1.7E-04 1.1E-01 664.88  
 






























Figure 7.3 Inhibition of IgE antibody binding from allergic individuals between WT 
Der p 2 and unfolded Der p 2. Binding of human polyclonal IgE to Der p 2 was 
inhibited with Der p 2 (■ solid line) and unfolded Der p 2 (▲dashed line). 
Representative results from individuals HE and KE are shown. Mean and standard 





 7.3 Skin Prick Test  
IgE binding alone is insufficient to mount an allergic reaction. A complete 
allergen should be able to bind and cross-link IgE on the FcεRI receptor on mast cells 
(Figure 1.1) (Valenta, 2002). Upon cross-linking, the mast cells degranulate, causing a 
rapid release of histamine, which causes a localized wheal and erythema reaction. 
Skin prick test is used in this study to measure in vivo histamine release when 
challenged with WT or mutant allergens. Fore arms of the allergic individuals were 
pricked in the presence of the allergen, and the resulting wheal formation was 
measured after 20 minutes. 
 All 5 allergic individuals showed strong skin prick response to WT Der p 2 
(Table 7.4). No wheal formation was observed when allergic individuals were pricked 
with mutants E102A or unfolded Der p 2 (Table 7.4). The absence of wheal formation 
suggests that mutant E102A and the unfolded Der p 2 were unable to cross-link IgE 
molecules in vivo to cause histamine release, as they lacked the IgE binding epitope. 
Wheal formation was also absent when the allergic individuals were pricked with 
hNPC2 or PBS (Table 7.4). Hence mutants E102A and unfolded Der p 2 showed no 
skin prick reactivity in all individuals, compared to WT Der p 2. 
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Table 7.4 Skin prick test for wild type Der p 2, mutant E102A or unfolded Der p 2. 
All 6 individuals showed positive results when skin pricked with 0.02 mg/mL of WT 
Der p 2, mutant E102A or unfolded Der p 2. One plus sign (+) denotes a positive 
reaction (wheal >3 mm) Negative sign (-) denotes negative reaction, with wheal 
diameter lesser or equal to 3 mm, PBS and hNPC2 were included as negative controls. 
Asterisks at mutant K96A indicate that this mutant is unfolded. 
 
 
Patients Der p 2 K96A* E102A hNPC2 PBS
HE + - - - -
OS + - - - -
KE + - - - -
YV + - - - -




7.4 Mouse IgG antibodies raised against mutant E102A and unfolded Der p 2 are 
able to block allergic individuals’ IgE binding to WT Der p 2 
One of the first indications of successful immunotherapy in humans is the 
increase in antigen specific IgG levels, which has been proposed to block the binding 
of IgE to the allergen, by competing with IgE (Valenta, 2002). To investigate the 
effectiveness of mutant E102A and unfolded Der p 2 as potential hypoallergens, 
specific IgG antibodies were raised in mice, in groups of 4, by immunization with WT 
Der p 2, mutant E102A or unfolded Der p 2. hNPC2 was included as a negative 
protein control, and PBS as a buffer control. Inhibition of human IgE binding to WT 
Der p 2 using specific mouse IgG antibodies was assessed using ELISA. 
Figure 7.4 shows the IgE inhibition by individual mouse IgG for WT Der p 2, 
mutant E102A, unfolded Der p 2, hNPC2 and control mice. Mouse IgG antibodies 
against WT Der p 2 showed almost complete inhibition of human IgE binding to Der 
p 2 at >90% inhibition. Similar inhibitory effect was also observed when IgG 
antibodies against mutant E102A were used to inhibit IgE binding to Der p 2, 
suggesting that mutant E102A is capable of generating blocking antibodies, which is a 
hallmark characteristic of a hypoallergen. Inhibition of mouse IgG antibodies raised 
against the unfolded Der p 2 ranged from 60 – 83%, and was only slightly lower than 
the homologous inhibition of WT Der p 2 (>90%). IgG antibodies from mice 
immunized against hNPC2 and PBS were not able to block binding of allergic 
individuals’ IgE to Der p 2. Similar results were observed for the other four 


















































































































































































































































































































































































































































































































Figure 7.4 Percentage of inhibition of human serum IgE binding to WT Der p 2 after 
preincubation with immunized mouse serum. Sera were obtained from separate 
groups of mice (4 mice per group, except for control mice group with 2 mice). Each 
group of mice was immunized with either wild type Der p 2 (WT), mutant E102A, 
unfolded Der p 2 (K96A*), control protein NPC2 or PBS buffer (Ctr). All 
experiments were performed in duplicates, and standard deviations of experiments are 
shown. Results of each individual are indicated with abbreviated names at the top of 
the graph. Asterisks at mutant K96A indicate that this mutant is unfolded. 
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7.5 T cell reactivity and cytokine profile 
T cell proliferation was used as a measure of the antigenicity of WT Der p 2, 
mutant E102A and unfolded Der p 2. Peripheral blood mononuclear cells (PBMCs) 
were isolated using Ficoll-Hypaque gradient centrifugation from fresh blood of 
allergic individuals. The PBMCs were next stimulated with 10 μg/mL of WT Der p 2, 
mutant E102A or unfolded Der p 2 for 6 days, and the amount of proliferation was 
measured using the BrdU colourimetric kit. The degree of T cell proliferation was 
calculated as stimulation index (SI), where the percent increase in proliferation was 
compared to PBS treated cells.  
For individuals HE and OS, proliferation of PBMCs stimulated with WT Der 
p 2, mutant E102A or unfolded Der p 2 were not significantly different. A 3 fold 
increase in SI was observed when PBMC of ED and YV were stimulated with 
unfolded Der p 2, compared to WT Der p 2 (Figure 7.5). SI for PBMCs stimulated 
with mutant E102A were similar or higher (up to 70% more for YV) compared to WT 
Der p 2 (Figure 7.5).  
To determine the subtype of T cells that proliferated when challenged with 
WT or mutants of Der p 2, the concentrations of IFN-γ (Th1 cytokine) and IL-13 (Th2 
cytokine) released into the supernatant were measured (Figure 7.6). PBMCs of 
individuals ED and YV demonstrated higher IFN-γ: IL-13 ratio when stimulated with 
the unfolded Der p 2, compared to WT Der p 2. No change in the IFN-γ: IL-13 ratio 
was observed for HE. There was an increase in IFN-γ: IL-13 ratio in individuals ED 
and YV when stimulated with mutants E102A or WT Der p 2.  
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Figure 7.5 PBMC proliferation induced by WT Der p 2, mutant E102A or unfolded 
Der p 2. PBMCs from allergic individuals who showed positive skin prick test to Der 
p 2 were stimulated with wild type (stripped bar), mutant E102A (empty bar) or 
mutant K96A (unfolded Der p 2) (checked bar). Proliferation was measured at day 6, 































Figure 7.6 Profile of cytokine secretion induced by WT Der p 2, mutant E102A or 
unfolded Der p 2. PBMCs (1X 105 cells/well) from individuals HE, ED and YV were 
stimulated with 10 μg/mL wild type (stripped bar), mutant E102A (empty bar) or 
unfolded Der p 2 (checkered bar). Cytokines IFN-γ and IL-13 were used as markers 
of Th1 and Th2 subtypes respectively. Results are presented as average and standard 
deviations from two independent experiments. 
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HE showed similar IFN-γ: IL-13 ratio for E102A and WT Der p 2. However, none of 
these differences were statistically significant (p<0.05). Therefore, a clear distinction 
of a particular T cell subtype (Th1 or Th2) when stimulated with WT Der p 2, mutant 




Der p 2 is regarded as an important allergen world wide, and it is therefore of 
scientific and clinical importance to understand its epitopes, and to evaluate the 
potential hypoallergen vaccine candidates for this protein. Conventional therapy for 
allergies such as the use of anti-cytokines, anti IgE or corticosteroids are only able to 
alleviate the symptoms experienced, but do not confer long term protection (Valenta, 
2002). Immunotherapy represents a form of curative treatment for allergies as it 
causes immune deviation or tolerance in a patient’s immune mechanism (Bousquet et 
al., 1998). Although natural allergens were initially used for immunotherapy, they 
could potentially cause anaphylactic shock in some patients due to the presence of 
their IgE-binding epitopes. T-cells have been shown to play an important role in the 
tolerance mechanism for immunotherapy (Akdis and Blaser, 1999). Therefore, to 
provide safer therapeutic reagents, immunotherapy molecules which lack the IgE 
epitopes (hypoallergens) but retained T-cell proliferation are generated (Akdis and 
Blaser, 1999).  
The potential hypoallergen vaccine candidates evaluated in this study, mutant 
E102A and unfolded Der p 2, showed reduced IgE binding and histamine release in 
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all patients when compared to WT Der p 2. Four of the five allergic individuals tested 
did not show reduced IgE binding to mutant E25A, although this mutant was earlier 
identified to be a common IgE epitope of Der p 2 (Chapter 6). This observation is 
likely due to the differences in IgE epitope specificities in the panel of the 5 allergic 
individuals selected. The presence of common IgE epitopes are not usually observed 
in other major allergens. A study of the IgE epitopes of Bet v 1, a major pollen 
allergen, using site directed mutagenesis showed that none of the single mutants 
generated demonstrated consistent reduction in IgE binding, rather, patient-specific 
IgE epitopes were identified (Holm et al., 2004), making the task of hypoallergen 
generation more challenging. In these cases, hypoallergen molecules with multiple 
mutations have to be generated, taking into account the variation of patient IgE 
specificity. 
The amount of IgE binding to unfolded Der p 2 was significantly lower than 
mutant E102A in all allergic individuals, which could be attributed to the loss of 
structure as determined by CD spectra. This further confirms the previous reports that 
the IgE epitopes of Der p 2 are conformational (Chua et al., 1991; van 't Hof et al., 
1991). Although mutation to residue E102 reduced its binding to IgE compared to WT 
Der p 2, the amount of IgE reaction detected in some allergic individuals (OS, ED and 
KE) were as high as 84% of the WT Der p 2 reaction. This suggests that there are 
multiple IgE epitopes in Der p 2, and residue E102 lies in one of the epitopes.  
The loss of IgE binding ability of mutant E102A and unfolded Der p 2 were 
validated using inhibition assays. Both mutants were unable to fully inhibit serum IgE 
of allergic individuals from binding to wild type allergen, indicating that the mutants 
lack the IgE epitope. The IC50 ratio of mutant:native was higher when unfolded Der p 
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2 was used as the inhibitor compared to mutant E102A, which supports the previous 
observation that other IgE binding epitopes on mutant E102A are present. Both 
mutants exhibited no skin prick reactivity in all 5 individuals tested, suggesting that 
they were not capable of cross linking specific IgE bound to mast or basophil cells. 
Production of allergen-specific IgG antibodies have been reported to be among 
the first signs of successful immunotherapy (Gleich et al., 1982; Djurup and 
Osterballe, 1984). There have been several proposed mechanisms by which allergen 
specific IgG play a role in immunotherapy. First, allergen specific IgG ‘block’ IgE 
from binding to the allergen by direct competition, resulting in the lack of IgE cross-
linking, reducing the release of mediators from mast cells and basophils (Dokic et al., 
1996). Alternatively, the IgG generated may interfere with the IgE-allergen complex 
which binds to the low affinity IgE receptor on antigen presenting cells, CD23, which 
facilitates the allergen presentation to T cells (van Neerven et al., 1999). Due to the 
non-reversible nature of immunoglobulin gene recombination, cells which already 
produce IgE antibodies will remain doing so, even after immunotherapy. Hence, no 
change in the amounts of IgE would be observed when pre- and post treatment levels 
are compared (Jacobsen et al., 1997). The increase in IgG production causes an 
increase in the IgG:IgE ratio, which then results in the immunological changes post-
immunotherapy. In pollen allergy, immunotherapy shows a seasonal rise in IgG, 
particularly IgG4 (Gabrielsson et al., 2001) while gradually attenuating the seasonal 
rise in IgE (Gleich et al., 1982).  
In this study, sera from mice immununized with E102A or unfolded Der p 2 
were able block human IgE binding to WT Der p 2 at similar levels, which was 
comparable to the homologous inhibition using WT Der p 2. In contrast, mouse IgG 
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antibodies raised against hNPC2 showed no inhibitory effect, and were comparable to 
sera obtained from control mice, although the amount of specific IgG antibodies 
against hNPC2 in all 4 mice were similar to the amount of IgG antibodies generated 
against WT and mutants of Der p 2. Since the mutants lack the IgE binding epitopes, 
this inhibition could be due to steric hindrance, and not direct competition in IgE 
binding. The production of blocking IgG antibodies have also been observed for other 
hypoallergen vaccine candidates such as Der f 13 (Chan et al., 2006) and Bet v 1 
(Holm et al., 2004).  
Although much emphasis has been placed on the production or expression 
levels of cytokines, which are characteristics of Th1 or Th2 cell subtypes in a culture 
following allergen stimulation, the results from various studies obtained so far have 
been conflicting. In this study, it was observed that although mutant E102A and 
unfolded Der p 2 were able to demonstrate IgG blocking properties, and retained T 
cell proliferation, but the shift in cytokine profile from Th2 to Th1 was absent. Similar 
findings were noted by Klimek et al. (1999) when birch pollen allergoid used for 
immunotherapy failed to change cytokine expression for IL-4, IL-5, IL-10 or IFN-γ in 
cell cultures but found expected increases in cytokines in nasal secretions on the 
immunotherapy patients. In a study of grass pollen immunotherapy, seasonal increase 
in the ratio of IFN-γ to IL-5 was found in the nasal mucosa, but not in the allergen-
stimulated T-cell cultures (Wachholz et al., 2002). Nevertheless, other studies have 
shown enhanced IFN-γ and reduced IL-4 production after allergen stimulation 
(Soderlund et al., 1997; Durham and Till, 1998). It is possible that the switch from 
Th2 to Th1 cytokines is only prominent in later stages of immunotherapy, but is less 
pronounced in a T cell culture, where the T cells were in contact with the allergen for 
a shorter period of time. 
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There are 2 possible methods of generating hypoallergens for allergens with 
conformational epitopes. First is to maintain the overall structure, but disrupt the IgE 
epitopes (as in the case of mutant E102A), and for this, prior knowledge of the IgE 
epitopes is necessary (Buhot et al., 2004; Chan et al., 2006). The second is to disrupt 
the overall structure, thus at the same time disrupting the secondary structures and 
abolishing IgE binding capacity (as in the case of alanine mutation to residue K96 
resulting in unfolded Der p 2). Previously, research on generating hypoallergens of 
Der p 2 was focused on disrupting its tertiary structure, by means of breaking the 
disulfide bonds which are important in structure stabilization. Mutation of C73R in 
Der p 2 caused a complete loss of 3D structure, leading to reduced IgE binding 
capacity. It was further demonstrated that this mutant was able to retain T cell 
proliferation, while showing lower skin test reactivity compared to WT Der p 2 
(Smith et al., 1998). Recently, there was a study done on an artificially unfolded Der f 
2 (Suzuki et al., 2006). This allergen was unfolded using several denaturating agents 
such as guanidine hydrochloride, urea and DTT. The unfolded Der f 2 protein showed 
a typical CD spectrum of an unstructured protein (minima wavelength ~200 nm). 
However, there was no difference in the amount of IgE binding observed between the 
unfolded and the correctly folded native Der f 2. Nevertheless, the unfolded Der f 2 
demonstrated its ability to maintain T cell proliferation (albeit much higher than WT 
Der f 2), and elicit Th2 to Th1 cytokine balance shift (Suzuki et al., 2006). In another 
study, mutation of residue 112 from serine to proline in a cherry allergen, Pru av I 
caused a disruption in the tertiary structure of the protein, leading to a complete loss 
in IgE reactivity (Neudecker et al., 2003). However, these studies did not demonstrate 
the ability of IgG antibodies generated against the mutants to block serum IgE binding 
to WT allergens. Site directed mutants with similar structures as the WT allergen have 
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also been shown to be effective hypoallergens in several studies (Swoboda et al., 
2002; Chan et al., 2006). Hence, both methods (retaining the overall protein structure 
or disruption of structure) can be used for the design of hypoallergens. 
In summary, of the two hypoallergen candidates evaluated, unfolded Der p 2 is 
a better candidate, as it exhibits no IgE binding or skin test reactivity. In addition, it 
was able to stimulate T cell proliferation, and IgG antibodies raised against unfolded 
Der p 2 were capable of inhibiting allergic individuals’ IgE binding to WT Der p 2. 
The ability of mutant E102A to bind to IgE in some individuals is of concern as this 
may result in allergic side effects in the event that this mutant was used as a 
hypoallergen vaccine.  
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Allergy is a complex disease, and it can manifest with varying degrees of 
symptoms which is associated with the severity of the disease. The causes of allergies 
are not well understood. Atopic individuals (having the genetic inheritance of 
allergies) and individuals who are exposed to high levels of allergens have higher 
changes of being allergic. Any protein is potentially allergenic as long as it is capable 
of 1) cross-linking IgE antibodies bound on mast cells and /or basophils and 2) 
stimulating T-cell proliferation by recognition of the T-cell epitope as a function of 
the MHC II receptor.  
The most common sources of allergens are from dust mites, pollen, food, 
venom, latex and domestic pets. Allergen avoidance is the best way to overcome 
allergies. However, avoidance of ubiquitous allergens, such as inhalant allergens 
(from dust mites or pollen) or venom allergens of bees or wasp, is almost impossible, 
and therefore, other means of treatments are needed to ease the symptoms of allergies. 
 Current therapy for allergies range from the use of corticosteroids and anti-
histamines to humanized anti-IgE and anti-cytokine antibodies. However, these 
medications can only treat the symptoms but cannot prevent allergies from occurring. 
Immunotherapy is now a widely studied area and is of great interest because it 
represents a curative form of treatment for allergies. Based on prior research, 
immunotherapy with crude allergen extracts have shown protection against allergy, 
and can be effective up to 3 years after the discontinuation of therapy. However, there 
are some drawbacks and risks associated with conventional immunotherapy using 
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natural allergen extracts. Crude allergen extracts from natural sources are subject to 
variability in composition, concentration and stability. Most importantly, the use of 
crude allergen extracts risks eliciting allergic reactions due to the presence of intact 
IgE epitopes in the natural extract preparations. To overcome this, research has been 
focused on generating hypoallergens; recombinant allergens with reduced IgE 
reactivity, which are easily standardized, to replace natural extracts for 
immunotherapy vaccination. 
 Group 2 allergens from dust mites cause allergies in >60% of the dust mite 
sensitized individuals, and therefore are classified as major allergens. This thesis 
focuses on the study of group 2 allergens, from the characterization of IgE reactivity 
to a panel of group 2 allergens, IgE epitope mapping of Der p 2, and evaluation of 
hypoallergen vaccine candidates of Der p 2. In addition, a new allergen, Der f 22 
which is homologous to group 2 allergens was characterized, and the ligand of Der p 
2 was identified. 
The isolation and characterization of three new allergens, Blo t 2, Sui m 2 and 
Ale o 2 reported in this study expands the current panel of known group 2 allergens. 
Blo t 2, Sui m 2 and Ale o 2 share the general characteristics of group 2 allergens, 
such as the presence of a signal peptide resulting in a mature protein ~15kDa 
containing 6 cystein residues that form 3 disulfide bonds and a β-sheeted secondary 
structure. 
 The IgE reactivity of a panel of eight group 2 allergens was next investigated 
using sera from Singaporean and Italian populations. The predominant mite fauna in 
Singapore and Italy are different; in Singapore, the predominant mite species are 
Blomia tropicalis and Dermatophagoides spp. while in Italy, Dermatophagoides spp. 
is the predominant mite species. The majority of the allergic individuals (70-80%) 
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from both locations demonstrated IgE binding to Der p 2 followed by Der f 2. Only 
30-40% of the dust mite allergic individuals studied reacted to group 2 allergens from 
the non-pyroglyphid mites. In both populations, the IgE reaction within the group 2 
allergens from the pyroglyphid mites and non-pyroglyphid mites were highly cross 
reactive. The majority of the dust mite allergic individuals who showed IgE reactivity 
to Blo t 2 and Der p 2 had higher IgE reactions to Der p 2, suggesting that the 
majority of these individuals show no or low cross reactivity to Blo t 2. In individuals 
with high IgE reactions to Blo t 2 and Der p 2, moderate to high cross reactivity was 
observed among Singaporean individuals, while high cross reactivity was observed 
among Italian individuals. The high levels of B. tropicalis in Singapore could have 
elicited the production of specific IgE antibodies against Blo t 2, which is not cross 
reactive to Der p 2, in agreement with the moderate cross reactivity observed. In 
contrast, as B. tropicalis was absent in Italy, any IgE reaction to Blo t 2 was likely due 
to cross reaction with Der p 2.   
 A clone showing homology to group 2 allergens from the D. farinae EST 
library was isolated and characterized. This clone was named Der f 22 as it had low 
amino acid sequence identity to Der f 2 (32%). About 50% of the dust mite positive 
individuals tested showed IgE reactivity to both Der f 2 and Der f 22, but Der f 22 
showed no IgE cross reactivity with Der f 2. There was no direct correlation between 
the amount of allergen present in the environmental dust samples and the amount of 
IgE binding. The concentrations of Der f 22 and Blo t 2 were found to be at least 6 
times higher than that of Der f 2, but this was not reflective in the levels of IgE 
binding observed to these allergens. It appears that it is only important for the allergen 
to be present above the threshold concentration of 2μg/g dust for sensitization to occur, 
as high concentrations of allergens do not seem to influence the extent of allergenicity. 
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Although Der f 22 possibly lacks one disulfide bond and shows a different 
secondary structure compared to Der f 2, both allergens bound to cholesterol with 
similar intensity, and stained the gut region of D. farinae mites indicating that they 
were functionally similar. Based on these observations, it was proposed that Der f 22 
and Der f 2 could be paralogous genes, genes that underwent duplication due to 
evolutionary pressure. Indeed, it was found that Der f 22 and Der f 2 originated from 
two separate genes located on the dust mite genome. The various group 2 allergens 
were next aligned with Der f 22 and other homologous sequences obtained from EST 
libraries prepared in the laboratory. The phylogenetic tree obtained from the multiple 
alignments suggest that Der f 22 is a likely paralogue of Der f 2, as both clones were 
clustered in the same clade, along with other allergens from the same mite family 
(Pyroglyphidae). In addition, it was observed that group 2 allergens (and its 
homologues) from the Acaridae family formed 3 separate clades indicating the 
possibility of gene duplication prior to speciation in addition to post-speciation gene 
duplication. Although these results are preliminary, it opens a new avenue in the 
research of allergens, as it is evident that paralogy in group 2 allergens is wide spread 
across the mite species. 
In this study, the first direct experimental evidence of lipid binding to Der p 2 
is provided. Structural analysis of Der p 2 and its close homologues indicate a 
hydrophobic cavity with a potential for lipid binding. Using biochemical assays, it has 
been shown that Der p 2 (recombinant and native) binds preferentially to cholesterol 
among structurally similar sterols and other lipids, including glycerolipids, 
glycerophospholipids and sphingiolipids. Cholesterol was also identified from lipid 
extracts obtained from native and recombinant Der p 2, suggesting that it is innately 
bound to the allergen. Site directed mutagenesis of selected amino acid residues lining 
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the cavity of Der p 2 was used to investigate their role on cholesterol binding. Two 
alanine mutants of Der p 2, V104A and V16A showed decreased and increased 
cholesterol binding respectively, when compared to wild type Der p 2. In silico 
docking studies showed multiple binding orientations of cholesterol within the cavity 
of Der p 2, suggesting promiscuity in lipid recognition.  
Research on allergens is now focused on understanding the IgE binding 
epitopes to generate hypoallergen vaccines for immunotherapy. Although some 
studies have been done on the conformational epitope mapping of Der p 2, the results 
obtained were variable, probably attributed to the small numbers of sera evaluated. 
Another possible reason of discrepancy in results could be due to the method of 
identifying the IgE epitopes, by inhibition of human IgE binding using monoclonal 
murine IgG. To overcome this, direct IgE binding to alanine mutants of Der p 2 were 
evaluated using sera of dust mite allergic individuals from two populations, 
Singaporean and Italian, representing exposure to different predominant mite fauna. 
Generally, it was observed that individuals who reacted to more allergens 
(polysensitized) displayed reduced IgE binding to fewer site directed mutants. For 
instance, individuals reacting to Der f 2 (but not Blo t 2 or hNPC2) showed reduced 
IgE binding to 13 mutants, whereas individuals reacting to Der p 2, Blo t 2 and 
hNPC2 only showed reduction in IgE binding to 5 mutants compared to wild type Der 
p 2. However, there was one exception as individuals having IgE binding to Der p 2 
and Blo t 2 (but not hNPC2) had IgE reaction to 20 of the 21 mutants tested. 
Three mutants, E25A, E102A and unfolded Der p 2 displayed reduction in IgE 
binding in all the 201 serum samples tested from both populations, indicating that 
these residues were common IgE epitopes. These mutants (E25A, E102A and 
unfolded Der p 2) were next tested for their efficacy as hypoallergen vaccine 
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candidates using sera from five allergic individuals who were previously tested to 
have IgE binding and positive skin prick reactivity to Der p 2. Only 2 of the 3 mutants 
previously short listed showed reduced IgE binding in all 5 individuals tested– E102A 
and unfolded Der p 2. In addition, both mutants showed no in vivo histamine release 
in all individuals. The production of allergen specific IgG to block IgE binding and 
cross-linking of is one of the first signs of successful immunotherapy. IgG antibodies 
raised against mutants E102A and unfolded Der p 2 were able to almost completely 
inhibit allergic individuals’ IgE binding to wild type Der p 2. Mutant E102A and 
unfolded Der p 2 retained their capacity to proliferate T cells isolated from the allergic 
individuals, which is a critical feature of hypoallergen candidates as T-cells are 
central to the immunotherapy mechanisms. The two mutants evaluated in this study 
represent 2 methods of generating vaccine candidates for immunotherapy, as one was 
an unfolded protein, while mutant E102A retained similar secondary structure as wild 
type Der p 2. Disruption of overall protein structure would allow researchers to 
bypass the need to map the IgE epitopes of a protein, expediting the generation of 
hypoallergens.  
 
8.2 Future directions 
  
 Two key features of a hypoallergen vaccine, safety and effectiveness needs to 
be further evaluated in vivo. To this end, mutants E102A and unfolded Der p 2 need to 
be first evaluated in pre-clinical trials using murine models. Pre-clinical trials using 
murine models can be designed to answer two questions: 1) is the hypoallergen able 
to reduce allergic symptoms in patients having allergies (therapeutic) and 2) can 
hypoallergens be used to prevent an individual from getting allergies (prophylactic). 
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Apart from evaluating the outcome measures of successful immunotherapy such as 
the ability of a hypoallergen to elicit reduced mediator release, blocking IgG 
antibodies, maintain T cell proliferation, and change the cytokine milieu from Th2 to 
Th1, the effects of the route of hypoallergen administration should be evaluated.  
The most studied route of immunotherapy is by subcutaneous injections. As a 
routine immunotherapy regime may take up to a few years to complete, non-invasive 
and less painful methods such as application of allergens via the mucosal surfaces 
(sub-lingual) could increase patient’s compliance, and therefore success rates of 
immunotherapy. Moreover, it has been demonstrated in animal models that mucosal 
tolerance is very effective in preventing allergic disease (Wiedermann et al., 1999; 
Jarnicki et al., 2001; Wiedermann et al., 2001).  
 Hypoallergen vaccine candidates that prove to be effective in the preclinical 
trials should then be introduced in human trials. This phase is very important to as it 
allows the evaluation of improvements of symptoms, and any potential immediate 
side effects and late phase reactions in human subjects.  
 The application of specific immunotherapy is one of the most effective 
treatments for allergies in monosensitized and young patients. Increased research on 
various purified allergens indicates that many allergic individuals have multiple 
sensitivities, i.e. they show IgE reactivity to immunologically unrelated allergens. In 
these patients, the efficacy of specific immunotherapy is low and may be associated 
with increased risk of side effects (Bousquet et al., 1998; Bousquet et al., 2001). In 
view of this, new treatment strategies need to be developed for this patient group. One 
of the improvements could be by administering a tailor-made immunotherapy cocktail 
designed based on the individual patient’s sensitization profile. Recently, there has 
been some research done on the production of hybrid allergens that consist of several 
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major allergens. This area of research is still young, and evaluation of the safety of 
these molecules needs to be thoroughly investigated. 
In this thesis, the identification and characterization of Der f 22 has been 
reported. Der f 22 is hypothesized to be a putative paralogue of Der f 2 as it shows 
similar functions, but low sequence identity. Der f 22 is a major allergen as 
approximately 50% of the dust mite allergic individuals tested showed IgE reactivity 
to this allergen. The identification of putative allergen paralogues in other dust mite 
species, based on sequences obtained from the EST database with homology to group 
2 allergens sparks several important issues. 1) Are the other putative paralogue 
allergens major allergens? 2) Do the other paralogue allergens share similar functions 
as group 2 allergens? 3) If indeed the paralogue allergens are major allergens, and do 
not cross react with the respective group 2 allergens, it would be necessary to include 
them in the diagnostic panel, and generate hypoallergens of the paralogues to treat 
allergic individuals. 
 Cholesterol was identified as the natural lipid ligand of Der p 2. Nevertheless, 
the role of cholesterol in allergy is not known. Could cholesterol contribute to the 
high allergenicity of Der p 2? The role of cholesterol in allergenicity (IgE binding and 
histamine release) can be tested using an apo-Der p 2 (prepared by either using 
delipidation columns or by multiple site directed mutagenesis of Der p 2) in skin prick 
tests or specific IgE binding ELISA. Group 1 dust mite allergens are cystein 
proteases. Recently, it was identified that the allergenicity of Der p 1 (group 1 
allergen from Dermatophagoides pteronyssinus) is enhanced due its cystein protease 
activity, which cleaves the tight juctions of the mucosal epithelial cells, thus allowing 
the entry of Der p 1 into the mucosal surface (Wan et al., 1999; Baker et al., 2003). 
Similarly, could cholesterol mediate the entry of Der p 2 (or other group 2 allergens) 
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into the mucosal surfaces by cholesterol transfer, as bodily fluids and plasma 
membranes of cells are rich with cholesterol? These are exciting and important 
questions to answer for a deeper understanding of the role of cholesterol as a ligand of 
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List of primers 
 
A. Primers for the amplification of group 2 allergens 













B. Primers for alanine mutants of Der p 2 
 
 
R128A_F: 5'-TGCTACTCATGCTAAAATCGCCGATTAAGAATTCGAGCTCC-3' 78.2°C 












H22A_F: 5'-AAAGTTTTGGTACCAGGATGCGCCGGTTCAGAACCATGTATCATT-3' 78.1°C 













K77A_F: 5'-TCCAAATGCATGCCATTATATGGCCTGTCCATTGGTTAAAGGACAAC-3' 78.2°C 
K77A_R: 5'-GTTGTCCTTTAACCAATGGACAGGCCATATAATGGCATGCATTTGGA-3' 78.2°C 
 
L61A_F: 5'-AATCAAAGCTTCAATCGATGGTGCCGAAGTTGATGTTCCCGGTAT-3' 78.1°C 
L61A_R: 5'-ATACCGGGAACATCAACTTCGGCACCATCGATTGAAGCTTTGATT-3' 78.1°C 
 
E25A_F: 5'-CAGGATGCCATGGTTCAGCC ATGTATCATTCATCGTG-3' 80.1°C CC












K6A_F: 5'-CGCCACCACCACTGAGAGCCGATTGTGCCAATCATGAAATC-3' 79.7°C 
K6A_R: 5'-GATTTCATGATTGGCACAATCGGCTCTCAGTGGTGGTGGCG-3' 79.7°C 
 
H30A_F: 5'-GGTTCAGAACCATGTATCATTGCCCGTGGTAAACCATTCCAATTG-3' 78.1°C 












K100A_F: 5'-GAATGTTCCAAAAATTGCACCAGCCTCTGAAAATGTTGTCGTCACTG-3' 78.2°C 





K15A_F: 5'-GTGCCAATCATGAAATCAAAGCAGTTTTGGTACCAGGATGC-3' 78.2°C  













E102A_F: 5'-TCCAAAAATTGCACCAAAATCTGCCAATGTTGTCGTCACTGTTAAAG-3' 78.6°C 
E102A_R: 5'-CTTTAACAGTGACGACAACATTGGCAGATTTTGGTGCAATTTTTGGA-3' 78.6°C  
 
E62A_F: 5'-AAGCTTCAATCGATGGTTTAGCCGTTGATGTTCCCGGTATC-3' 79.2°C 
E62A_R: 5'-GATACCGGGAACATCAACGGCTAAACCATCGATTGAAGCTT-3' 79.2°C 
 
V110A_F: 5'-AAATGTTGTCGTCACTGTTAAAGCAATGGGTGATAATGGTGTTTTGG-3' 78.6°C  
V110A_R: 5'-CCAAAACACCATTATCACCCATTGCTTTAACAGTGACGACAACATTT-3' 78.6°C 
 
V108A_F: 5'-ATCTGAAAATGTTGTCGTCACTGCAAAAGTTATGGGTGATAATGGTG-3' 78.6°C  

















V16A_F: 5'-GTGCCAATCATGAAATCAAAAAAGCATTGGTACCAGGATGCCATG-3' 79.4°C  
V16A_R: 5'-CATGGCATCCTGGTACCAATGCTTTTTTGATTTCATGATTGGCAC-3' 79.4°C 
 
Y90A_F: 5'-GGTTAAAGGACAACAATATGATATTAAAGCAACATGGAATGTTCCAAAAATTGCACC-




L37A_F: 5'-TCATCGTGGTAAACCATTCCAAGCAGAAGCTTTATTCGAAGCCAATC-3' 78.2°C  
L37A_R: 5'-GATTGGCTTCGAATAAAGCTTCTGCTTGGAATGGTTTACCACGATGA-3' 78.2°C 
 
V18A_F: 5'-CATGAAATCAAAAAAGTTTTGGCACCAGGATGCCATGGTTC-3' 79.6°C  
V18A_R: 5'-GAACCATGGCATCCTGGTGCCAAAACTTTTTTGATTTCATG-3' 79.6°C 
 
W92A_F: 5'-AGGACAACAATATGATATTAAATATACAGCGAATGTTCCAAAAATTGCACCAAAATC-























Supplementary Figure 1 Microtome-cut D. farinae sections probed with pre-
immune sera of rabbits which were later immunized with (A) Der f 2 and (B) Der f 22. 
Sections were viewed using light microscope with 200X magnification.  
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